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SUMMARY 
 Amputation is a life-changing event that results in a severe reduction in quality of 
life. In addition to the loss of a limb, there is drastic loss of function and severe mental, 
emotional and physical pain. In order to mitigate these negative outcomes, there is great 
interest in the design of ‘advanced’ prosthetics that cosmetically and functionally mimic 
the lost limb. While, the robotics side of advanced prosthetics has seen substantial 
progress recently, they still provide only a fraction of the natural limbs’ functionality. At 
the heart of the issue is the interface between the robotic limb and the individual that 
needs significant development. Amputees retain significant function in their nerves post-
amputation, which offers a unique opportunity to interface with the peripheral nerve.  
 Here we evaluate a relatively new approach to peripheral nerve interfacing by 
using microchannels which hold the intrinsic ability to record larger neural signals from 
nerves than previously developed peripheral nerve interfaces. We first demonstrate that 
microchannel scaffolds are well suited for chronic integration with amputated nerves and 
promote highly organized nerve regeneration. We then demonstrate the ability to record 
neural signals, specifically single unit action potentials, using microchannels permanently 
integrated with electrodes after chronic implantation in a terminal study. Together these 
studies suggest that microchannels are well suited for chronic implantation and stable 
peripheral nerve interfacing.  
 As a next step toward clinical translation, we developed fully-integrated high 
electrode count microchannel interfacing technology capable of functioning while 
implanted in awake and freely moving animal models as needed for pre-clinical 
evaluation. Importantly, fabrication techniques were developed that apply to a broad 
range of flexible devices/sensors benefiting from flexible interconnects, surface mount 
device (SMD) integration, and/or operation in aqueous environments. Examples include 
glucose sensors for diabetes, flexible skin based health monitors, and the burgeoning
         xviii 
flexible wearable technology industry. Finally we successfully utilized the fully-
integrated microchannel interfaces to record action potentials in the challenging awake 
and freely moving animal model validating the microchannel approach for peripheral 
nerve interfacing. In the end, the findings of these studies help direct and give significant 
credence to future technology development enabling eventual clinical application of 
microchannels for peripheral nerve interfacing. 
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CHAPTER 1  INTRODUCTION  
 Currently, neural prosthetics provide only a small fraction of the functionality of a 
natural limb. However, compelling evidence in the last decade that amputees retain 
significant motor and sensory function in the peripheral nerve stump has paved the way 
for bidirectional sensorimotor prosthetics to restore function following amputation [1]. A 
bidirectional sensorimotor prosthetic aims to record volitional motor commands from 
peripheral nerves to control a robotic limb, while sensors on the device produce direct 
stimulation of peripheral nerves to deliver feedback. Advances in robotics have led to 
high dimensionality robotic limbs, but the peripheral nerve interface remains the “weak-
link” due to issues with reliability and engaging sufficient numbers of independent and 
specific channels of communication with the peripheral nerve. To realize the dream of a 
fully functional interface for amputees, it is imperative that engineered systems interface 
with the periphery in a highly specific and reliable manner to deliver and receive 
information that is relevant for natural sensation and movement. 
 State of the art prosthetics often use electromyograms from various sets of 
muscles. However, this method provides limited prosthetic control and does not allow for 
proprioception, tactile feedback, and other sensation. Next generation peripheral nerve 
prosthetics aim to interface with the original limb’s remaining nervous system by taking 
advantage of the retained motor and sensory function. Even here, peripheral nerve 
interfacing attempts have faced significant challenges stemming from a tradeoff between 
interfacing specifically with individual axons within a nerve and long-term reliability 
with the nerve.  The widely used cuff electrodes, which wrap around the nerve, provide 
long-term stability at the physical tissue-device interface at the expense of stimulation 
and recording specificity because of poor proximity to central portions of the nerve [2,3].  
A device that penetrates into the nerve, like the Utah Slanted Electrode Array (USEA), 
provides enhanced specificity over its large number of needle-like electrodes. However, 
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the penetration causes multiple injuries and as a result the device remains susceptible to a 
buildup of scar tissue and an immune response limiting chronic efficacy [4]. On the other 
hand, regenerative devices have the capability to circumvent the tradeoff between 
specificity and reliability by allowing axons to regenerate through specific geometries in 
close contact with electrodes. Unfortunately the Sieve electrode, the hallmark 
regenerative device, by design only supports axon regeneration over a small distance on 
the order of hundreds of microns [5]. As a result, many electrodes are rendered useless 
when they are far from a node of Ranvier, the point at which the signal of an axon is 
largest. This is in fact a fate suffered by all existing electrode technologies.  
 Our long-term goal is to create a novel regenerative neural interface to establish 
high-channel, bi-directional communication between an amputated nerve and a prosthetic 
limb. This interface would allow for intimate contact between electrodes and small 
groups of axons. The objective of this thesis was to evaluate the use of microchannels for 
chronic peripheral nerve interfacing and develop a fully integrated high electrode count 
microchannel interface, the Georgie Tech. Regenerative Electrode (GT-RE), able to 
perform in this application. The rationale behind the microchannel design was based 
upon the fact that confining an axon to a microchannel limits the volume of low 
impedance extracellular fluid surrounding the axon. Limiting the extracellular volume 
effectively increases the extracellular resistance and following from Ohm’s Law, 
increases the extracellular potential [6]. Other interfacing approaches are forced to endure 
the low impedance of the surrounding volume. Furthermore, other interfaces are spatially 
dependent on the nodes of Ranvier, which are breaks in axon insulation where the 
extracellular potential is largest. Using a 3mm microchannel ensures that a node falls 
within the channel as they occur at least every 2mm [7]. This allows the incorporated 
electrodes to be spatially independent of the nodes of Ranvier. Finally, encouraging the 
axons to regenerate in small numbers through numerous microchannels allows for highly 
selective recording and stimulation based upon electrical and spatial isolation.  
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The long term goal and objective were achieved through the following 3 aims. 
 




 The underlying success of a regenerative microchannel device for neural 
interfacing is fundamentally contingent on long term tolerance by the peripheral nervous 
system in amputees. Thus, the neural implant is inherently dependant on the chronic 
condition of the matured nerve post regeneration when original reinnervation targets are 
no longer present due to amputation. Accordingly, we first developed microchannel 
scaffolding composed of polydimethylsiloxane (PDMS) and the polymer SU-8 to enable 
this investigation. We evaluated cytocompatibility using an in vitro culture system and 
then focused in vivo on the amputated nerve lacking distal reinnvervation targets and its 
capability to regenerate through an artificially imposed microchannel obstacle. The nerve 
was characterized morphologically as a whole and on a cellular level. Growth was 
characterized both within the microchannels and distal to the microchannels to evaluate 
regenerative capability, chronic stability, and the risk of neuropathic complications. 
Finally, we evaluated whether neural signals from regenerated axons can be recorded 
using microchannels permanently integrated with electrodes after chronic implantation in 
a separate terminal study. The outcomes of this aim are discussed in Chapter 3.  




 Srinivasan, A., et al., Microchannel-based regenerative scaffold for chronic peripheral nerve interfacing 
in amputees. Biomaterials, 2015. 41: p. 151-65 
2
 Srinivasan A., et al., Regenerative microchannel electrode array for peripheral nerve interfacing. 5th Int. 
IEEE/EMBS Conf. Neural Eng, 2011. p. 253–6 
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Specific Aim 2: Fabrication Processes for Flexible Electrode Arrays, SMT 
Integration, and Implantation. 
 In order for microchannel interfacing to be clinically translated, full integrated 
microchannel interfacing technology must first be developed. This includes the 
incorporation of large count microelectrode arrays (MEA), the ability to easily integrate 
surface mount technology (SMT) for multiplexing and amplification, and be capable of 
functioning while implanted in awake and freely moving animal models for pre-clinical 
evaluation. Along these lines, we designed fabrication techniques for flexible (Parylene 
C) and elastomeric (PDMS) based MEAs with large numbers of high-density 
microelectrodes generating two different GT-RE’s differing only in substrate material. 
Second, we devised and validated a simple and broadly applicable SMT integration 
strategy for flexible and elastomeric devices. Third we utilized flexible and elastomeric 
polymer based hermetic insulation and encapsulation strategies for the GT-RE’s enabling 
implantation and electrophysiology in awake and freely moving rats. These design and 
fabrication techniques, while enabling peripheral nerve interfacing with microchannels, 
are applicable to a broad range of flexible devices and sensors benefiting from stretchable 
and/or flexible interconnects, SMD integration, and/or operation in hostile aqueous 
environments. The outcomes of these fabrication techniques are discussed in Chapter 4. 
 
Specific Aim 3: Evaluating the fully integrated high electrode count microchannel 
interface for clinically translatable peripheral nerve interfacing.  
 We then evaluated the capability of the fully integrated GT-RE microchannel 
interfaces to be used for challenging single unit action potential recordings. First, in vitro 
functionality of the GT-RE’s was explored using artificial neural signals. Secondly, in 
vitro dorsal root ganglia (DRG) studies were utilized to assess cytocompatibility after 
microfabrication of the GT-RE’s which involved a number of toxic processes. Finally, in 
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vivo the GT-RE’s were implanted in the rat sciatic nerve transection model. In vivo 
recordings were performed while the rats were awake and ambulating to evaluate the 
capability to record single unit action potentials through microchannel interfaces in a 
clinical relevant experimental model. The outcomes of these evaluations studies are 
discussed in Chapter 5. 
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CHAPTER 2  LITERATURE REVIEW 
2.1 Introduction 
2.1.1 Amputation Occurrence and Prevalence 
 In general it is difficult to find up to date information regarding amputations with 
just a couple studies reviewing the occurrence and prevalence in the US over the last 20+ 
years and the most recent being in 2005. In the 2005, 1.6 million persons were living with 
a limb amputation (one in 190 Americans) and it has been projected that by 2050 this 
number will more than double to 3.6 million in the United States alone [8]. Amputations 
are performed for a number of reasons, but the majority stem from diabetic and 
dysvascular diseases, trauma, and cancer related operations. In 2005 amputations 
stemming from individuals suffering from dysvascular disease accounted for 54% of the 
total with two thirds of these individuals also suffering from diabetes. Amputation due to 
trauma accounted for 45% and cancer for less than 2%. The majority of amputations, 
approximately 65%, were of the lower extremity with over half of these being major 
amputations and excludes toes. Only 8% of upper limb amputations were categorized as 
major, excluding fingers, in comparison. [8] The larger number of lower limb 
amputations follows naturally from the fact that a study found in 2008 diabetes was the 
leading cause of non-traumatic lower limb amputations with rates approximately eight 
times higher than with the non-diabetic population [9]. Another study reported that the 
diabetic population accounted for more than 60% of lower limb amputations in 2011 
[10].  
 Regarding the age demographics of amputees, in 2005 it was shown that the rate 
of amputations dramatically increased with age where 42% of all amputees and 57% of 
the incident cases were in adults 65 years or older. A contributing factor to this age 
demographic was the large tendency, 64%, of amputations occurring in individuals 
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suffering from dysvascular disease to also be 65 years or older. That being said, in 2005 
there were approximately 1 million amputees below the age of 65 and 302,000 below the 
age of 45. Furthermore, over two thirds of trauma related amputations occurred in 
individuals below the age of 45. [8] In many cases, it is these individuals that stand to 
benefit the most from new advances in prosthetic technology as it will enable them to 
maintain a higher quality of life for their longer life expectancy. 
2.1.2 Amputation and the Clinical Need 
 Amputation is a life-changing event that results in a severe reduction in quality of 
life. In addition to the loss of a limb, there is a drastic loss of function and mobility and 
also severe mental, emotional and physical pain. The lifestyle change and emotional 
challenges extend to the individual’s loved ones as well. The extra care needed can also 
drastically increase costs of living. Finally, family income and society suffer if the 
amputee is unable to return to work and maintain a job. 
 In order to mitigate these negative outcomes after amputation, there is great 
interest in the design of ‘advanced’ or ‘robotic’ prosthetics that cosmetically and 
functionally mimic the lost appendages. Amputees want a prosthetic that returns them to 
their previous level of function and looks like their lost limb. In essence, these are robotic 
prosthetic limbs that need to be controlled and operated according to a person’s will or 
thought as a normal arm or leg would be.  Furthermore, the robotic prosthetic needs to 
provide sensation such as hot or cold, rough or smooth, hard or soft back to the individual 
so that he or she is able to feel through the prosthetic.  
 The robotics side of advanced prosthetics has seen many advances in the recent 
decade with lifelike limbs that can be programmed to perform intricate motions. They 
also have various integrated sensors providing data of the environment to onboard chips 
or computers. Examples include the ‘Otto Bock C-leg’ and the ‘i-limb Robotic Hand’. 
However, these advanced prosthetics still only provide a small fraction of the 
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functionality of a natural limb. It is the ability to understand an individual’s intended 
action and translate that to prosthetic movement that lags behind. Furthermore, these 
advanced prosthetics while having numerous integrated sensors for the environment do 
not send this information back to the individual in a seamless fashion and instead stop at 
the onboard chip for processing. Essentially it is the interface between the robotic limb 
and the individual that needs significant development to enable large scale clinical 
translation and market adoption of advanced robotic prosthetics. 
 The body’s nervous system offers a unique opportunity to establish this interface 
between the robotic limb and the individual. The nervous system is not only responsible 
for generating signals resulting in limb movements, but also conveys sensation from the 
environment to the individual. Tapping into the nervous system could allow a seamless 
integration with robotic limbs enabling movement of the limbs based on thought and 
sensation through the limb. Based on these ideas there have been ongoing efforts to 
develop ‘neural interfacing’ technology.  
 Broadly speaking, neural interfacing technologies can be divided into two major 
segments based on location of interaction with the body’s nervous system. There are 
central neural interfaces consisting of the brain and spine and peripheral neural interfaces 
consisting of nerves predominantly in the limbs. There have been a number of approaches 
within both of these areas, but all have met with significant difficulties and limitations. 
Central neural interfaces are plagued by the invasiveness of needing to implant electrodes 
directly in the brain and the fact that this will cause another injury in addition to the 
amputation of the limb. Furthermore, even after the implantation and recording of neural 
signals a huge obstacle of decoding these ‘abstract’ signals remains. Peripheral neural 
interfaces are significantly less invasive as they are implanted in peripheral nerves and 
can be implanted at the time of amputation. Another large advantage peripheral neural 
interfaces have is that the signals obtained from peripheral nerves, closely represents the 
signal intended for muscle activation. The decoding has been taken care of by the 
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descending pathways of the brain and spinal cord, obviating the need for artificial 
decoding. 
2.2 Peripheral Nerve 
2.2.1 Physiology 
 The peripheral nerve, in its physiological structure, is similar in some sense to a 
multi-wire electrical cable. A nerve can be thought of simplistically as a ‘cable’ 
comprised of many thousands of wires, termed axons. These axons are processes 
(extensions) of cells whose cell bodies reside in or just outside the spinal cord or at the 
base of the brain. The axons are the entities within a nerve that conduct motor (muscle) 
and sensory information to and from the brain and the body’s periphery. The 
‘information’ that is conducted by the axon is termed an action potential (AP) and is an 
electrochemical event that propagates down the length of the axon to its end target. The 
electrochemical event is a local change in ion concentrations inside and outside the axon 
which creates a local voltage change across the axons’ cellular membrane. As a result of 
the voltage change of an AP, it is possible to measure or record the occurrence and 
magnitude of the AP signal. The magnitude of these APs however is on the order of 
microvolts making this an exceedingly challenging endeavor. This is especially true when 
considering an in vivo environment where much of the noise, motion artifact and 
electrical signals from local muscles are orders of magnitude larger.  
 Another similarity axons have with wires in an electrical cable is the presence of 
insulation. This insulation is biological in nature stemming from cells of a glial origin 
termed Schwann cells. These Schwann cells wrap themselves around the axons in 
numerous layers and produce a protein (myelin) ensheathment which makes up the 
insulation surrounding the axons. In addition to providing insulation, Schwann cells play 
an important role in providing nutrients and maintaining the health and stability of the 
axon [11]. However, one important difference between the insulation of a wire and that of 
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an axon is that the Schwann cell and myelin sheath is not continuous down the length of 
an axon. Instead the Schwann cell and myelin sheath extend at most 2mm before a small 
gap in insulation appears and another Schwann cell insulates the following portion of the 
axon. [7] The gaps between the Scwhann cells and myelin insulation are on the order of 1 
micron and are known as the ‘nodes of Ranvier’. Owing to the lack of insulation in these 
nodes, they are also the regions of an axon where the AP magnitude is largest. The 
insulation, while making the measurable AP magnitude small except at the nodes of 
Ranvier, help the APs propagate faster from its source to its destination through a process 
known as ‘saltatory conduction’. In salutatory conduction, the AP is able to essentially 
hop from node to node down the length of the axon increasing the AP conduction speed 
and reducing the time for information to travel from the brain to the periphery and vice 
versa. 
 Another important cell known as a fibroblast resides within the connective tissue 
throughout the nerve. The fibroblast is predominantly responsible for producing and 
maintaining the extracellular matrix and support tissue of the nerve which is largely 
composed of laminin and collagen. The fibroblasts within a nerve are typically found in 
concentric rings or layers denoting different tissues of the nerve.  
 There are three major tissues known as the epineurium, perineurium, and 
endoneurium. The epineurium is the outer most tissue layer of the nerve and tends to be 
more fibrous in nature and functions as a protective layer to the nerve. The perineurium is 
a tissue layer that wraps around groups or bundles of axons and Schwann cells. These 
groupings are known as fascicles and larger nerves typically have multiple fascicles while 
smaller diameter nerves may not have any. The endoneurium is the extracellular matrix 
which resides immediately next to and surrounding the axons and Schwann cells 
providing a structure for support and cell adhesion. As a result the endoneurium is often 
observed as a tube like structure and called an endoneurial tube.  
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2.2.2 Peripheral Nerve Injury and Regeneration 
 In the case of peripheral nerve injury the nerve and cells within undergo a series 
of well-defined processes culminating in an attempt to regenerate and heal from the 
injury. In the case of nerve cut or transection a process known as Wallerian degeneration 
starts almost immediately after the injury. The axons distal to the transection have been 
separated from their cell body residing more proximally and as a result start to 
degenerate. The debris from the injury and axon degradation is cleared away by an influx 
of immune cells, predominantly macrophages [12,13], and local Schwann cells. 
Concurrently a fibrin protein cable forms between the proximal and distal ends of the cut 
nerve, bridging the gap and providing a matrix for cell migration and axon extension. 
[14]  
 Following Wallerian degeneration Schwann cells in the distal nerve proliferate 
and differentiate, taking on a pro-regenerative phenotype and aligning themselves within 
the remaining endoneurial tubes forming aligned tracts called “bands of Büngner”. These 
tracts help guide regenerating axons from the proximal nerve stump once they reach the 
distal nerve stump. Fibroblasts also proliferate and along with Schwann cells migrate 
from both ends of the transected nerve along the fibrin matrix enriching and restructuring 
the matrix to support subsequent axon regeneration [15,16]. During this time the 
fibroblasts and Schwann cells also secrete a milieu of growth factors and cytokines to 
further support regeneration and pathfinding of the newly regenerating axons from the 
proximal nerve stump [17,18].  
 At this point in the regeneration cascade, the severed axons in the proximal nerve 
stump form a growth cone at the severed tip. This growth cone follows the migrating 
Schwann cells from the proximal nerve stump and leads the regenerating axon along the 
enriched fibrin/cellular cable, eventually meeting the distal nerve stump and the bands of 
Büngner. The regenerating axons then use the endoneurial tubes and structure of the 
distal nerve stump to continue regenerating back to and eventually reinnervating the end 
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organs and distal targets in successful nerve regeneration. [19,20] It is important to note 
however, that often the growth cone from a regenerating axon will enter a different 
endoneurial tube from where it was prior to the injury. As a result that axon will follow a 
different path through the distal nerve and reinnervate a different target/end organ than 
which it was previously connected to. This manifests clinically in a common mixing of 
sensations post nerve regeneration where instead of feeling touch, one feels hot or cold or 
simply a tingling sensation, for example. The individual must ‘relearn’ over the course of 
months and years which axons are responsive to which sensations and similarly which 
muscles in the case of motor control. [21] 
2.2.3 Peripheral Nerve Regeneration and Viability in an Amputee Scenario 
 When the distal stump of a nerve is missing, as in the case of amputation, 
reinnervation of the original distal targets cannot occur. However, the nerve itself is still 
capable of regenerating. Previous studies have shown that in the complete absence of the 
distal nerve stump, transected nerves sutured into semi-permeable conduits/tubes are 
capable of regenerating through the conduits [22,23]. Inserting a small nerve segment at 
the distal end of the conduit further helps this case as it provides a distal source of 
Schwann cells and fibroblasts to help support the phases of nerve regeneration. Doing so 
enables nerve regeneration that in some cases can even match regeneration through open 
conduits when the distal nerve stump is present. [24–26]  
 Not only is an amputated nerve capable of regeneration, but the axons and 
corresponding neurons remain viable and do not under cell death post amputation. 
Multiple studies have documented the survival of both motor neurons extending axons 
from within the spinal cord and sensory neurons extending axons from dorsal root 
ganglia next to the spinal cord after peripheral nerve transection. Motor neurons seem 
particularly capable of survival after axotomy whereas sensory neurons have shown at 
least 50% survival. [27–32] It is important to note however, that the neurons and axons 
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do undergo physiological changes post amputation. Notably, atrophied states are 
observed where the axons exhibit reduced axonal diameters. These diameters are stable 
over time however and as stated before, do not die away. The action potentials associated 
with amputated axons also undergo changes, such as slower conduction velocities, but the 
ability to generate and propagate action potentials is retained as well. [29,30,33]  
 The viability of axons/neurons and ability to generate and propagate action 
potentials post amputation have also been validated clinically. Wire electrodes called 
Longitudinal intrafascicular electrodes (LIFE) were inserted into the remaining nerves in 
the limbs of amputees. The amputations had occurred out to 15 years before the 
experiment took place. The LIFEs were successfully used to record action potentials 
associated with intended movements of the missing limbs. The LIFEs were also 
successfully used to evoke sensory action potentials and induce various sensations 
associated with the missing limbs. The ability to accomplish both the recording and 
stimulation in amputees whose amputations occurred many years in the past clearly 
demonstrates the chronic viability of axons/nerves and their ability to generate and 
propagate action potentials post amputation. [1] 
2.3 Peripheral Interfacing 
2.3.1 State of the Art Prosthetic Control 
2.3.1.1 EMG  
 Myoelectric systems are the current state of the art and record electrical signals 
using sensors on various muscles (electromyograms) as efferent (motor) control inputs. 
These systems are minimally invasive but provide only limited prosthetic control and are 
not readily capable of providing afferent (sensory) feedback signals [1]. These systems 
are limited by the remaining number of muscles on a limb post amputation for input, 
which in the case of upper limb amputations can be quite few. The production of sweat 
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and shifts in the position of the prosthetic and its EMG sensors over time in relation to 
the remaining muscles on the amputees’ limb also drastically affects it performance and 
interferes with its EMG recording capabilities. Furthermore, individuals must learn to use 
their remaining muscles for prosthetic limb movements which are completely different 
from the original movements of their amputated limb. This is a time intensive and 
challenging processes.  
 Surgical techniques have been developed to help increase the number of muscles 
available for control input to the EMG prosthetics. This technique involves surgically 
rerouting nerves from the amputated limb to non-critical muscles for the amputated nerve 
to reinnervate. This technique is known as ‘targeted muscle reinnervation’. In the case of 
upper-limb amputees the nerves are often rerouted to the pectoral muscles. Using this 
technique the number of muscles available for prosthetic limb control increases and in 
many cases the movement is now directly synced to the individuals intended movement 
of their amputated limb. The amputee does not need to relearn different movements for 
new muscles. Of significance, it has also been shown that sensory reinnervation has 
occurred as well where portions of the skin in the chest region become tied to the 
amputated limb and the individual feels sensation on their missing limb instead of the 
chest region. [34,35] While these are exciting outcomes from the targeted muscle 
innervation technique, the surgery is extremely invasive. Furthermore, there remains a 
real-estate issue between EMG sensor placement and sensory feedback devices on the 
chest limiting the actually capability of this technique to drive a closed-loop prosthetic 
system. Finally, this technique still suffers from the practical issues of EMG sensor 
movement and sweat generation during prosthetic limb operation.   
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2.3.2 Peripheral Nerve Interfaces 
2.3.2.1 Cuff Electrodes 
 Cuff electrodes, which wrap around the nerve (Figure 1A), cause little damage to 
the nerve and provide long-term stability at the tissue-electrode interface. They have even 
shown efficacy in clinical translation regarding some applications in nerve stimulation 
[36–38]. However, cuff electrodes achieve their stability at the expense of recording 
fidelity and stimulation specificity because they are not in direct contact with individual 
axons. [2,3,6,39] Instead, due to the fact that they reside outside of the nerve’s 
epineurium and the distance this creates between the electrodes and individual axons, 
they tend to record and stimulate nerves on a fascicular level. While interfacing with 
fascicles is useful in some applications, it does not provide the specificity needed to 
control a neural prosthetic with large degrees of freedom. Attempts to improve selectivity 
with multiple electrode configurations and nerve compression, such as in the Flat 
Interface Nerve Electrode (FINE), have been somewhat successful but again not beyond 
the fascicular level [39,40]. Additionally many electrodes are rendered useless due to 
poor contact between the nerve and the electrode. 






Figure 1. Traditional peripheral nerve interfaces. 
(A) Cuff electrode. (B) Penetrating Utah Slanted Electrode Array. (C) Penetrating 
Longitudinal Intrafascicular Electrode. (D) Regenerative Sieve electrode. Adapted from 
Boretius, Biosensors and Bioelectronics, 2010; Branner, IEEE Transactions on 
Biomedical Engineering, 2004; Negredo, Neuroscience, 2004. 
2.3.2.2 Penetrating Electrodes 
 In contrast, the Utah Slanted Electrode Array (USEA) with 100+ needle-like 
electrodes (Figure 1B) penetrates into the nerve and resides within individual fascicles, 
axon bundles. This design provides direct contact between electrodes and axons and leads 
has demonstrated enhanced specificity over a large number of channels in acute 
experiments [39,41,42]. However the insertion causes irreparable physical damage to the 
nerve, which would have already undergone significant trauma in the case of limb 
amputation. Additionally, the USEA electrodes suffer from chronic inflammation and the 
eventual formation of scar tissue and fibrotic encapsulation. Due to these drawbacks, the 
overall efficacy has been limited to 80% of the electrodes for approximately 5 months in 
chronic experiments [4].  
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 The Longitudinal Intrafascicular Electrode (LIFE) is another penetrating interface 
with a wire like electrode that is inserted longitudinally into the nerve along the direction 
of the axons (Figure 1C). It also has improved stimulating and recording fidelity and 
specificity due to proximity of electrodes to axons but currently with only a limited 
number [43,44]. However, while showing a balance between specificity and reliability 
[45], the insertion still causes damage to the remaining viable portion of the nerve. 
Perhaps most importantly, by design the LIFE is limited to a small number of electrodes 
when compared to the FINE or USEA and simply does not scale to the level necessary 
for functional and viable interfaces for amputees.  
2.3.2.3 Regenerative Electrodes 
2.3.2.3.1 Sieve Electrode 
 As shown by these hallmark peripheral nerve interfaces, there exists a large 
tradeoff between the ability to selectively interface with individual axons versus the 
amount of disruption to the nerve and long-term stability as a result of trying to get in 
close proximity to axons.[39] In order to combat the negative outcomes of trying to get in 
close proximity to axons, a regenerative approach has been explored where amputated 
nerves are encouraged to regenerate into specific geometries within close proximity to 
electrodes. While this approach is dependent on a previously cut nerve and therefore 
limited in application, it is advantageous because it allows close proximity between axons 
and electrodes without the need to penetrate the nerve. [46–50] However, these 
approaches have met again with limited success. The Sieve Electrode, the hallmark 
regenerative interface, is effectively a thin perforated disk that is attached to the nerve 
perpendicularly so the nerve is forced to regenerate through the device. [51] Some of the 
perforations in the disk have ring electrodes that contact the axons regenerating through 
the holes (Figure 1D). [52] Theoretically, each hole could have a ring electrode allowing 
this device to interface with an extraordinarily large number of axons. Designs such as 
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the Sieve Electrode demonstrate highly selective stimulation after regeneration but 
limited recording fidelity. This is in large part due to the challenges of recording the very 
low amplitude action potentials (APs) from axons and a spatial dependence of the 
electrodes to the Nodes of Ranvier where the AP is largest [5,6,39,53,54].  
2.3.2.3.2 Microchannel Approach 
 The measurable extracellular potential of action potentials is small due in large 
part to the extracellular volume surrounding axons and nerves. This volume, mainly 
water and ions, disperses the extracellular potential of the action potential due to its low 
impedance nature and the resulting high ionic diffusion/dispersion [6]. This in turn 
reduces the magnitude of the action potential outside the axonal membrane. The end 
result is the extremely difficult design requirement that any electrode with the hope of 
capturing the action potential be placed as physically close to the axon membrane as 
possible. It is important to note that not only are Sieve electrodes forced to endure this 
low signal, but all peripheral nerve interfaces to date are forced to endure it. Furthermore, 
all peripheral nerve interfaces that contact the nerve in a perpendicular manner (Sieve 
electrodes, Utah electrode arrays, etc.) have the additional design requirement of being 
spatially dependent on the nodes of Ranvier, breaks in axon insulation where the 
extracellular potential is largest. These breaks in insulation do occur fairly frequently, on 
average at least every 2mm [7,55]. However, it is highly impractical to attempt to target 
them when implanting large numbers of electrodes in a patient because they are on the 
order of 1 micron in length [55] and not easily located. This is yet another severe 
limitation and difficult design criteria state-of-the-art peripheral nerve interfacing 
technologies must cope with. 
 The present work builds upon these nerve interfacing designs by using 
microchannel technology, a promising new regenerative approach to peripheral nerve 
interfacing. In this approach, axons from an amputated nerve regenerate through a large 
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number of microchannels made of electrically insulating materials. Interfacing with 
axons within a microchannel offers three distinct advantages. First, by using electrically 
insulating materials for the microchannels, the axons are effectively isolated from the low 
impedance extracellular fluid. It has been theorized and simulated through mathematical 
modeling that limiting the extracellular fluid/volume offers a huge advantage by 
increasing the extracellular resistance and following from Ohm’s Law, the extracellular 
potential of an axon’s AP [6]. Essentially the microchannels provide a method to 
circumvent the reduction in AP magnitude stemming from the low impedance 
extracellular volume and provide an interfacing scenario as if the electrodes were placed 
right next to the axonal membrane.  
 Second, if microchannels with lengths greater than 2 mm are used, a node of 
Ranvier will always be contained within the microchannels. This coupled with the fact 
that microchannels help contain the AP signal and mitigate the reduction in magnitude, 
allows electrodes within microchannels to be spatially independent of the nodes of 
Ranvier. One need not attempt targeting the placement of electrodes to minimize 
proximity to the nodes. This unique phenomenon to microchannels has been validated in 
vitro where axons were recorded from inside a microchannel, their spatial position 
changed by pulling the axons further through the microchannel, and recordings were 
attempted again. The authors found there was no significant difference in recordings 
between the different axon and node of Ranvier positions. [56]  
 Third, if a nerve regenerates through a large number of microchannels, then the 
axons will be forced into small groups each held within its own microchannel made of 
electrically insulating materials. This allows specific interfacing capabilities unlike any of 
the previously developed peripheral nerve interfacing technologies because the small 
groups of axons are electrically and spatially isolated from each other and can be treated 
independently. This would allow the recording of signals from one group of axons in one 
microchannel, while simultaneously stimulating another group of axons in another 
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microchannel without worrying about cross-talk or interference. The end result is the 
potential for highly specific and simultaneous regimes of stimulation, conduction 
blocking, and recording for sensory feedback, pain blocking, and motor signal 
acquisition. [56] 
 Within the past half-decade or so, significant work has gone into evaluating the 
use of microchannel technology for peripheral nerve interfacing in the context of in vivo 
application. Initial work investigated the functionality and capability of nerves to 
regenerative through microchannels in a transection/non-amputee animal model. It was 
shown that axon regeneration (myelinated and unmyelinated) is highly susceptible to 
microchannel dimensions with cross-sections ranging from 3025 – 12100 μm
2
 and 
lengths ranging 1 – 5mm. When regeneration is present within the microchannels, single 
unit action potentials can be recorded from the axons using electrodes inserted into the 
microchannels post-regeneration at the time of experimentation/recording [49,57]. While 
the animal model does not translate to an amputee population and the electrodes used to 
record the single unit action potentials were not actually implanted, the studies 
demonstrate the potential for chronic nerve-microchannel integration and interfacing.  
 Other work has focused on non-regenerative implementations of microchannel 
technology for peripheral nerve interfacing. These include flexible and elastomeric 
polydimethylsiloxane (PDMS) based microchannel interfaces with microfabricated 
electrodes. In these cases dorsal roots were dissected into small strands (rootlets), as 
opposed to being transected, and then placed within ‘open’ microchannels. Dorsal roots 
are the roots of a nerve passing dorsally to the spinal cord. A capping PDMS layer was 
finally placed on top of the microchannels to close them during the recording experiment. 
These microchannel interfaces have been used to record both sensory evoked and bladder 
responsive single unit action potentials in acute recording experiments with axons from 
the dissected dorsal rootlets [50,58,59]. While these microchannel interfaces do not have 
large electrode counts (5 electrodes per device) due to the challenging fabrication 
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demands of PDMS, it does not appear necessary for application in bladder control with 
spinal cord injury patients [58]. Furthermore this is an insightful approach to utilizing 
dorsal rootlets that can be dissected for bladder control. Unfortunately this approach is 
not easily achieved with nerves innervating limbs due to the increasing degree of 
dissection that would be required based on significantly larger numbers of axons and 
nerve roots. Regardless of the clinical application, these studies are yet another example 
for the viability of microchannel interfacing. 
2.4 Conclusion 
 Building upon the promising work showing the potential of microchannels for 
peripheral nerve interfacing, it was warranted and the overarching aim of this thesis to 
investigate chronic regenerative interfacing for amputees and to develop advanced 
microchannel interfacing technology capable of performing in such chronic interfacing 
applications. The capability of microchannels and amputated nerves to integrate in a 
chronically stable manner was first investigated to establish the fundamental requirement 
that nerves be tolerant towards the foreign implant even after sustaining the massive 
injury of amputation. Secondly, a large electrode count microchannel based interface was 
designed, fabrication processes developed applicable to implantable microelectronics 
such as these, and predominant failure modes investigated for chronic interfacing, 
specifically recording APs, in the in vivo environment. 
         22 
CHAPTER 3   
Evaluating the Chronic Capability of Regenerative Microchannel 
Interfacing 
3.1 Introduction 
 Prosthetics aim to restore the functional capacity once held by an amputee. A 
number of neural prostheses have been developed with the goal to artificially substitute 
or mimic sensorimotor functions in patients. For instance, this goal can be accomplished 
via an interface with the peripheral nervous system by means of implanted electrodes 
capable of neuromuscular stimulation and neural signal recording. Stable bi-directional 
communication could allow for a natural control over advanced prosthetic limbs and 
other similar assistive devices for amputees. 
 State of the art peripheral nerve interfacing has centered around three main types 
of device designs: cuff, penetrating, and regenerative sieve electrodes. Cuff and 
penetrating interfaces face a large tradeoff between the ability to selectively interface 
with individual axons versus the amount of disruption to the nerve and long-term stability 
as a result of trying to get in close proximity to axons [39]. Cuff electrodes, which wrap 
around the nerve, cause minimal damage and provide long-term stability at the expense 
of stimulation/recording specificity due to a lack of direct contact with individual axons 
[2,3,6,39]. In contrast the Utah Slanted Electrode Array (USEA) penetrates the nerve and 
provides enhanced specificity through direct contact between the electrodes and axons. 
However, the insertion causes injury and the electrodes elicit chronic inflammation and 
scar tissue [4]. An alternative to combat these negative outcomes is a regenerative 
approach, where transected axons grow into specific geometries within close proximity of 
electrodes [5]. The hallmark Sieve Electrode is implanted so axons are forced to 
regenerate through its many perforations/holes making contact with ring electrodes [52]. 
         23 
However, this design has few viable electrodes because the extracellular potential of an 
axon’s action potential (AP) is small. Furthermore, there is a spatial dependence of the 
electrodes to the nodes of Ranvier, which occur at least every 2 mm and are where the 
extracellular potential is largest [7,39,53,56].  
 Microchannels offer a unique opportunity to take advantage of the regenerative 
approach while circumventing issues with small APs and the node of Ranvier 
dependence, as detailed elsewhere [6,49,50,56,59]. Briefly, if a nerve regenerates through 
electrically insulating microchannels, small groups of axons can be isolated from each 
other and the surrounding low impedance extracellular fluid. Limiting the extracellular 
volume increases the extracellular resistance and from Ohm’s law, increases the 
extracellular potential of an axon’s AP [6]. Using microchannels with a length of 3 mm 
ensures a node of Ranvier will always be contained within the microchannels making 
them spatially independent of the nodes. Such conditions have been validated in vitro. 
APs from axons were recorded from inside a microchannel, the spatial position of the 
axons changed, and recordings taken again without any significant difference in AP 
signal amplitude [56].  
 However, the underlying success of a regenerative microchannel interface as a 
dependable solution for neural interfacing is not only its ability to detect high quality 
APs, but also a function of long term tolerance by the peripheral nervous system. Thus, 
the neural implant is inherently dependent on the chronic condition of the matured nerve 
post-regeneration. To prevent neuropathic complications post-implantation, the device 
must facilitate sufficient room for nerve maturation over time while in close contact with 
as many axons as possible to obtain clear neural signals. The device must also facilitate 
healthy nerve characteristics such as a maintained tissue architecture, established 
myelinated fibers, and prominent axon profiles through the regeneration and maturation 
phases [11,52,60]. Lacking such nerve characteristics has proven to yield poor nerve 
functionality, compressive axonopathy, and neuromas which result in poor translation of 
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neural signal and loss of nerve utility [11,52,61–64]. The tendency of regenerating 
injured nerves to form neuromas is also a major clinical concern for amputees due to 
associated chronic pain as well as a major concern for specificity during neural 
interfacing due to characteristic random AP firing [65–69]. Neuromas not only negatively 
impact performance but also the tolerance of an implant by the host’s PNS by creating a 
hostile environment not conducive to typical axon regeneration and maturation. They are 
abnormal in their physiological characteristics as manifested by a marked degeneration 
and absence of myelination and axons, myelin debris, a decrease in Schwann cell 
population, loss of nerve organization/structure and oriented axon growth, loose basal 
lamina structure surrounding axons, edema and swelling, and the overall decline of 
axonal health in a regenerating nerve [62,63,66–68,70]. If a regenerative microchannel 
interface is unable to support the maturation and chronic retention of healthy axons, then 
even if it can record action potentials, it still fails from a biological perspective due to 
these neuropathic complications. 
 Our long term goal is to establish a large-electrode count microchannel interface 
for bi-directional communication within an amputated nerve. The basic design of the 
microchannel architecture is inspired by work from Dr. Fawcett and Dr. Lacour while at 
the University of Cambridge, and is shown in Figure 2. The interface utilizes top and 
bottom polydimethylsiloxane (PDMS) layers with SU-8 walls forming series of adjacent 
microchannels. Prior to implantation, the array of microchannels is rolled onto itself 
forming the device filled with microchannel conduits, mimicking the general cross-
sectional architecture of a nerve. The device is implanted so that the transected axons can 
regenerate through the microchannels and over the electrodes housed in the bottom 
PDMS layer for interfacing.  
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Figure 2. Microchannel interface schematic. 
(A) Overview of the rat amputee model depicting the site of implantation, tracing of 
subcutaneous wires, and percutaneous headstage for neural interfacing. (B) Schematic of 
microchannel architecture detailing materials, dimensions, and possible layout of 
incorporated gold electrodes. (C) Depiction of final microchannel scaffold after rolling 
for implantation. 
 
 Here, we focus on the response of the regenerating nerve to an artificially 
imposed microchannel obstacle and separately the ability to obtain neural signals from 
these microchannels that are meaningful for the eventual goal of neural interfacing. We 
first validate cytocompatibility of the scaffolding materials through in vitro 
experimentation. We then explore the capability of axons in an amputated nerve that 
lacks distal reinnervation targets to regenerate through the device and mature in a PDMS 
and SU-8 based microchannel scaffolding. Furthermore, we characterize the regenerated 
nerve from a morphological perspective once the axons have grown out of the 
microchannel scaffolding and attempt to assess whether neuroma formation is a major 
concern by evaluating the characteristics described previously common to neuromas. 
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Specifically we consider the presence or lack of organization within the nerve and 
oriented axon regeneration, Schwann cells and myelin deposition on axons, tight basal 
lamina structures around axons/Schwann cell units, and edema/swelling. Finally, we 
evaluate the ability to record single and multi-unit action potentials through 
microchannels permanently integrated with microwire electrodes in a terminal study after 
chronic implantation in the rat sciatic nerve. The chronic terminal electrophysiology 
experiment allows the testing of interfacing capabilities without needing to invest in the 
development of advanced wiring and packaging technologies for chronic continuous 
behavioral studies.  
3.2 Materials and Methods 
3.2.1 Regenerative microchannel scaffold fabrication 
 To fabricate the regenerative microchannel scaffolds, a 40 μm PDMS (1:10 
weight ratio Sylgard 184, Dow Corning) base layer was first spun on glass coated in 
titanium (10Å) and gold (50 Å) for anti-adhesion. The PDMS base layer was then briefly 
treated with oxygen plasma to increase the adhesion between PDMS and SU-8. A 100 
μm layer of SU-8 (SU-8 2100, MicroChem Corp) was then spun on top of the PDMS. 
The SU-8 was cured, exposed using an experimentally determined exposure dose of 520 
mJ/cm
2
, and developed forming the patterned microchannel walls on the PDMS base 
layer. The width and length of the microchannel walls were 20 μm and 10 mm, 
respectively. The width of the microchannels ranged from 50, 100, or 150 μm. The 
dimensions and spacing between the microchannel walls were controlled by the 
photolithography mask used for each microchannel type. The basic fabrication process of 
these steps is depicted in Figure 3. Detailed methods for the fabrication of these steps can 
be found in literature [71].  
 Adding the top PDMS layer involved first spinning polyacrylic acid, a water 
resorbable layer, on another glass slide and drying it on a hotplate at 60°C for five min. 
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This was done twice. A 10 µm layer of PDMS was immediately spun on the polyacrylic 
acid (PAA) layers and partially cured on a hotplate at 65°C for 4 min. During this time, 
the bottom PDMS layer with the SU-8 microchannel walls was treated with oxygen 
plasma to increase the adhesion between the two layers. The two glass slides were placed 
together with weight on top and baked on a hotplate at 60°C for 30 min and then 90°C for 
1 hr to ensure that the top PDMS layer was fully cured. Finally, the glass slide sandwich 
was soaked in water until the PAA dissolved and allowed for easy removal of the top 
glass slide. The basic process is depicted in Figure 3. Once the layer of microchannels 
was removed from the glass slide, they were rolled perpendicularly to the direction of the 
microchannels and cut to 3 mm forming microchannel scaffolds with a cylindrical shape 
resembling that of the rat sciatic nerve. Each microchannel scaffold type was designed to 
contain a different number of microchannels based on the microchannel cross-sectional 
area. This was necessary in order to maintain a uniform rolled scaffold cross-section of 
approximately 1.5 mm across all three types of microchannel scaffolds. The 150 µm x 
100 µm microchannel scaffolds contained 59 microchannels, the 100 µm x 100 µm 
microchannel scaffolds contained 84 microchannels, and the 50 µm x 100 µm 
microchannel scaffolds contained 143 microchannels. 
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Figure 3. Microchannel scaffold fabrication. 
Overview of all major fabrication processes for the regenerative microchannel scaffolds 
along with schematics depicting the device in each step. ‘Open’ microchannels from step 
5 were used in in vitro studies. In vivo studies used microchannels from step 10. 
Drawings are not to scale. 
 
3.2.2 Regenerative microchannel interface fabrication 
 The ends of eight insulated microwires (Stainless Steel 304, California Fine Wire 
Company) 60 µm in diameter and 10 cm in length were fed midway into eight random 
microchannels within the regenerative microchannel scaffold. 0.5 mm of each microwire 
at the end in the microchannel was de-insulated, forming the microchannel recording 
electrodes. The microchannel electrodes were inserted at the distal end of the 
regenerative microchannel scaffolds to minimally obstruct regeneration from the 
proximal side.  Two coupled microwires were placed outside the scaffold running parallel 
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to the microchannels with de-insulated electrodes at both ends positioned to record from 
each end of the 3mm device forming a tripolar reference. This reference was held in place 
using standard silicone tubing placed around the reference and microchannel interface. 
This silicone tubing also served as a cuff to suture the proximal and distal transected 
nerves stumps into place during implantation. A second microwire reference was 
deinsulated by 0.5 mm and adhered to the outer wall of the silicone tubing using silicone 
adhesive (3140, Dow Corning®) forming a bipolar reference. This allowed the option of 
choosing either reference during electrophysiology experimentation.  
3.2.3 In vitro cytocompatibility 
 Unrolled regenerative microchannel scaffolds lacking the PDMS cover layer were 
used for the in vitro experiments. Once fabricated, the ‘open’ regenerative microchannel 
scaffolds were placed at the bottom of tissue culture wells. Importantly, no protein 
coatings of any kind, such as laminin, were used. Lumbar dorsal root ganglia (DRGs) 
were explanted from P1 rat pups. The nerve roots were removed and the DRGs were 
placed on the open scaffolds at the entrance to the microchannels. For the first several 
hours, the DRGs were incubated with only a thin layer of DMEM/F12 media with 10% 
fetal bovine serum and 50 ng/mL nerve growth factor (NGF) (Roche). Subsequently, the 
wells were fully covered with the same media. The media, including NGF, were replaced 
every two days for a total of seven days. After seven days, the cultures of DRGs were 
fixed with 4% paraformaldehyde in PBS for 20 min and washed three times with 1X 
PBS. To visualize neurite outgrowth and non-neuronal cell migration, axons and 
Schwann cells of the DRGs were reacted overnight at 4°C with  antibodies to the 160kDa 
neurofilament protein (NF160, 1:500, mouse IgG1, Sigma) and S-100 (1:250, rabbit IgG 
S100, Dako), respectively, followed by secondary antibodies: goat anti-mouse IgG1 
Alexa 594 (1:220, Invitrogen) and goat anti-rabbit IgG Alexa 488 (1:220, Invitrogen). 
Cell nuclei in the DRG cultures were marked by incubation in DAPI (Invitrogen) in PBS 
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at a concentration of 10 µM for 15 min at room temperature. The fluorescently labeled 
cells and nuclei were visualized using a Zeiss upright microscope and the images were 
captured with an Olympus digital camera. 
3.2.4 Microchannel scaffold implantation, explantation, and immunohistochemical 
preparation 
 A total of 18 regenerative microchannel scaffolds were implanted in the rat sciatic 
nerve amputee animal model, with an n=6 for each of the three microchannel widths 
studied. In isoflurane anesthetized rats, the sciatic nerve was transected at the mid-thigh 
and the regenerative microchannel scaffold was sutured to the proximal and distal 
segments of the cut nerve. The nerve was then transected again, this time two mm distal 
to the distal end of the device and a large portion (approximately 1cm) of the nerve distal 
to this second transection site was excised. The goal of this procedure is to leave a two 
mm ‘distal nerve stump’ attached to the distal end of the device so that regenerating 
axons may grow through the device in response to cues from the distal segment.  By 
excising a segment of the nerve distal to this stump, we sought to prevent any 
regenerating axons from reinnervating their original targets. The net result is a sciatic 
nerve amputee model which forms a more stringent test for regenerative peripheral nerve 
interfaces than a conventional sciatic nerve transection and repair model. 
 After eight weeks, the regenerative microchannel scaffolds were explanted for 
histological analysis for axonal regeneration and nerve characterization. Explants were 
post fixed in 4% paraformaldehyde in PBS (Sigma-Aldrich) for 48 hours at 4°C and 
cryoprotected in 30% w/v sucrose in PBS for 72 hours at 4°C. Samples were then 
embedded in O.C.T compound (Tissue Tek) and stored at -80°C. A 1.5 mm segment of 
nerve tissue distal to the microchannel scaffolds was sectioned in a transverse plane at 16 
µm thickness with a cryostat (CM30505, Leica). Cross sections of the microchannel 
scaffolds with regenerated nervous tissue were made at 100 µm. These thicker sections 
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were used to reduce mechanical stress and uncoiling which results from thinner 
sectioning. Sections mounted on slides were stored at -20°C until staining. 
3.2.5 Immunohistochemical analysis of microchannel scaffolds 
 Prior to staining, slides were brought to room temperature and excess O.C.T. 
surrounding the samples was removed with a razor blade. Next, an encompassing square 
section of precision mesh netting (McMaster-Carr) was applied over the whole cross 
section to prevent uncoiling of the microchannels during subsequent washes. The mesh 
netting was secured by applying a finite drop of cyanoacrylate glue at each corner onto 
the glass slide. Additional care was taken during subsequent reagent pipetting under a 
stereomicroscope to eliminate any air bubbles trapped in the mesh netting and to prevent 
uncoiling due to mechanical stress from excessive fluid flow. Microchannel slides were 
washed in PBS and then incubated in blocking solution for one and a half hours at room 
temperature. Blocking solution was prepared using a 1:25 dilution of goat serum (Gibco) 
with 0.5% Triton X-100 prepared in PBS. After incubation in blocking solution, the 
samples were washed with a wash solution made of 0.5% Triton X-100 in PBS. The 
samples were incubated in primary antibody solutions (see above) for 24 hr at 4° C.  
Primary markers selected to stain for axons (NF160), Schwann cells (S100), and 
fibroblasts (1:500, mouse vimentin, Sigma–Aldrich) were prepared in blocking solution. 
The following day, the samples were again washed with wash solution and then 
incubated for 2 hr in secondary antibodies at room temperature. Secondary antibodies 
used were goat anti-rabbit IgG Alexa 488 and goat anti-mouse IgG1 Alexa 594 and 
prepared with wash solution. Lastly, the samples were incubated with DAPI (see above), 
washed with PBS, and cover slipped using fluoromount-G (SouthernBiotech). It should 
be noted that the goal of the immunohistochemistry method used was to stain the 
superficial portion of the 100 µm thick tissue samples and not the entire tissue thickness 
as doing so was unnecessary for the analyses performed. Tile scan images of the samples 
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were taken approximately 20 µm into the sample at 20x, 40x, and 100x magnification 
with a confocal microscope (LSM 510, Carl Zeiss) and stitched using Zen 2009 software 
(Carl Zeiss).  
3.2.6 Immunohistochemical analysis of nerve tissue distal to the microchannel 
scaffolds 
 Glass slides with the 16 µm thick sections of nerve tissue distal to the 
microchannel scaffolds were brought to room temperature and rinsed three times with 
PBS to remove excess O.C.T. gel. Next, the samples were incubated in goat serum 
blocking solution for 1 hr at room temperature, as described earlier. After blocking 
solution incubation, the samples were washed three times with wash solution and 
incubated overnight at 4°C with primary antibodies. Primary markers were selected to 
stain for axons (NF160), Schwann cells (S100), fibroblasts (vimentin), and myelin 
(1:100, chicken IgY P0, Chemicon Intl.) each prepared in blocking solution. The 
following day, the samples were washed three times with wash solution and incubated for 
1 hr in secondary antibodies at room temperature. Secondary antibodies used were goat 
anti-rabbit IgG Alexa 488, goat anti-mouse IgG1 Alexa 594, and goat anti-chicken IgG1 
Alexa 488 (1:220, Invitrogen); all were prepared with wash solution. After secondary 
antibody incubations, the samples were again rinsed with wash solution three times and 
then incubated with DAPI,  washed, and cover slipped as described above. Samples were 
imaged at 20x and 40x magnification with an inverted microscope (Axiovert 200, Carl 
Zeiss). Tile scan images were taken at 20x, 40x, and 100x with a confocal microscope 
(LSM 510, Carl Zeiss).   
3.2.7 Microchannel interface implantation and electrophysiology 
 A total of five regenerative microchannel interfaces were implanted in the rat 
sciatic nerve. In isoflurane anesthetized rats, the sciatic nerve was transected at the mid-
thigh and the regenerative microchannel interface was sutured to the proximal and distal 
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segments of the cut nerve. The microwires ends were led out through the musculature to 
lie subcutaneously in the local region. After 20 weeks (approximately five months) the 
rats were re-anesthetized lightly using isoflurane for induction followed by a 
ketamine/xylazine injection (i.p., 0.75 ml/kg). Booster shots of ketamine/xylazine (i.p., 
0.25 ml/kg) were given as needed. The subcutaneous ends of the microwires were 
exposed and connected to a Cerebus Neural Signal Processing System (Blackrock 
Microsystems, USA) for signal acquisition. An 18 gauge needle was placed 
subcutaneously along the back of the rat serving as a distant low impedance reference.  
 Once the microwires were connected to the Cerebus System, spontaneous action 
potentials were recorded through the microchannel interface. Next, attempts were made 
to evoke sensory single unit action potentials using a variety of natural stimuli. These 
included brushing of the leg distal to the implant, foot pad and toe region, pinching of the 
foot pad and toe region, ankle flexion/extension, and brushing of hair follicles distal to 
the implant. To control for movement related artifacts, identical sensory stimuli were 
delivered to the contra-lateral limb.   
 Lastly, the sciatic nerve was exposed near the sciatic notch using the same 
approach as the implantation surgery. A DS8000 stimulator (World Precision Instruments 
Inc, USA) was used to stimulate the sciatic nerve with 100 µsec, symmetric, charged 
balanced, bipolar, square wave voltage pulses at 0.33 Hz through a pair of stainless steel 
hook electrodes with 1.5 mm electrode spacing. A stimulus ramp of pulse amplitudes 
ranging from zero volts to 1 V at 0.01 V increments was used to evoke a range of neural 
responses, from a few action potentials to a general compound action potential. These 
were recorded through the microchannel interface. 
 All recorded signals were sampled at 30 KHz (33 µsec/sample) and first filtered 
in hardware using a 1st order high-pass Butterworth at 0.3 Hz and a 3rd order low-pass 
Butterworth at 7.5 KHz. Additional filtering was performed in software using a 4th order 
high-pass Butterworth at 250 Hz. Single unit action potentials were isolated online using 
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conventional window discrimination spike sorting techniques based on spike amplitude 
and duration, and offline using an automated expectation-maximization algorithm though 
the Plexon Offline Sorter™ software package (Plexon, USA). Signal-to-noise ratios of 
isolated units were calculated by taking the average peak-to-peak amplitude of the unit 
and dividing it by 3 times the standard deviation of noise in that specific electrode. 
3.2.8 Data analysis 
 Images from 100 µm thick histological sections through the scaffolding samples 
were used to analyze the number of microchannels containing axons, and number of 
axons and area of tissue occupied in each microchannel. The number of microchannels 
containing regenerated axons and the numbers of axons per microchannel across the three 
types of scaffolds were counted manually using ImageJ software. To evaluate the average 
amount of microchannels containing axons, for example in the 100 µm x 100 µm 
microchannel scaffolds, the percent of microchannels containing axons for each of the six 
100 µm x 100 µm microchannel scaffolds scaffold were averaged together.  
 To evaluate the numbers of regenerating axons in each of the 100 µm x 100 µm 
microchannel scaffolds, up to 100 axon profiles per microchannel were counted. Using 
this data, the microchannels in each scaffold were categorized using arbitrary bins set at 
0-10 axons, 11-100 axons, and 100+ axons. The percent of microchannels falling in these 
bins for the six 100 µm x 100 µm microchannel scaffolds are reported.  
 To evaluate the average free space in each microchannel within the 100 µm x 100 
µm microchannel scaffolds, the tissue cross-sectional area in each microchannel was 
identified using the fibroblast stain as a proxy for the regenerated tissue cable. The area 
of positive staining for fibroblasts was measured and compared to the total microchannel 
cross-sectional area using ImageJ. These values were used to determine the percent area 
of a given microchannel filled with regenerated tissue. Similar to the axon counting 
analysis, data from the area analysis was used to categorize the microchannels of each 
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scaffold into arbitrary bins of 0-25%, 25-50%, 50-75%, 75-100% microchannel area 
filled with tissue. The percent of microchannels falling in these bins for the six 100 µm x 
100 µm microchannel scaffolds are reported. 
 Microchannels not structurally intact due to damage from sectioning and the 
associated tissue located within were not included in any analysis. Data from axon counts 
and tissue cross-sectional areas were analyzed using one-way ANOVA followed by a 
Tukey’s least significant difference post-hoc test, where appropriate, to determine 
significant differences with at least 95% confidence. 
3.3 Results 
3.3.1 Regenerative microchannel scaffold  
 An image of the fabricated regenerative microchannel scaffold prior to the 
bonding of the PDMS cover layer (step 5 in Figure 3) is shown in Figure 4A. In this 
image a reflection of the SU-8 channel walls can be seen on the PDMS base layer. The 
SU-8 channel walls were successfully patterned using photolithography on the PDMS 
base layer and the SU-8 was capable of forming 20 µm by 100 µm channel walls. These 
‘open’ microchannel scaffolds lacking the PDMS cover layer were used for all in vitro 
studies.  
 Application of the PDMS cover layer resulted in adherence to the top of the SU-8 
microchannel walls forming arrays of closed microchannels (Figure 4B). The PDMS 
cover layer is the thin line at the top of the microchannel walls. The arrays of 
microchannels were rolled perpendicular to the SU-8 walls forming the final regenerative 
microchannel scaffold for in vivo studies (Figure 4C and Figure 4D). The overall 
diameter of the scaffold was slightly larger than 1.5 mm. In these images, the SU-8 
appears slightly gold and the PDMS appears grey or light blue. The microchannels are 
clearly visible. The dotted red line in Figure 4D shows the separation between two layers 
of microchannels where the PDMS cover layer of the inner microchannel roll is in 
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contact with the PDMS base layer of the outer microchannel roll. As a consequence of 
the rolling procedure, an unavoidable small open core was present in the center of the 
scaffolds (Figure 4C). 
 
 
Figure 4. Microchannel scaffold images. 
(A) Image of ‘open’ microchannels corresponding to step 5 in Figure 3. (B) Image of 
microchannels with the PDMS cover layer adhered to the SU-8 walls corresponding to 
step 10 in Figure 3. (C) Cross-sectional view of 100 µm x 100 µm microchannel scaffold 
rolled for implantation. (D) Close up of rolled microchannel scaffold showing 
neighboring microchannel layers delineated by a red line. 
 
 
 Overall, three distinct types of microchannel scaffolds were fabricated where each 
had microchannel widths of either 50 µm, 100 µm, or 150 µm for chronic in-vivo studies. 
All microchannels had heights of 100 µm and lengths of 3 mm. It was observed however, 
that rolling the microchannel arrays to form the scaffolds resulted in slight 
inconsistencies in microchannel dimensions within a scaffold. Microchannels near the 
interior of the scaffolds tended to be wider than the peripheral microchannels. So, while 
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each microchannel scaffold started with microchannel widths of 50 µm, 100 µm, or 150 
µm, the rolling process created a range of widths within any given scaffold. A cross-
sectional area comparison of the inner two rings of microchannels to the outer most ring 
of microchannels showed that this range was most apparent in the 50 µm x 100 µm 
microchannel scaffolds which had approximately an average 25% increase in 
microchannel cross-sectional area due to rolling. In contrast the 100 µm x 100 µm 
microchannel scaffolds and 150 µm x 100 µm microchannel scaffolds had a small 
increase of approximately 2.5% and 7.5%, respectively. In the end, this diversity of width 
provides an ability to study the effect of microchannel size in greater detail. 
3.3.2 In vitro cytocompatibility studies 
 The cultured DRGs adhered well to the ‘open’ microchannel scaffolds. A 
representative DRG cultured on a scaffold with 50 µm microchannel widths stained for 
axons (red) and Schwann cells (green) is shown in Figure 5. The microchannels are 
visible as dark horizontal lines separated by the faintly auto-fluorescent SU-8 
microchannel walls. Immunoreactivity to axons (NF-160, red) and Schwann cells (S100, 
green) is shown in the main image of the figure, while the subset images show 
immunoreactivity to either axons (NF-160, red) or Schwann cells (S100, green). As seen 
from the main image, both axons and Schwann cells grew and proliferated in a robust 
manner out to 4 mm in length in some cases. Both axon extension and Schwann cell 
migration were aligned and oriented in the direction of the microchannels (Figure 5A, B). 
Neurite extension and Schwann cell migration from the explanted DRGs often appeared 
to be preferential towards the microchannels (Figure 5C). While difficult to quantify, it 
was observed that more axon extension and Schwann cell growth occurred along the 
edges of the microchannels, on the SU-8 channel walls, as opposed to on the PDMS. 
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Figure 5. DRG in vitro cytocompatibility. 
(Main image) DRG in vitro culture with axon processes and migrating Schwann cells on 
‘open’ 50 µm wide microchannels. (A) and (B) Axons and Schwann cells were aligned 
and oriented in the microchannels and grew/migrated out to 4mm in some cases. (C) 
Growth and migration of axons and Schwann cells re-orienting towards the 
microchannels. Axons (red); Schwann cells (green); DRG and regions of axon/Schwann 
cell co-localization appear orange/yellow; Microchannels are visible as dark horizontal 
regions separated by auto-fluorescent SU-8 microchannel walls; Arrowheads indicate 
axons; Arrows indicate Schwann cells; Scale bar = 200 µm unless otherwise noted. 
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3.3.3 In vivo axon regeneration and dependence on channel cross-sectional area 
 Microchannel scaffolds with three different microchannel cross-sectional areas, 
50 µm x 100 µm, 100 µm x 100 µm or 150 µm x 100 µm, were implanted for eight 
weeks to characterize the impact cross-sectional area has on nerve regeneration in a nerve 
amputee model. As mentioned previously the 50 µm x 100 µm, 100 µm x 100 µm, and 
150 µm x 100 µm microchannel scaffolds contained 143, 84, and 59 microchannels, 
respectively. Among the three channel dimensions, axon regeneration inside the 50 µm x 
100 µm microchannels was significantly less than that through the 100 µm x 100 µm or 
150 µm x 100 µm microchannels. Representative microchannel cross-sections of all three 
scaffold dimensions are shown in Figure 6A. The microchannels in all three scaffold 
dimensions containing regenerated axons were analyzed. Fewer than half (50%) of the 
microchannels in the 50 µm x 100 µm microchannel scaffolds were populated with 
axons. On the other hand, a majority (greater than 95%) of the microchannels in both the 
100 µm x 100 µm microchannel scaffolds and 150 µm x 100 µm microchannel scaffolds 
were populated with axons (Figure 6B). In both the 100 µm x 100 µm and 150 µm x 100 
µm microchannel scaffolds, axon regeneration within the open central core of the 
scaffolds was observed. These axon numbers were not quantified or included in the 
analysis.  
 Further analysis focused on the 100 µm x 100 µm microchannel scaffolds. A 
representative cross-section of a scaffold with discernible individual axon profiles is 
shown at higher magnification in Figure 6C. Axon profiles per microchannel were 
counted up to 100 and the results are graphically depicted in Figure 6D using arbitrary 
bins set at 100+ axons, 11-100 axons, and 0-10 axons. On average, approximately 30% of 
all analyzed microchannels contained more than 100 axons, 40% microchannels 
contained 11 – 100 axons, and 30% of the microchannels contained fewer than 10 axons.  
There was no observable dependence or variation of axon regeneration to the slight 
         40 
changes in microchannel cross-sectional area due to rolling or on spatial location of the 
microchannel within the scaffold.  
 
Figure 6. Axon regeneration. 
(A) Representative cross-sectional comparison of axon (red) profiles through the 
scaffolding among the three different microchannel dimensions: 50 µm x 100 µm; 100 
µm x 100 µm; 150 µm x 100 µm, respectively. Cross-sections were taken at the midpoint 
of each scaffold. Arrows indicate microchannels containing axons. Arrowheads indicate 
microchannels lacking axons. (B) Quantitative analysis on the percent of microchannels 
in a scaffold containing regenerated axons for each microchannel dimension. (C) Close 
up of 100 µm x 100 µm scaffold cross-section depicting single axons profiles within 
microchannels. (D) Quantitative analysis on the percent of microchannels within the 100 
µm x 100 µm microchannel scaffolds containing axon populations of 0-10, 11-100, or 
100+ axons. (Mean ± S.E.M., ***p < 0.001) 
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3.3.4 Space for future axon maturation 
 Analyses were performed to evaluate free space in the microchannels available 
for axon maturation over time. Accordingly, the area occupied by the regenerated tissue 
cable was compared to the area of the microchannels in the 100 µm x 100 µm 
microchannel scaffolding samples.  Staining for fibroblasts was used to calculate the area 
of the regenerated cable (Figure 7A). A close up of the cross-section along with 
delineations of the tissue and microchannel area are shown in Figure 7B. Approximately 
95% of all microchannels containing tissue in the 100x100 µm
2
 microchannel scaffolds 
were observed to have at least 25% free cross-sectional area remaining (Figure 7C).  
3.3.5 Distal nerve morphological analysis  
 The response of the nerve to induced guidance from the microchannel architecture 
was characterized using immunofluorescence for fibroblasts and basal lamina. In cross 
sections of the nerve tissue distal to the microchannel scaffold there was evidence of 
reorganization into ‘microchannel fascicles’, similar to typical nerve fascicles. These 
microchannel fascicles were characterized by defined perineurial-like sheaths of 
fibroblasts hosting aggregates of regenerating axons and Schwann cells (Figure 8C) and 
supportive extracellular matrix (Figure 8D). Additionally, an epineurial-like layer 
successfully reformed around the whole regenerating nerve characterized by concentric 
fibroblast organization (Figure 8C). The aggregates of axons and Schwann cells 
corresponding to the microchannel architecture were observed up to ~1 mm distal to the 
implant (Figure 8A). This distance coincided approximately with the end of the distal 
attached nerve segment. As expected, during nerve regeneration, sprouting of axons was 
visually observed as indicated by the evident increase of axon profiles progressively 
distal to the scaffolding (Figure 8A). Additionally, overall nerve regeneration was 
observed to be unidirectional and organized (Figure 8A). There were no signs of aberrant, 
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unorganized axon regeneration and/or bulbous nerve swelling distal to the microchannel 
scaffold. 
 
Figure 7. Characterization of area of 
regenerated tissue cable.  
(A) Representative cross section of 100 µm x 
100 µm microchannel scaffold stained for 
fibroblasts (red). Cross-sections were taken 
near the midpoint of the scaffold. (B) Close 
up of microchannels with delineations of 
microchannel area (yellow) and positive 
fibroblast staining used as a proxy for tissue 
cross-sectional area (green). (C) Quantitative 
analysis on the percent of microchannels 
within the 100 µm x 100 µm microchannel 
scaffolds with 0-25%, 25-50%, 50-75%, and 
75-100% area filled with tissue. (Mean ± 








Figure 8. Distal nerve morphology. 
(A) Distal nerve cross-sections stained for axons (red) at increasing distances away from the scaffold (left image is the scaffold mid-
section for reference). (B-D) Nerve cross-sections distal to the scaffolding. (B) Close up of distal nerve cross-section stained for axons 
(red) showing aggregates of axons. (C) Distal nerve cross-section stained for fibroblasts (red) and Schwann cells (green/yellow) 
showing perineurial like structures. (D) Distal nerve cross-section stained for laminin (green) and axons (red) showing basal lamina 
and connective tissue. 
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3.3.6 Distal axon regeneration analysis 
 At a closer inspection of the extracellular matrix, evident reformation of the basal 
lamina and endoneurial tubes was observed tightly surrounding all the axons and 
accompanying Schwann cells within the distal segments of the nerve (Figure 9A). 
Immunofluorescence for Schwann cells identified the abundant presence of Schwann 
cells within the microchannel fascicles (Figure 9B) accompanying the regenerated axons. 
Further immunofluorescence showed at least a portion of the Schwann cells were of the 
myelinating phenotype and had re-deposited myelin on axons providing insulation for 
normal nerve conduction (Figure 9C). In general, the nerve cross-section contained a 
uniform distribution of tissue without large edema like voids that lack both cells and 
extracellular matrix within the nerve. 
3.3.7 Regenerative microchannel interface 
 The microchannel interfaces utilized 60 μm diameter microwires as the recording 
electrodes. Due to the size of the microwires and based on the results from axon 
regeneration into the 100 µm x 100 µm microchannel scaffolds, the 150 µm x 100 µm 
microchannel scaffolds were chosen for interfacing. This ensured the space within the 
microchannels containing a microwire was close to, but not less than 100 µm x 100 µm. 
The recording electrodes were positioned in the middle of the microchannels and were 
0.5 mm long. A proximal, distal, and side view of a representative microchannel interface 
is shown in Figure 10A, B, and C, respectively. 
3.3.8 Spontaneous and Sensory Evoked Single Unit Action Potential Recordings 
 Spontaneous and/or sensory evoked single unit action potentials could be 
recorded from all microchannel interfaces after five months of implantation. Out of the 
40 electrodes from the 5 devices, 9 were non-functional due to broken microwire leads 
leaving 31 electrodes that could be used for recording activity. Recordings from 8 of the  
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Figure 9. Distal axon characterization. 
(A) Close up of distal nerve cross section stained for laminin (green), axons (red), and 
cell nuclei (blue). Microchannel fascicles shown in the top right insert. Bottom right 
insert depicts a close up of the basal laminae structure. (B) Aggregates of Schwann cells 
(green) and (C) re-myelinated axons, shown by co-localization of myelin (green) and 








Figure 10. Regenerative microchannel interface. 
Images of a representative microchannel interface with microwire electrodes. (A) 
Proximal view. (B) Distal view with microwire electrodes entering the microchannels. 
(C) Side view. 
 
31 functioning electrodes were found to contain single unit action potentials. Peak to 
peak amplitudes of the action potentials ranged from approximately 30 – 80 µV. Thus 
regenerated axons in the microchannel interfaces were functional and had successfully 
innervated the most distal regions of the leg and foot. A variety of sensory stimuli were 
capable of producing single unit action potential activity across all animals including 
ankle flexion/extension, pinching and rubbing of the foot pad and toe region, and hair 
follicle brushing. In general, ankle flexion/extension produced the largest and most 
reliable action potentials across all animals.   
 A representative sensory evoked action potential recording from a single 
microchannel is shown in Figure 11. This action potential is believed to be from an 
afferent sensory fiber, likely a proprioceptive axon reinnervating a muscle spindle or 
golgi tendon organ based on responsiveness to plantar flexion. The action potential wave 
form, isolated using window discrimination and an automated expectation-maximization 
algorithm through the Plexon Offline Sorter™, is shown in Figure 11A. A typical tri-
phasic appearance reported elsewhere for recordings taken within microchannels is noted 
in the waveform [49,59]. Figure 11B shows the raw recorded signal during plantar 
flexion held over 4 seconds in an 8 second time window where the flexion was released 
at time = 61 seconds and is denoted by a motion artifact. Figure 11C shows a plot of  
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Figure 11. Sensory evoked single-unit action potential recording. 
Representative sensory evoked single unit action potential recording through an electrode 
in a microchannel interface. (A) Action potential waveform. (B) Raw recording signal 
over 4 seconds of plantar flexion followed by 4 seconds lacking plantar flexion. Plantar 
flexion was released at time = 61 seconds and is denoted by a motion artifact during 
release of the ankle. (C) Spike rate of the action potential where plantar flexion was held 
for 60 seconds, released for 30 seconds, and repeated. A 1 second bin size was used to 
generate the plot. 
 
firing rate over a longer duration where the plantar flexion was held for 60 seconds, 
released for 30 seconds, held for 60 seconds, and again released for 30 seconds. Robust 
and steady firing of action potentials was observed during the flexion periods in contrast 
to the lack of firing during the release periods. The average peak to peak amplitude of 
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this unit was measured to be 54 µV with an average SNR calculated to be 2. There was 
no activity in response to control sensory stimulation of the contralateral leg for this unit 
or any other sensory evoked unit across all animals.  
3.3.9 Electrically Evoked Multi Unit Action Potential Recordings 
 The presence of evoked multi-unit activity recorded from the microchannel 
electrodes at five months was used to calculate the number of electrodes per device that 
could be used for successful recordings, which we have termed ‘device viability’. Evoked 
multi-unit activity was observed on an average from 4.5/8 electrodes per device, which 
corresponds to a mean device viability of 56.25% (SD 12.5%) after the five months of 
implantation. It should be noted that this mean viability includes nine electrodes with 
broken microwire leads. These nine electrodes were deemed non-functional after the 
broken microwire leads were visually verified and by a lack of an electrical stimulation 
artifact present on all functional electrodes. In one device all of the electrodes contained 
evoked multi-unit activity except those which were deemed non-functional. 
 The ramped voltage stimulation evoked increasing levels of multi-unit activity 
with increasing recruitment of axons within the microchannels. The peak to peak 
amplitudes ranged from approximately 260 – 520 µV near the upper threshold of 
stimulation. The amplitudes and waveforms of the multi-unit microchannel action 
potentials varied between animals and microchannel interface electrodes; however, in all 
cases signals were clearly distinguishable and did not require averaging to detect. 
Furthermore, the differences in multi-unit microchannel action potential amplitudes, 
latencies, and waveforms across electrodes and animals indicated there were different 
axon populations that regenerated into each of the respective microchannels, which was 
expected. In all animals, electrical stimulation via hook electrodes produced visible 
contractions of the gastrocnemius muscles and ankle extension, indicating successful 
nerve regeneration and functional reinnervation of distal targets.  
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 Representative electrically evoked multi-unit activity from three electrodes of a 
single microchannel interface using the 0-1 V stimulus ramp is shown in Figure 12. As 
just noted, different multi-unit microchannel action potentials were found in all three 
channels (and others not shown). Additionally, the recruitment of different units adding 
to the multi-unit microchannel action potentials can be seen in all three electrode 
recordings as the voltage stimulus was increased.  
 
Figure 12. Electrically evoked multi-unit action potential recordings. 
Representative electrically evoked multi-unit activity with different amplitudes, latencies, 
and waveforms from 3 representative electrodes in a microchannel interface. 
 
3.4 Discussion 
 One of the major challenges in the area of neural interfacing is to develop reliable 
devices that establish neuronal communication for prosthetic control. There have been 
many efforts towards this endeavor that can be broadly categorized into central neural 
interfacing or peripheral nerve interfacing. The efforts in these areas to restore, at least 
partially, sensorimotor function predominantly hinges on developing interfaces that can 
restore communication through neuronal recording and stimulation.  While cortical 
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neural interfacing is plagued by challenges of interfacing with the brain and decoding 
abstract signals intended for functional restoration, peripheral nerve interfacing has the 
potential to obtain signals that are more closely related to the intended muscle activation 
and are significantly less invasive. The culmination of a number of peripheral nerve 
interfacing studies has resulted in the development of interfaces such as cuff, penetrating 
and regenerative sieve electrodes [2–6,39,52]. While being helpful to some extent, these 
interfaces have drawbacks ranging from lack of selectivity in the case of the cuff 
electrode to more severe consequences in the case of the penetrating USEA where the 
interface implantation leads to inflammation and generation of scar tissue [2–4,6,39].  
The present study was focused on development of a device that would be effective as an 
interface for amputees with the potential for long term utility and minimal adverse 
effects. 
 One of the key features of the design strategy was to take advantage of the 
regenerative approach using microchannels and materials non-toxic to the peripheral 
nervous system including PDMS and SU-8. A simple and common fabrication technique 
was developed for scaffold production and involved initially generating flat sheets of 
microchannels which were subsequently rolled into conduits mimicking the size and 
fascicular organization of the rat sciatic nerve (Figure 4). This simple fabrication 
methodology should tremendously help in the large scale production of these devices.  
 However, one of the limitations of this approach is that the procedure creates a 
small open core in the center of the rolled microchannel scaffold. Even though one could 
pursue ways to occlude this space [49], this was not initially considered because it would 
hinder overall regeneration. If it was found that a disproportionate number of axons 
regenerated through the central core instead of the microchannels, occluding the hole 
would have been critical.  As this scenario did not occur, occluding the central core was 
not pursued. Another issue with the rolled approach was the inconsistency in the cross-
sectional area of each microchannel from the center of the scaffold moving outwards 
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radially. The cross-sectional area tended to increase slightly towards the center of the 
scaffold. However, this change in microchannel cross-sectional area within the scaffolds 
(2.5% in the 100 µm x 100 µm microchannel scaffolds) did not significantly impact the 
performance of the device, unlike the three distinct microchannel widths evaluated, and 
hence was not rectified in the current study. In future modifications of the device, this 
issue can be resolved by decreasing the spacing of the SU-8 walls in the inner region of 
the device.  
 There are additional advantages of using the rolling approach to generate the 
microchannels. First, the size of the scaffold is easily scalable to nerves of different 
diameters. If the nerve is larger, the sheet simply needs to be longer (more 
microchannels) in order for the rolled scaffold to have an increased diameter. Another 
benefit is that the number of microchannels available for interfacing scales accordingly 
for larger nerves. This is especially important when dealing with upper arm or upper leg 
amputees where the larger amputated nerves contain significantly more relevant 
information needed to control a neural prosthetic.  
 Additionally, an important finding of this study is that the components of the 
microchannel device were non-toxic to both DRG neurites and Schwann cells without 
needing any extracellular protein coating, such as laminin. The in vitro experimentation 
also showed the microchannel design was capable of guiding and directing neurites and 
Schwann cells as judged by the unidirectional neurite outgrowth and Schwann cell 
migration along and through the microchannels (Figure 5A, B). Further, it was interesting 
to note that neurites and Schwann cells initially growing and migrating perpendicular to 
the microchannels changed their initial direction and re-oriented towards the 
microchannels (Figure 5C). This suggests the presence of an, at this time, unknown 
mechanism for preferential growth/migration towards the microchannels. However, this 
was not the case with neurites and Schwann cells farther away from the microchannels, 
suggesting probably a spatial dependence. There was also preferential growth on the SU-
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8 microchannel walls. However, this was fairly inconsequential in vivo because the 
microchannels were covered with the top PDMS layer thereby containing the axons 
within the microchannels regardless of which surface they preferred.  
 In vivo experimentation with the microchannel scaffold to assess potential for 
chronic interfacing in amputees brought to light a number of additional significant 
observations. First, the implants were well tolerated in all cases with little to no scar 
tissue, in general. Second, robust numbers of axons were observed in the 100 µm x 100 
µm and 150 µm x 100 µm microchannels showing that these microchannel scaffolds 
readily support nerve regeneration despite lacking distal reinnervation targets. The 
microchannels in the 100 µm x 100 µm microchannel scaffolds did have varying 
numbers of axons ranging from a handful in some cases to many hundreds in others 
(Figure 6D), but seldom were completely lacking axons altogether (Figure 6B). 
Furthermore, the 100 µm x 100 µm microchannels were at or near the lower boundary for 
microchannel sizes capable of supporting axon regeneration as judged by the poor 
regeneration in the 50 µm x 100 µm microchannels (Figure 6A, B). With regards to both 
the 100 µm x 100 µm and 150 µm x 100 µm microchannels, it was observed anecdotally 
that microchannels completely lacking axon growth tended to occur near the periphery or 
in the outer rings of the scaffold. This was expected based on the typical nerve 
regeneration pattern where preferential regeneration occurs along the Bands of Büngner 
which form a central cord occurring roughly near the center of scaffolds [32,72,73]. 
Given the robust regeneration across these scaffolds though, microchannels lacking axons 
were very infrequent and would be difficult to predict prior to implantation. Besides the 
few microchannels lacking axon regeneration, no trends of greater or lesser axon 
regeneration dependent on microchannel location (center vs. periphery of the scaffold) or 
any other discernible topographical pattern were observed. It is also important to note that 
these trends of regeneration and dependence on microchannel size agree well with other 
studies looking at non-amputee scenarios [49,57]. 
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 For the in vivo studies, the rationale for choosing 100 µm x 100 µm 
microchannels for detailed analysis was based on the need to use the smallest possible 
microchannel cross-section to increase the amplitude of an axon’s AP while still 
maintaining reliable regeneration in a majority of the microchannels. In the implantations 
with this device, a vast majority of the microchannels had at least 25% of the original 
cross-sectional area remaining for future maturation of axons, Schwann cells, and the 
supporting tissue in general (Figure 7). A significant increase in regenerating axon 
numbers is not expected to occur within the microchannels given that an eight week time 
point was chosen for analysis. Another important point is that this analysis does not take 
into account the axon pruning that will occur at later time points resulting in fewer axons 
in the microchannels. This validated that axon constriction, as observed in the Sieve 
electrode [52,74], should not be a major concern when microchannel sizes similar to 
those in this study or larger are used in peripheral nerve interfacing applications. There 
was a small subset of microchannels, 5%, in which greater potential for future axon 
constriction might be expected, due to their being filled more than 75% with tissue when 
these scaffolds were explanted. However, the actual occurrence of axon constriction in 
this small subset would have to be assessed at significantly later time points to account 
for axon pruning, as previously mentioned. It is also important to note that even if axon 
constriction occurred in these few microchannels, it would not drastically affect the 
interfacing capabilities of the scaffold due to the overall number of microchannels 
presenting numerous opportunities to record from other axons.  
 Analysis of the nerve and axons distally as they regenerated out of the implanted 
microchannel scaffold also revealed a number of interesting details. The basic structure 
of the nerve stump distal to the scaffold had been reorganized in response to and 
matching the architecture of the proximal microchannels (Figure 8). This was first 
observed with the axons and Schwann cells that were grouped and organized according to 
the proximal microchannels (Figure 8B, C). In addition to the axon and Schwann cell 
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organization, connective tissue layers similar to those observed in a normal nerve had 
reformed. A stereotypical uninjured nerve is morphologically compartmentalized by 
epineurial, perineurial, and endoneurial connective tissues [11,75,76]. What was observed 
in this study was the reformation of all three types of connective tissue in the regenerated 
nerve distal to the implant. An epineurial like sheath surrounding the whole nerve cross 
section could be identified by concentric fibroblast arrangements. Furthermore, as a result 
of the re-organization within the distal nerve, multiple perineurial like sheaths forming 
‘microchannel fascicles’ marked by concentric fibroblast arrangements around the 
aggregates of axons and Schwann cells was observed (Figure 8C). These ring like sheaths 
of fibroblasts correlated with the presence of extracellular matrix shown by the lamellae 
support structure (Figure 8D). This is similar in nature to the perineurium of a 
stereotypical nerve which has been noted for its concentric layers of flattened cells with 
prominent basement membranes [11,76]. In general, the microchannel architecture 
facilitated and encouraged parallel nerve fiber growth by directing axon regeneration 
through the microchannels and producing an organized microchannel fascicle 
morphology. The reformation of endoneurial connective tissue is discussed in a later 
paragraph. 
 It was also evident that the ‘microchannel fascicles’ maintained their morphology 
as much as 1 mm distal to the scaffolding. With distance, the fascicles gradually lost their 
perineurial structure and the axons gradually disassociated from the microchannel 
morphology to a homogeneous morphology. However, the axons still maintained a 
general, unidirectional growth (Figure 8A) and eventually branched out into the local 
muscle bed (data not shown). It is also important to consider previous work which has 
shown that muscle reinnervation, while a key component for functional nerve 
regeneration across critical gaps, is not necessary for nerve stability. In fact there has 
been no evidence of motoneuron death after chronic axotomy in nerves and axons lacking 
their reinnervation targets out to 14 weeks [28]. Furthermore, nerves and axons retain a 
 55 
regenerative capability and can functionally reinnervate muscles after long periods such 
as 12 months of chronic axotomy, albeit a reduced number of regenerating axons over 
long distances, but with similar functional outcomes compared to controls [31,77,78].  
 While the macroscopic structure of the distal nerve changed significantly, the 
axons, Schwann cells, and associated connective tissue were undergoing the normal 
regenerative processes. Similar to the perineurium in a normal nerve, endoneurial 
connective tissue is heavily associated with basal lamina for structural support and cell 
adhesion between axons and proliferating Schwann cells. Proliferating Schwann cells are 
crucial for nerve regeneration by forming conduits and providing a favorable 
environment for subsequent axon elongation, maturation, and long term Schwann cell-
axon pairing [11,32,70,75,76,79]. Such conduit like structures of connective tissue were 
visualized in each individual microchannel fascicle by laminin staining, as indicated by 
the porous texture. Accordingly, each mature Schwann cell and axon pair was invested 
with a tight basal lamina structure and encompassed by extracellular matrix (ECM), 
forming endoneurial tubes (Figure 9A). In a regenerated nerve, mature Schwann cells 
play a crucial role by providing aid in the conduction of nerve impulses and providing 
trophic support for neurons [11,32,75,79]. Further, it was revealed in the analysis of 
myelin and Schwann cell staining that many axons were re-myelinated and a majority 
were closely associated with Schwann cells, thus suggesting the presence of both 
myelinating and non-myelinating Schwann cell phenotypes (Figure 9B, C). With regard 
to the general tissue distribution, immunohistochemistry indicated that large edema filled 
voids lacking cell populations and extracellular matrix within regions of the nerve were 
absent (Figure 9A). Together these observations support the finding that microchannels 
are not only supportive of the proper initial microenvironment for basal lamina/ 
connective tissue deposition by proliferating Schwann cells but also for chronic stability 
of the regenerated healthy nerve.  
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 Not only do these observations support chronic stability of the regenerated nerve 
with the device, but they also suggest that neuroma formation may not be a concern for 
use of this device in the amputee population. The regenerating nerve and axons, lacking 
distal reinnervation targets, displayed opposite characteristics to those most commonly 
associated with neuromas after being constrained to regenerate through the device. 
Neuromas are characterized by aberrant, random regeneration and highly disorganized 
axon distribution resulting in the commonly observed bulbous nerve swelling 
[62,63,67,70] which occurs as early as 1 week post nerve transection leading to chronic 
complications [63,67,70]. However, quite the opposite was observed in this study as 
shown by the microchannel fascicle morphology, general unidirectional growth of 
regenerating axons distal to the device, and lack of bulbous nerve swelling (Figure 8). 
Additional axonal characteristics within neuromas include a lacking Schwann cell 
population and myelination of axons [62,63,67], loose basal lamina structure surrounding 
axon/Schwann cell units [67,68], and endoneurial edema within the nerve structure 
[62,64]. Again, quite the opposite was observed in this study. An abundant population of 
Schwann cells closely associated with myelinated axons was observed. Furthermore, a 
tight, supportive basal lamina structure surrounded the axon/Schwann cell units and there 
was no presence of large voids within the nerve structure indicating an absence of edema 
or swelling (Figure 9). 
 In addition to the chronic stability of the microchannel scaffolds observed in an 
amputated nerve, both spontaneous and sensory evoked single unit activity were 
successfully recorded in vivo using the permanently integrated electrodes at the chronic 
time point a full five months after implantation. Thus indicating that the devices are both 
durable and that regenerating axons in them are viable over prolonged periods. The 
sensory evoked single unit action potentials included a multitude of activity originating 
from the distal foot pad region suggesting at least partial reinnervation of distal targets 
and potentially the recovery of proprioceptive, nocioceptive, and other sensory 
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perception. Additionally, multi-unit action potentials were recorded through all 
microchannel interfaces in response to proximal electrical stimulation (Figure 12). 
Observed contractions of the gastrocnemius muscles and plantar flexion in response to 
the electrical stimulation further suggest reinnervation of distal targets and potentially 
some recovery of motor function. 
 While it is challenging to record single unit action potentials from regenerated 
axons in anesthetized rats, eight of 31 functioning electrodes were successfully used 
towards this end. Furthermore, it is highly unlikely that all sensory afferents were 
stimulated even though a variety of sensory stimuli were used. So it is possible single unit 
action potentials could have been recorded through additional electrodes. Additional 
attempts were made using electrical stimuli to evoke single unit action potentials, but 
small levels of multi-unit activity were consistently observed even at low stimulation 
levels. The inability to evoke single unit action potentials is attributed to using hook 
electrodes which stimulate the nerve outside the epineurium and have large areas of 
contact. However, the presence of evoked multi-unit activity on the microchannel 
electrodes did allow an assessment of overall device viability which was found to be 
greater than 50% after five months of implantation, i.e. neural activity could be observed 
in greater than four of the eight integrated electrodes in each device. This calculation 
included nine nonfunctional electrodes with broken microwire leads. It should also be 
noted that the electrical stimulation ramp was performed to 1V, which was possibly 
submaximal to produce a full compound action potential of the entire sciatic nerve. It is 
therefore possible that some channels were viable but needed greater stimulation levels. 
The stimulation ramp also allowed the identification of multiple different axon 
populations within the various microchannels integrated with electrodes, which was 
expected based on the randomness of axon regeneration.  
 Overall, using the regenerative microchannel interface presented here, recordings 
of single and multi-unit action potentials could be made that are comparable if not better 
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in some aspects to what has been previously reported with regard to numbers of 
functional microchannel electrodes [49]. Notably, the fabrication of this interface was 
accomplished without the need for advanced metal deposition/patterning and insulation 
techniques for electrode integration. Instead simple off the shelf microwires were 
integrated and successfully utilized in a chronic setting. Additional work should focus on 
protecting the microwires from breakage though, as this was the main source of failure.  
 The amplitudes of the recorded action potentials also fell within ranges previously 
reported using a variety of peripheral nerve interfaces from LIFE electrodes to other 
microchannel based interfaces [1,41,50,59,80]. While these values fell within ranges 
reported, they were not consistently as large as reported in studies using microchannels 
[49,50,59]. There are a few design characteristics of the microchannel interfaces 
presented in this work that could contribute to the lower signal amplification. First, the 
microwire electrodes had a recording region that was 0.097 mm
2
. This relatively large 
electrode/recording area would reduce the amplitude of any recorded action potential 
because the entire electrode surface is equipotential and therefore tends to average out 
signals. Furthermore, the microchannels have an amplifying effect, based on the ability to 
constrain the extracellular fluid surrounding an axon and, in theory, increase the 
amplitude of the recordable extracellular action potential [6]. The large microchannel size 
chosen to accommodate the 60 μm diameter microwires and the fact that the walls ‘splay 
out’ due to rolling could have reduced this overall amplifying effect (Figure 10A and B).  
 Another important point is much of the modeling and in vitro work performed to 
validate this theory used microchannels of either significantly smaller diameters or longer 
lengths [56]. While smaller diameters and longer lengths might be expected to result in 
larger action potential amplitudes, based on the results of this study, they may not be 
suitable for maintaining healthy axons over chronic periods in amputees. In other acute in 
vivo experiments, cut rootlets or portions of nerves were physically placed in 
microchannels [50,59]. The axons used in these experiments were freshly harvested 
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axons that had not undergone regeneration and are therefore not readily comparable. In a 
chronic terminal study, single unit action potentials were recorded through a tungsten 
microelectrode inserted into an implanted microchannel scaffold at the time of 
recording[49]. However, the electrode was not permanently integrated into nor implanted 
along with the microchannel scaffold. Thus completely eliminating the foreign body 
response to the electrode and the deposition of fibrous tissue on the electrode surface 
which are fundamental factors in chronic interfacing and would reduce recording 
capabilities. The experimental paradigm of inserting an electrode at the time of recording 
also provides one the ability to make multiple attempts at ‘searching’ for the best units 
and is simply not possible with integrated electrodes. In the present study, microchannel 
recording capabilities were evaluated using a regenerative nerve model with permanently 
implanted electrodes and this chronic experimental paradigm in many ways may account 
for the reduced amplitudes observed.  
 It should be noted that an additional significantly longer time point, at least one 
year, is needed to prove conclusively that regenerated axons from an amputated nerve 
remain healthy and that stable recordings can be made from them. However, based on all 
the nerve characteristics investigated here, the regenerative microchannel scaffold 
provides an environment that permits substantial axon growth and maturation within the 
device over a considerable time period. The regeneration occurred in a spatially 
orchestrated manner due to the microchannels, which induced spatial segregation into 
small groups of axons to the benefit of selective interfacing. Growth through the 
microchannels resulted in a reformation of stereotypical nerve/axon morphologies and 
tissue compartmentalization that contributed to chronically stable and healthy 
regeneration through and past the device without complications of irregular nerve 
regeneration characterizing a neuroma. These findings support the fundamental criteria 
for a regenerative peripheral nerve interface targeted towards amputees. Finally, based on 
the electrophysiology data presented here, action potentials can be recorded from 
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regenerated axons in microchannels with permanently integrated electrodes on a chronic 
timescale. With this the stability and viability of regenerative microchannel interfacing is 
established, warranting the development of advanced wiring, packaging, and wireless 
technologies to be utilized with large electrode count microchannel interfaces for chronic 
continuous behavioral studies and these are ongoing.  
3.5 Conclusions 
 Overall the results from the current study demonstrated that the microchannel 
design provides an efficient platform to support regenerating axons and incorporate 
electronics for interfacing with small groups of axons. The simple fabrication process 
with biocompatible materials such as PDMS and SU-8 elevates the potential for easy 
scale up of production of this device. The ease with which one can incorporate microwire 
electrodes allows a versatile use of this device where advanced insulation and 
interconnect techniques are not available. The overall flexibility of the fabrication process 
to adapt and tailor the microchannels to the nerve size has great value in individualized 
customization of this device. Further, the re-organization, architecture and composition of 
the regenerating nerve lacking distal reinnervation targets showed numerous parallels to a 
normal nerve and underscores the potential for chronic bidirectional neuronal 
communication. The demonstrated capability to use microchannel interfaces to record 
spontaneous, sensory evoked, and electrically evoked single and multi unit action 
potentials on a chronic scale in the sciatic nerve after implantation for five months further 
supports this. These properties of the regenerated nerve when coupled with the 
interfacing capability of microchannels and the lack of adverse effects characteristic of 
neuroma formation lends this device to be a valuable element in aiding neural prosthetic 




CHAPTER 4   
Fabrication Processes for Flexible Electrode Arrays, SMT Integration, 
and Implantation 
4.1 Introduction 
 While large advances have been made recently in neural prosthetics, accompanied 
by significant media attention, they still provide only a small fraction of the functionality 
of a natural limb. At the heart of the issue is the neural interface which enables control of 
advanced robotic limbs by the individual or patient. Advances in peripheral nerve 
interfacing (PNI) and specifically microchannel technology have the potential to bridge 
this gap through the capability to increase the extracellular resistance of the axon’s action 
potentials (APs). This confers key unique advantages including node of Ranvier 
independent recordings and the mitigation of reduced AP magnitudes due to the low-
impedance extracellular fluid. [6,56] These advantages make microchannel electrodes a 
promising peripheral nerve interfacing approach compared to current state of the art 
penetrating, cuff, and sieve electrode arrays. Within the last 5+ years significant work has 
gone towards establishing the groundwork for microchannels as a viable method for 
interfacing in the peripheral nervous system with the largest success seen in a non-
regenerative implementation for the bladder system. [58,59] However there still remains 
room for significant development with more complicated peripheral nerve systems such 
as that of the limbs. This is especially true in scenarios where a chronic regenerative 
implementation is practical. 
 Furthermore, there is a need to develop advanced microchannel interfacing 
technology capable of performing in chronic interfacing applications. Inherent challenges 
to the peripheral nerve system include soft nerve tissue that can be easily damaged by 
rigid electronics such as those based on silicon technology and the fact that it is a hostile 
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aqueous environment. Initial attempts with flexible and elastomeric PDMS based devices 
have been made to assess microchannel interfacing in an acute scenario. [50,58,59] 
However these either do not contain large micro-electrode arrays (MEA), capability to 
easily integrate surface mount technology (SMT) for multiplexing and amplification, or 
are not applicable for implantation and awake behavioral animal evaluation as needed for 
clinical translation.  
 Patterning MEAs and photolithography in general on PDMS has been notoriously 
challenging and it is incredibly difficult to produce high-density small features on the 
substrate. For that reason devices will utilize other substrates such as polyimide that, 
while not elastomeric in nature, are still flexible. [49] However, an elastomeric substrate 
for electronics enables a new class of stretchable electronics with significant advantages 
that can find numerous applications ranging from in vivo sensors to skin based 
diagnostics to consumer electronics. Metal patterning for sensors and/or interconnects on 
PDMS is often accomplished utilizing shadow masks where one accepts larger features 
instead of going through the difficulty of attempting to pattern a photoresist lift-off mask 
directly on the PDMS. [50,59] A lift-off approach to patterning metal is preferred to 
etching away excess metal because metal etchants are highly toxic and are absorbed into 
the PDMS substrate making them difficult to implement in in vivo applications. Other 
approaches have utilized permanently cross-linked photoresists such as SU-8 because of 
the strength of the photoresist and its resistance to cracking. [81,82] The disadvantage 
being it is permanently cross-linked so removal of the mask is achieved through physical 
means by pulling it off the PDMS substrate. None of these approaches however directly 
address the inherent underlying issues plaguing photolithography on PDMS. Here we 
have developed five processing solutions targeting the underlying issues preventing 
widespread photolithography on PDMS.  
 The ability to easily integrate micro-chips and other electronics is incredibly 
important to the overall utility of a peripheral nerve interface as well as any general 
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device meant for diagnostics, sensors, or consumer oriented applications. It affords one 
the option to ‘upgrade’ or switch out components of the device at later stages as they 
become available or needs of the device change. For instance, with the GT-RE a large 
channel wireless chip that can be implanted is currently not available. Work is actively 
being pursued to develop these technologies [83] and it is prudent to design the GT-RE 
for eventual integration with technologies such as these. Currently, the vast majority of 
electronic components including resistors, capacitors, transistors, batteries, microchips, 
etc. are available in surface mount packaging. This packaging places flat connection 
terminals for the components at the base of the component so it can merely be placed in 
contact on top of other terminals and soldered together. This allows a significant 
reduction in component size and the smallest components on the market are only 
available as surface mount devices. However, integrating these devices with stretchable 
and flexible substrates has been difficult as soldering is not applicable due to heat 
induced failure of the substrates. Other approaches have centered on direct integration of 
the SMDs during fabrication, stiffening the substrate to prevent flexibility/stretchability 
in the region of integration, thermosonic ball bumping process to produce rivet-like 
connections, or through-holes and connector pins. [82,84–90] These techniques require 
additional fabrication steps which are challenging and complex, specialized equipment in 
the case of the ball bumping process and/or lose the advantages of small SMD component 
size. Furthermore, none of these approaches are easily streamlined with industry’s 
standard SMD integration processes. The easiest method is to utilize the surface mount 
approach originally intended for these components and PCB’s.  
 Hermetic packaging is another challenge implantable devices must overcome 
especially when microchips and other electrical components have been integrated. 
Parylene C has seen much use in this application as a vapor deposited polymer which is 
deposited at room temperature. Parylene C has a long standing history of use with 
medical devices and has been FDA approved in a variety of applications. It also functions 
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as an electrical insulator and the lifetime of Parylene C insulated circuits has even been 
shown to be 20+ years using accelerated failure testing and the Arrhenius relationship. 
Finally deposition as a thin-film, for example 10 µm, allows it to be highly flexible 
making it a good first choice for a flexible peripheral nerve interface. [91–94] 
Encapsulants based on silicone derivatives are another approach that has seen wide use 
with devices for both mechanical potting as well as insulation. These silicones come in a 
variety of commercially available forms including room temperature vulcanizing (RTV) 
and often contain additives aiding with adhesion to a variety of substrates including 
metals, ceramics, and other polymers. Furthermore, they are flexible and elastomeric 
making them ideally suited for devices with the same properties. It should be noted 
however, that these silicones are not impermeable to water vapor. So, it is important that 
they not contain air bubbles in contact with electronic components as water will 
eventually penetrate the silicone and accumulate in the bubble leading to a short. If there 
are no bubbles or voids, then there is no room for moisture to accumulate making the 
silicone an effective encapsulant. [39,95–98] 
 Here we report on flexible and elastomeric regenerative microchannel interfaces 
with large micro-electrode counts and easy integration of SMT for high-throughput 
peripheral nerve interfacing in awake and ambulatory rats. This is depicted schematically 
in Figure 13. First a design and fabrication approach for flexible (Parylene C) and 
elastomeric (PDMS) micro-electrode arrays (MEA) with large numbers of high-density 
microelectrodes is discussed. In particular we have developed five processing solutions 
targeting the underlying issues preventing widespread patterning and photolithography on 
PDMS. Microchannels walls are then patterned onto the surface of the MEAs along with 
a capping PDMS layer to enable microchannel interfacing with peripheral nerves. 
Second, a simple and broadly applicable SMT integration strategy is examined. Finally, 
flexible and elastomeric polymer based hermetic insulation and encapsulation strategies 
are utilized enabling implantation and electrophysiology in awake and freely moving rats. 
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Of importance, these design and fabrication techniques are applicable to a broad range of 
flexible devices and sensors benefiting from stretchable and/or flexible interconnects, 
SMD integration, and/or operation in hostile aqueous environments. Examples of devices 
benefitting from the techniques and technology reported here include flexible sensors 
such a continuous glucose monitors, flexible diagnostics such as recent skin based health 
monitors, and the burgeoning flexible wearable technology industry. [99–108] 
 
4.2 Materials and Methods 
4.2.1 GT-RE Design 
 The basic concept of the GT-RE microchannel interface (Figure 13) has been 
discussed previously [71,109]. Briefly, an MEA is patterned onto a base polymer layer. 
Two different devices were developed where the polymer utilized was either 
polydimethylsiloxane (PDMS) or Parylene C. The metal traces were then passivated with 
PDMS or Parylene C forming a flexible, and elastomeric in the case of PDMS, MEA. 
SU-8 microchannel walls were patterned on top of the MEA and a capping PDMS layer 
was adhered on top forming a sheet of microchannels with electrode sites housed in the 
base of the microchannels. This sheet was rolled perpendicularly to the direction of the 
microchannels forming a cylinder matching the shape and size of a nerve, in this case the 
sciatic nerve of a rat. Importantly the rolling took place along the base polymer layer 
forcing the capping PDMS layer to stretch. If the sheet were to be rolled around the top 
PDMS layer, it would buckle and block the microchannels. The microchannels were 100 
µm wide, 100 µm tall, and 3.5mm long with 20 µm wide microchannels walls. These 
dimensions were based on previous work that in part investigated microchannel sizes and 
the relationship to nerve regeneration in a clinically translatable amputee animal model. 
[109] Metal traces connected to the electrodes in the microchannels ended at a series of 
bonding pads intended for connection to surface mount devices (SMDs) utilizing a SMT 
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integration methodology detailed further on. Importantly, any SMD or surface mount 
printed circuit board (PCB) can be integrated with the GT-RE or other flexible and/or 





Figure 13. Schematic of fully integrated microchannel interface – The Georgia Tech 
Regenerative Electrode (GT-RE). 
(A) Microchannel architecture showing a blue polymer substrate with integrated gold 
microelectrodes and traces leading to bonding pads, green SU-8 microchannel walls, and 
a blue top capping polymer layer forming a sheet of microchannels with integrated 
electrodes. The sheet of microchannels is rolled forming a cylinder of microchannels. (B) 
Integration of surface mount device (SMD) components for a variety of capabilities 
including potentially multiplexing, amplification, and wireless communication. (C) 
Encapsulation of the SMD region enabling operation in aqueous environments such as 
the body. Instead of a wireless SMD microchip, signal extraction wires are also shown. 
(D) Implantation of the GT-RE in the rat sciatic nerve model where signal extraction 
wires are burrowed subcutaneously to a percutaneous headcap mounted on the skull to 
enable neural signal recordings.  
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 In this study two different PCB’s (Sierra Circuits, Inc.) were integrated utilizing 
the surface mount approach. One PCB was pre-assembled by Sierra Circuits, Inc. and 
contained Intan Technologies 32-channel micro-chip (RHA2132) and off-components for 
on-board multiplexing and amplification. The PCB design is depicted in Figure A 1 and  
was utilized in in vitro validation. The micro-chip and components could have been 
directly integrated onto the bonding pads of the GT-RE. However, this was not pursued 
for the sake of simplicity gained by outsourcing assembly on a PCB which allowed 
integration of just one item with the GT-RE as opposed to the many components 
associated with the microchip. The second PCB (6 mm x 9 mm) integrated with the GT-
RE was intended for in vivo applications. It was used as a wire attachment hub and had 
34 wires (0.001” Stainless Steel 7 strand PFA, A-M Systems) soldered accounting for the 
electrodes, references, and a local ground which allowed eventual connection to a 
separate off-board amplifier for electrophysiology experimentation. The off-board 
amplifier was connected directly to a computer for analysis and did not utilize any 
multiplexing. The 34 wires coming off the PCB were divided into separate groups of 17 
wires and utilized a 3 braid bundle with sets of 3, 4, and 4 wires for mechanical 
reinforcement and to prevent breakage in vivo. Each braid was fed into a silicone tube 
(Standard Silicone Tubing, Helix Medical, LLC) to act as an extra layer of insulation and 
mechanical protection. The ends of these wires were connected by Omnetics Connector 
Corp. to a 36-pin Male Nano Strip Omnetics connector. This connector was eventually 
utilized as a percutaneous connector on a rat’s skull enabling awake and freely moving 
electrophysiology experimentation. 
4.2.2 Electrode Design  
 Electrodes were patterned to be 100 µm x 70 µm. Accounting for a slight overlap 
of the passivation layer to help prevent delamination of the metal from the polymer 
substrate led to an effective electrode area of 80 µm x 40 µm. Metal traces leading from 
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the electrodes to the bonding pads for SMD integration were 30 µm wide with 70 µm 
spacing. The bonding pads were 105 µm x 190 µm. The electrodes were spaced once 
every third microchannel to allow for an equal distribution of electrodes throughout the 
cross-section of the GT-RE post rolling. A common bipolar reference was placed near the 
bonding pads and a common pseudo-tripolar reference was designed with electrode sites 
at the entrance and exit of every microchannel containing an electrode. The 
photolithography mask dictating the referencing design along with the electrodes, traces, 
and bonding pads can be seen in Figure 14. Of importance, seemingly extraneous features 
were placed surrounding the GT-RE features on the mask designs. While not having any 
direct implications to the design of the GT-RE, these features served the incredibly 












Figure 14.  Photolithography mask design. 
Mask design of electrodes, traces, bonding pads, references and stress relief features. 




4.2.3 Flexible and Elastomeric PDMS based MEA Fabrication 
 The fabrication steps for patterning the metal electrodes, traces, and bonding pads 
are represented schematically in Figure 15A with the general steps numbered 
accordingly. To fabricate the flexible and elastomeric PDMS based MEAs a 40 µm 
PDMS base layer (1:10 weight ratio Sylgard 184, Dow Corning) was first spun and cured 
on glass coated in titanium (50 Å) and gold (350 Å) for anti-adhesion using a hot plate. 
This was followed by lift-off patterning to define titanium and gold electrodes, traces, 
and bonding pads on the PDMS substrate. Of importance, thick-film photoresist layers   
were used for these photolithography steps and all general patterning steps on PDMS. 
Detailed reasoning for doing so is left for the discussion.  
 After curing the PDMS base substrate, the sample was briefly treated with oxygen 
plasma to increase adhesion and enable wetting of the PDMS with the photoresist NR4-
8000P (Futurrex, Inc.). A lift-off approach was used to pattern metal electrodes, 
traces/interconnects, and bonding pads next. A 30 µm layer (thick-film) of NR4-8000P 
was spun immediately after oxygen plasma treatment and cured in an oven at 120 °C for 
9 min, not on a hotplate. All photoresist baking (pre and post-exposure baking) for the 
MEA fabrication was performed in an oven with a slow ramp down to room temperature 
for post-exposure baking and is another important factor in the thick-film 
photolithography approach described. The reasoning is again left for the discussion. The 
NR4-8000P was exposed using an experimentally determined exposure dose of 590 
mJ/cm
2
. Exposures for all subsequent photolithography steps took place under the same 
filter. Post-exposure baking took place in an oven at 90 °C for 25 min with at least a 1 
hour cool down to room temperature. Development was performed with the sample 
inverted at an angle in a beaker to allow dissolved photoresist to sink to the bottom 
































Figure 15. GT-RE fabrication. 
(A) Metal patterning using a lift-off approach to define electrodes, traces, and bonding 
pads. (B) PDMS passivation using a sacrificial post approach. (C) Parylene C passivation 
using a bulk etching approach. (D) Addition of microchannels and rolling of the 
microchannel region along the base substrate layer. An integrated surface mount PCB 
with signal extraction wires is also shown. (E) SMT integration technique using 
conductive epoxy placed on bonding pads and a spacer to define a minimum bondline. 
(F) Molds for silicone adhesive encapsulation of the PCB region and headcap region. The 
PCB mold is depicted on the left and the headcap mold on the right. 
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faster development times without the need for agitation which consistently results in 
delamination of the cross-linked photoresist from the PDMS substrate. A final careful dip 
in fresh developer followed by gentle rinsing in DI water and passive air drying was 
performed. Etching residual photoresist in the developed areas, also known as 
descumming, was performed with oxygen plasma anywhere from 30 sec to 3 min 
depending on the degree of photoresist remaining. In general it is preferred to etch over 
developing longer periods of time due to the propensity for the photoresist to delaminate 
from PDMS during development. 
 Prior to metal deposition, brief oxygen plasma treatment was again used to 
activate the exposed regions of the PDMS surface. Titanium (100 Å) and gold (1000 Å) 
were deposited using an e-beam evaporator and lift-off was performed again with the 
sample inverted at an angle in the beaker. Mild stirring of the resist remover solution was 
performed to enable faster lift-off. Afterwards, the sample was air dried and baked at 90 
°C for 30 min to evaporate any absorbed solvent.  
 A sacrificial-post approach [82] was used in order to passivate the metal traces 
with PDMS while leaving the electrodes and bonding pads exposed. These fabrication 
steps are represented schematically in Figure 15B with the general steps numbered 
accordingly. This was thought to be preferable over bulk plasma etching to pattern PDMS 
as plasma etching PDMS is notoriously difficult and tends to be more of a ‘dirty’ 
physical bombardment process as opposed to chemical etching. First, another 30 µm 
layer of NR4-8000P was spun on the substrate immediately after oxygen plasma 
treatment and cured in an oven at 127 °C for 9 min. The NR4-8000P, while the same 
thickness as previously used for metal patterning was exposed using an experimentally 
determined exposure dose of 1575 mJ/cm
2
. This large difference in exposure dose is a 
function of feature size and is an important aspect for photolithography on PDMS 
discussed later in the discussion. Post-exposure baking took place again in an oven at 90 
°C for 30 min with at least a 1 hour cool down to room temperature. Development of the 
 72 
photoresist film leaving behind the sacrificial posts on the electrodes and bonding pads 
was performed in the same manner as that for metal patterning. However, extra care was 
taken during development to avoid agitation and samples were defaulted to extra oxygen 
plasma etching to avoid over development of the sacrificial posts and subsequent 
delamination from the substrate. Edges of the substrate were also developed separately as 
they took additional time due to typical edge bead formation from spinning. Developing 
the edges at the same time as the sacrificial posts results in over development and 
delamination as just mentioned. 
 After sacrificial post development and etching, the sample was briefly treated 
again with oxygen plasma in an attempt to increase adhesion and enable the formation of 
stable bonds between the PDMS passivation layer and the PDMS substrate with metal 
traces. Immediately after plasma treatment a 10 µm layer of PDMS was spun on. The 
sacrificial posts cause ripples to form in the passivation layer during spinning. In order to 
allow these ripples to dissipate, the sample was allowed to sit at room temperature, before 
curing, on a level surface for 1.5 hours. The PDMS passivation layer was then cured on a 
hotplate at 65 °C for 1 hour followed by an oven bake at 75 °C for 4 hours to ensure a full 
cure.  
 While the sacrificial posts were 30 µm in height and the PDMS passivation was 
only 10 µm, a thin residual film of PDMS invariably coats the posts during the spinning 
process. This thin residual film of PDMS prevents solvent from accessing the posts 
during sacrificial post removal necessitating etching of the residual PDMS to expose the 
sacrificial posts. An etching mask was next patterned onto the substrate to protect the 
passivation layer from the effects of etching. The necessity of this etching mask, while 
not used elsewhere [82,90], is validated and explained in the results and discussion. After 
curing of the PDMS passivation layer, the substrate was briefly treated with oxygen 
plasma for adhesion. A 13 µm layer of the photoresist SPR 220-7.0 (Shipley Company, 
L.L.C.) was immediately spun on and baked at 90 °C for 10 min with a 1 hour minimum 
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cool down to room temperature. The SPR 220-7.0 was exposed using an experimentally 
determined exposure dose of 150 mJ/cm
2
. A 1 hour hold time was used after exposure to 
allow water to diffuse back into the photoresist film, which is necessary to complete the 
cross-linking reaction. Importantly, a post-exposure bake is not necessary with SPR 220-
7.0 before development and helps eliminate the risk of cracking in the photoresist film 
during the following processing steps. After the hold time, the SPR 220-7.0 was 
developed and allowed to air dry exposing only the residual PDMS film covering the 
NR4-8000P sacrificial posts. The substrate was then hard baked in an over at 70 °C for 
30 min to anneal the SPR 220-7.0 photoresist film, strengthening it prior to etching of the 
residual PDMS film. The substrate was subject to SF6 and O2 plasma for 6 min to etch the 
residual PDMS film on the sacrificial posts. Following etching, the SPR 220-7.0 etch 
mask and NR4-8000P sacrificial post photoresists were stripped from the substrate 
together. The sample was then baked in an oven at 75 °C for 45 min to evaporate any 
solvent absorbed by the PDMS substrate during the stripping process. Thus, completed 
the fabrication of the flexible and elastomeric PDMS based MEAs. 
4.2.4 Flexible Parylene C Base MEA Fabrication 
 Fabrication of flexible Parylene C based MEAs followed a similar process with a 
few differences. First a 10 µm base layer of Parylene C was deposited on glass coated in 
2% Micro-Clean solution to aid in removal of the Parylene C from the glass post-
fabrication. For the sake of simplicity, the same lift-off approach utilized for the PDMS 
based MEAs was used to pattern the Au/Ti electrodes, traces/interconnects, and bonding 
pads. It should be noted that this approach is not necessary to pattern metal on Parylene C 
based devices as it is with PDMS based devices because Parylene C does not have a high 
coefficient of thermal expansion (35.5 ppm [110]) relative to photoresists. This is in stark 
contrast to PDMS (310 ppm [111]).  
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 The sacrificial post method was not used to pattern the Parylene C passivation 
layer as Parylene C is not deposited in a liquid form, but through a vapor deposition 
polymerization process. Additionally it is relatively easy to bulk plasma etch Parylene C 
compared to the difficult in doing so with PDMS as stated previously. The following 
fabrication steps are represented schematically in Figure 15C with the general steps 
numbered accordingly. First, the Parylene C substrate with patterned Au/Ti was briefly 
treated with oxygen plasma in an attempt to increase adhesion and enable the formation 
of stable bonds to the Parylene C passivation layer. A 5 µm passivation layer of Parylene 
C was then deposited on the substrate. The same SPR 220-7.0 etch mask as described for 
PDMS etching was utilized to expose the electrodes and bonding pads of the Parylene C 
based MEAs. However, etching of the Parylene C passivation layer was performed using 
only O2 plasma for 25 min with 90° rotations of the substrate every 5 min to ensure an 
even and complete etch. The gold electrodes and bonding pads served as an etch stop 
layer. The remaining photoresist was stripped and MEA baked as described before. Two 
of the devices tested in vivo utilized 15 µm and 10 µm Parylene C base layer and 
passivation layers respectively to aid in physical handling and Parylene C – Parylene C 
layer adhesion. These changes were implemented based on personal recommendations 
from research groups with long standing expertise in Parylene C based MEAs. In these 
MEA’s the SPR 220-7.0 etch mask and annealing step were increased to 15 µm and 80 
°C for 2 hours, respectively to ensure the masks’ presence during the Parylene C 
passivation etching process. Additionally the etch time of the Parylene C passivation 
layer was increased to 45 min with 90° rotations of the substrate every 11 min and a final 
etch of 4 min to ensure an even and complete etch.  
4.2.5 Microchannel Fabrication 
 First, microchannel walls were patterned onto the MEA’s. Adding the SU-8 
microchannel walls has been reported previously. (Biomaterials Paper) Briefly, a 100 µm 
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layer of SU-8 is spun on the MEA’s after O2 plasma treatment to aid in adhesion in the 
case of the PDMS based MEAs. O2 plasma was not utilized with the Parylene C based 
MEAs because delamination was not an issue and due to incomplete development of SU-
8 in unexposed regions likely stemming from the significantly increased adhesion. After 
spinning, the MEAs underwent pre-exposure baking, exposure, post-exposure baking and 
finally development resulting in microchannel walls patterned on top of the MEAs. 
 After the microchannel wall fabrication, the capping PDMS layer was adhered. 
First a 40 µm PDMS layer was spun on clean glass forming the ‘top PDMS substrate’. 
This was a permanent PDMS layer not part of the GT-RE. Its purpose was to account for 
slight variability in SU-8 microchannel wall heights ensuring contact between the PDMS 
cover layer and the entire surface area of every microchannel wall. This was then briefly 
treated with O2 plasma to aid in ‘wetability’ after which polyacrylic acid (PAA), a water 
resorbable layer, was immediately spun on and dried on a hotplate at 65° for 5 min. Next 
a 5 µm PDMS layer was spun on and cured using a hotplate at 90° for 20 min without 
allowing the PAA to cool or absorb ambient moisture. After curing, the top PDMS 
substrate was briefly subject to O2 plasma again to aid adhesion and a second 5 µm 
PDMS layer was immediately spun on. During this time, the MEA with SU-8 
microchannel walls facing upwards was placed on a hotplate set to 90° in preparation for 
the top PDMS substrate. After the second 5 µm PDMS layer finished spinning, the top 
PDMS substrate was immediately placed on the MEA substrate under weight with the 
uncured 5 µm PDMS layer and SU-8 microchannel walls in contact with each other. The 
two substrates (MEA and top PDMS layer) were cured together on the hotplate at 90° for 
20 min. After cooling the substrates were soaked in water until the PAA dissolved and 
the top PDMS glass substrate slid easily off leaving the capping 10 µm PDMS layer 
securely adhered to the SU-8 microchannel walls. The capping 10 µm PDMS layer was 
formed through the two 5 µm PDMS layers spun on top of each other. Finally the MEAs 
with complete microchannels were peeled off the glass substrate and the microchannel 
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region rolled. Importantly, the rolling took place along the substrate base layer forcing 
the capping PDMS layer to stretch. If the sheet were to be rolled around the top PDMS 
layer, it would buckle and block the microchannels. To aid in the rolling process, silicone 
adhesive was applied to the midline of the microchannel region on top of the PDMS 
capping layer. The silicone adhesive was used to adhere each consecutively rolled layer 
to the previous to prevent unrolling. The concept of these fabrication steps is represented 
schematically in Figure 15D. 
4.2.6 SMT Integration 
 Bonding pads on the GT-RE were designed to match those on a PCB to be 
connected using a surface mount technique similar and translatable to industry standard 
practices. Silver based conductive epoxy (H20E, Epoxy Technology, Inc.) was used as 
the junction between the two sets of bonding pads. A small amount of conductive epoxy 
was first applied to the bonding pads of the GT-RE using the extreme tip of an insulin 
needle (3/10 cc Insulin Syringe 28G1/2”, BD). This was then placed under vacuum to 
ensure there were no bubbles in the bonding pad region as it was recessed compared to 
the level of the passivation layer. An 80 µm PDMS spacer, formed by spinning the layer 
on a separate substrate and cutting samples, was next applied to the bottom of the PCB 
taking care not to cover any of the PCB bonding pads. The goal of the PDMS spacer was 
to create an 80 µm bond line between the GT-RE bonding pads and the PCB bonding 
pads. This bond line is crucial to enabling conductivity between the incredibly small 
bonding pads of the GT-RE and those of the smallest SMDs commercially available. The 
reasoning for this is explained later in the discussion. Conductive epoxy was then applied 
to the PCB bonding pads. The clear nature of the PDMS GT-RE and Parylene-C GT-RE 
made it easy to align the bonding pads by looking through the GT-RE bonding pad region 
at the PCB bonding pads and align both visually before matting the two by hand. Care 
was taken to apply only a limited volume of the liquid conductive epoxy to ensure 
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neighboring bonding pads on the GT-RE or PCB did not short due to inadvertent flow. 
After mating, the GT-RE and PCB were placed in an oven at 120° C for 20 min to cure 
the conductive epoxy. The general concept of this approach for SMT integration is shown 
schematically in Figure 15D and E.  
4.2.7 Hermetic Insulation and Encapsulation (Device, Silicone Tubing, & 
Headcap) 
 Molds for insulating and encapsulating the PCB region (PCB mold) and headcap 
(headcap mold) of the GT-RE’s were first 3-D printed using an Objet Eden 250 (Stratasys 
Ltd.). CAD renderings of the two molds utilized are shown in Figure 15F. A uniform 10 
µm layer of the AZ P4620 photoresist (MicroChemicals) was then spray coated on all 
surfaces of the molds using a Suss MicroTec AltaSpray coater, baked, and exposed. The 
photoresist served as an eventual dissolvable release layer to release the GT-RE PCB 
region and headcap from the molds.  
 Prior to insulation and encapsulation in the molds, the GT-RE’s were treated 
briefly with plasma using ambient air as the source to enhance adhesion. Silicone 
adhesive (40076, Applied Silicone Corporation) was then applied to the cable region 
between the microchannels and the bonding pads for mechanical protection to aid in 
handling. The silicone adhesive was applied uniformly over the top, bottom, and sides of 
the cable region and also served as an encapsulating layer to help with insulation in the 
body.  
 Dilute silicone adhesive for use with the PCB mold was prepared by adding 1.5 
mL of xylene to 1 g of silicone adhesive in a sealed tube and subjecting it to sonication 
for approximately 6 hours until the silicone adhesive was completely dissolved. The GT-
RE’s were again briefly treated with plasma using ambient air to enhance adhesion. The 
PCB region of the GT-RE’s was placed immediately in the PCB mold, immersed in 
dilute silicone adhesive, and subject to vacuum for approximately 1 hour to ensure all air 
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bubbles were removed. During the course of vacuuming additional layers of dilute 
silicone adhesive were added to the PCB mold to account for the shrinking volume of 
dilute silicone adhesive as the xylene was removed. The dilute silicone adhesive would 
also shrink during the curing process and was an advantage creating a more robust 
mechanical seal around protruding components of the GT-RE from the PCB region. The 
dilute silicone adhesive was allowed to cure for a minimum of 24 hours before the PCB 
molds were immersed in ethanol. The ethanol dissolved the photoresist release layer and 
with slight mechanical force, allowed easy removal of the insulated and encapsulated 
PCB region of the GT-RE. Prior to encapsulating the PCB region, some of the GT-RE’s 
were first briefly treated with O2 plasma to enhance adhesion and coated with a 10um 
layer of Parylene C. Later devices avoided this step as adhesion between the GT-RE 
regardless of PDMS or Parylene C substrate was observed to be strongest with silicone 
adhesive. In order to protect the exposed microchannel electrodes from being coated in 
Parylene C, the microchannel region was temporarily enclosed in a Parafilm envelope. 
Similarly the gold pin connector region of the headcap was enclosed in Parafilm. 
 The silicone tubes with signal extraction wires were also filled with dilute silicone 
adhesive aiding in mechanical protection of the signal extraction wires and providing an 
extra layer of insulation. Silicone adhesive (non-dilute) was also applied to the exterior of 
the silicone tubes in a ring shape approximately 3 cm away from the PCB region 
providing a tethering point during implantation as discussed later.  
 Insulation of the signal extraction wires as they entered the Omnetics headcap 
followed a similar procedure as the PCB region of the GT-RE. The GT-RE was again 
treated with plasma using ambient air to increase adhesion. The headcap was 
immediately placed in the headcap mold, immersed in silicone adhesive (non-dilute) and 
allowed to cure for a minimum of 24 hours. The headcap mold was immersed in ethanol 
which dissolved the photoresist release layer and with slight mechanical force, allowed 
easy removal of the insulated and encapsulated headcap of the GT-RE. It should be 
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noted, the ends of the signal extraction wires connected to the headcap were already 
insulated using a proprietary process and epoxy by the Omnetics Connector Corp. As it 
was not known how effective their process and epoxy would be, in-house insulation and 
encapsulation of the headcap was necessitated. As a final measure of insulation the GT-
RE’s were briefly subject to O2 plasma to enhance adhesion and coated with a final 5um 
layer of Parylene C. The parafilm enclosures around the microchannel region and gold 
pins of the headcap were removed and the junction protected with silicone adhesive.  
4.3 Results and Discussion 
4.3.1 Photolithography on PDMS for Flexible/Elastomeric MEAs and 
Interconnects 
 The following details the results of attempts to perform photolithography and 
photoresist patterning on PDMS. A detailed discussion of the issues preventing success 
and the theory behind five processing solutions and why they circumvent the issues 
commonly observed is also present.  
 Much of the underlying issues with performing photolithography on PDMS stem 
from the large coefficient of thermal expansion of PDMS (310 ppm [111]). As a result, 
the PDMS substrate expands and contracts during the various curing steps of the 
photoresists films. Photoresist films in general do not expand or contract at the same rate 
however and are subject to extreme stress resulting in the cracking commonly observed. 
Furthermore, poor adhesion to PDMS requires higher curing temperatures to facilitate 
adhesion when the photoresists are first applied to the PDMS surface. This is in addition 
to pre-treatment of the PDMS with O2 plasma to enhance adhesion. Figure 16A shows 
the initial results of attempts to pattern the photoresist lift-off mask for metal deposition. 
As can be clearly seen, there were a combination of cracking and delamination issues 
commonly observed when performing photolithography on PDMS. Attempts to reduce 
cracking by reducing the curing temperature resulted in increased delamination. Attempts 
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to facilitate adhesion to the PDMS substrate by increase curing temperatures, while 
helping mitigate delamination, resulted in increased cracking. There was no curing 
temperature found at which both the cracking and delamination could be circumvented as 
shown by the presence of both in Figure 16A. Figure 16B shows the initial results of 
attempts to pattern the sacrificial posts for PDMS passivation after metal deposition on 




















Figure 16. Photolithography, metal patterning and passivation with elastomeric 
substrates (PDMS). 
(A) Traditional photolithography for the photoresist lift-off pattern on PDMS resulting in 
cracks and delamination. (B) Traditional photolithography for the photoresist sacrificial 
posts on PDMS resulting in overdevelopment and delamination. (C) Successful metal 
patterning using the 5 processing solutions enabling patterning on PDMS. Stress relief 
features can also be observed along with the successful mitigation of crack propagation 
across the sample. (D) Successful sacrificial post patterning and PDMS passivation using 
the 5 processing solutions enabling patterning on PDMS.  
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over-development of the bulk feature and at the photoresist/PDMS interface resulting in 
structural adhesion failure during washing steps and delamination. As mentioned with the 
lift-off mask, attempts to increase curing temperatures to reduce development rates 
resulted in photoresist cracking. Attempts to maintain the correct feature size and prevent 
delamination by reducing development time resulted in residual photoresist remaining in 
un-crosslinked areas of the substrate.  
 A combination of five different novel processing solutions were implemented to 
circumvent the issues commonly observed with high-density, small feature size 
photolithography on PDMS. These included first, novel stress relief features observed in 
the initial lift-off mask design from Figure 14 as well as in Figure 16C after successful 
Au/Ti metal patterning for the electrodes, traces, and bonding pads. While not having any 
direct implications to the design of the GT-RE, this novel design incorporation is a 
crucial design criterion for successful high-resolution photolithography and patterning on 
PDMS substrates. The stress relief features served to not only significantly decrease the 
extent of cracking observed in the photoresist films, but also prevent crack propagation 
through the sample. This is denoted in Figure 16C by the arrow showing gold deposition 
in a photoresist crack ending at a stress relief feature. Instead of preventing PDMS 
expansion and contraction during the curing steps of the photoresist the stress relief 
features allow this to occur but in areas away from the device features. This helps reduce 
the overall stress the photoresist films are subject to. In addition the stress relief features 
form a protective boundary around the device features helping mitigate crack propagation 
as previously mentioned. It should be noted, the stress relief features utilized in this study 
were not optimized and were in fact a first attempt at the design. The success, in 
combination with the other four processing changes was so large that further optimization 
was not needed for this study’s purposes.  The logical next step however would be to 
optimize the stress relief features for size and shape and understand the interplay this has 
with device feature design through a finite element analysis and modeling exercise.  
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 Second, thick-film photolithography was used where the photoresist used for both 
the lift-off mask and sacrificial posts were 30 µm thick as opposed to the 1 µm – 5 µm 
films commonly used. This increased the inherent strength of the photoresist film and 
helped further reduce the propensity to crack during the various curing steps. The reduced 
propensity to crack allowed an increase in curing temperature which helped mitigate 
delamination. The increased film thickness also enables both the third processing solution 
following in the next paragraph and the fifth processing solution shortly thereafter. This 
is an example of how the five processing changes are intertwined and depend on one 
another.  
 Third, an oven was utilized for all curing steps for the photoresist films instead of 
the traditional hot plate. This enabled more controllable curing as well as a differential 
cure profile of the photoresist film. Heat provided by a hotplate comes from beneath the 
sample via conduction causing solvent within the photoresist film to rise within the film 
and eventually leave the film from the surface. In contrast, heat provided by an oven 
comes from the ambient air inside the oven via convection which uniformly covers the 
photoresist. As a result the surface of the photoresist cures first creating a skin layer. This 
skin layer in turn resists the evolution of solvent from the bulk of the photoresist films. 
[112–114] As a result this dramatically increases curing times needed to obtain a full 
even cure through the bulk of the photoresist film in comparison to a hot plate. This is 
usually considered a disadvantage and is a reason why hot plates are the chosen method 
for photoresist curing. In the case of photolithography on PDMS, this actually provides 
an advantage. The increased cure time allows for more controllable curing. Of 
significance, the formation of the skin layer enables the differential cure profile 
mentioned previously where the skin layer of the photoresist is fully cured as needed for 
feature definition in photolithography. In contrast the layer of photoresist in contact with 
the PDMS substrate retains more solvent and is therefore less brittle and less likely to 
crack during future processing steps. The formation of the differential cure however is 
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dependent on the photoresist film thickness and is enabled by the second processing 
solution as mentioned previously. It should also be noted that with small feature sizes the 
reduced curing of the base of the photoresist film would result in delamination due to 
poor cross-linking and resulting over-development. Larger feature sizes like those used in 
the lift-off mask are resistant to this because of the increased surface area in contact with 
the PDMS substrate and the extra development time needed for delamination to occur.  
 Fourth, exposure times for small photoresist features, such as the sacrificial posts, 
were increased by 250% to account for the reduced curing of the features stemming from 
the third processing solution. The increased exposure resulted in increased crosslinking of 
the features despite the reduce curing and dramatically reduced the subsequent rate of 
development. In turn, the reduce rate of development prevented issues with poor feature 
definition stemming from over-development. The tendency for delamination was also 
reduced as the interface between the PDMS and photoresist was more resistant to over-
development and adhesion failure. It should be noted that the increased exposure time 
would make defining an undercut at the edge of the photoresist feature difficult. An 
undercut was not necessary for the sacrificial posts and therefore this limitation did not 
adversely affect the fabrication of the GT-RE. Increasing the feature size however would 
prevent the tendency for delamination and allow a reduction of the exposure time 
enabling the formation of an undercut if it is desired. An example of this is with the 
photoresist lift-off mask where an undercut was required for adequate lift-off during 
metal patterning.  
 Fifth, the method of un-crosslinked photoresist removal was altered from purely 
development to development and bulk etching, also known as descumming. As 
mentioned a few times previously developing the photoresist for long periods of time 
risks bulk over-development of the features generating incorrect feature sizes and shapes. 
It also drastically increases the likelihood of feature delamination from the PDMS 
substrate. However, it was found that in order to mitigate these issues the resulting 
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reduction in development time resulted in residual photoresist left across the surface of 
the PDMS in non-feature regions. To combat this, the samples were etched using O2 
plasma as part of a prolonged descumming step. Normally this would be an ill-advised 
processing step as longer periods of etching would also etch the photoresist features 
generating incorrect feature sizes and shapes similar to over development, in some ways. 
The interplay with the third and fourth processing changes however prevented this from 
occurring. The generation of the skin layer during the oven curing steps enabled the 
surface of the photoresist to be more resistant to etching than the bulk layers of the 
photoresist, especially those immediately in contact with the PDMS substrate. 
Furthermore, the significantly extended exposure times in the fourth processing step led 
to significantly increased crosslinking of the features and as a result, increased resistance 
to etching compared to non-feature regions.  
 These five processing solutions directly address the underlying issues faced when 
attempting photolithography on PDMS. When enacted together they enable successful 
photolithography on PDMS which can be used for lift-off in metal patterning and 
sacrificial posts in PDMS passivation patterning. As noted earlier, Figure 16C depicts the 
results of successful lift-off and metal patterning for the Au/Ti electrodes, traces, and 
bonding pads. Figure 16D depicts the results of successful sacrificial post patterning and 
subsequent PDMS passivation patterning after sacrificial post removal. Overall these 
patterning successes enabled the fabrication of a PDMS based micro-electrode array that 
was then integrated with microchannels and SMT for peripheral nerve interfacing.  
4.3.2 Parylene C MEAs 
 In contrast to the fabrication of the PDMS MEAs, fabrication of the Parylene C 
MEAs for the Parylene C GT-RE’s was incredibly straightforward and without 
complication. As mentioned in the methods, the fabrication process used for the Parylene 
C MEAs was similar in nature to that of the PDMS MEAs. However this was not 
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necessary because Parylene C is not elastomeric and does not have a large thermal 
coefficient of expansion (35.5 ppm [110]). The original process for the PDMS MEAs was 
used merely for the sake of simplicity. That being said, the fact that the fabrication 
techniques developed for the PDMS MEAs could be used outright for the Parylene C 
MEAs is an indication of the broad applicability of the fabrication techniques and the five 
processing solutions. An oven annealing process was also attempted with the Parylene C 
GT-RE’s post MEA fabrication as it has been reported to aid in adhesion between 
Parylene C layers. [91–93,115] The protocols previously reported were replicated. 
Unfortunately the increased crystallinity of the Parylene C post-annealing was so high it 
could no longer be rolled without substantial cracking. Rampant cracking was also 
observed in the cable region between the microchannels region and bonding pads just 
over the course of additional fabrication even with significant attempts to handle the 
device with care. Accordingly the annealing steps were abandoned. It appears that while 
annealing Parylene C layers is reported to provide advantages in adhesion and water 
permeation, this can only be utilized in relatively immobilized applications such as retinal 
or cortical interfacing. [91,115–117] This is likely due to the reduced need for flexible 
devices and the lack of large mechanical motion with the brain and retina compared to 
the limbs of an individual or animal.  
4.3.3 Microchannel Patterning & 3-D Configuration 
 While patterning SU-8 microchannel walls on PDMS has been previously 
reported [109], significant challenges were initially encountered when attempting this on 
the PDMS MEA’s. Initial attempts resulted in tunnels present at the bottom of the SU-8 
microchannel walls. This can be observed in Figure 17A where a top down view depicts 






















Figure 17. Microchannel patterning and 3-D configuration. 
(A) Tunnels in SU-8 microchannel walls stemming from cracks in the PDMS passivation 
layer shown through a top down and side view of the SU-8 walls. (B) Cracking of the 
PDMS passivation layer stemming from the previous PDMS etching step and mass 
delamination of the SU-8 microchannel walls. Tunnels are present within the SU-8 walls, 
but are not visible at this magnification. (C) Successful patterning of SU-8 microchannel 
walls after utilizing an etching mask during the PDMS passivation fabrication. (D) 
Addition of the PDMS capping layer to the top of the SU-8 microchannel walls forming a 
sheet of microchannels. (E) Rolled sheet of microchannels forming a cylinder of 
microchannels matching the dimensions of a nerve. The electrode trace cable connecting 
to bonding pads (out of image) can be seen on the right.  
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the microchannel walls depicts the cavity at the bottom of the SU-8 microchannel wall. 
These tunnels were present on almost every microchannel across every sample fabricated. 
After investigation it was found these tunnels corresponded to cracks in the PDMS 
passivation layer. These cracks were present across the entire surface of the PDMS 
passivation, even in non-device regions. It was hypothesized that the cracks were 
enlarged during the SU-8 curing steps and as a result created a non-uniform heat profile 
at the bottom of the SU-8 microchannel walls. This resulted in poor crosslinking directly 
above the cracks and tunnel formation during development. Attempts to reduce the curing 
temperatures to reduce the crack enlargement not only did not reduce the presence of 
cracks, but also resulted in mass delamination of the SU-8 feature due to poor adhesion. 
This can be observed in Figure 17B where cracks in the PDMS passivation are widely 
present and SU-8 delamination is also easily visible. The lighting was held at an angle to 
emphasize the cracks in the passivation layer.  
 Given that the cracking was only present in the passivation layer, it was 
hypothesized that they were a result of the etching the PDMS passivation layer during the 
sacrificial post patterning. It should be noted that cracks running over gold traces did not 
result in cracks within the gold traces thereby indicating the cracks were only present in 
the passivation layer. As described in the methods, a PDMS passivation layer etching 
mask was patterned prior to etching to protect all regions of the PDMS. As a result of the 
presence of the etching mask, all cracking in the passivation layer was mitigated. 
Furthermore, there was no evidence of tunnel formation with the SU-8 microchannel 
walls. Successful patterning of the SU-8 microchannel walls on the PDMS MEA can be 
observed in Figure 17C along with the lack of cracks and tunnels. The microelectrodes 
were positioned every third microchannel in the middle of the microchannels. Based on 
these results it was concluded that the cracking observed in the PDMS passivation layer 
stemmed from the etching of the PDMS passivation to undercover the sacrificial posts. 
Cracking was also observed when etched with CF4 instead of SF6. While this has not 
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been reported previously using a similar etching processes, prior studies did not attempt 
to pattern on top of etched PDMS and would not have encountered this issue. 
[82,90,118,119] 
 Patterning SU-8 microchannel walls on the Parylene C MEAs for the Parylene C 
GT-RE’s was in contrast fairly straightforward again and proceeded according to 
previously published work as mentioned in the methods. However, it is worth noting that 
initial attempts included a brief O2 plasma treatment which resulted in residual SU-8 
remaining post development in un-exposed regions. This was predominantly the case on 
the gold electrodes and bonding pads and is thought to be due to significantly enhanced 
adhesion to the gold. Accordingly the O2 plasma treatment was avoided. Delamination in 
either case was never observed.  
 After successful patterning of the SU-8 microchannel walls on both the PDMS 
and Parylene C MEAs, the capping 10 µm PDMS layer was adhered on top of the walls 
as shown in Figure 17D for an example Parylene C MEA. The methodology reported 
here for accomplishing this, while similar, was significantly less complicated and 
intricate than previously reported. [109] There were a total of 97 microchannels and when 
this sheet of microchannels was rolled, it formed a cylinder of microchannels 
approximately 1.5 mm in total diameter (Figure 17E). The use of silicone adhesive to 
prevent unrolling of the microchannel layers in the Parylene C GT-RE’s proved highly 
effective as unrolling was never an issue. However, if silicone adhesive was not used, it 
was found to be impossible to keep the microchannel sheet rolled long enough to enable 
placing the nerve cuff around it. Silicone adhesive was not necessary with the PDMS GT-
RE’s as the various PDMS layers adhered well to each other and prevented unrolling. A 
consequence of rolling the microchannel sheet by hand was the tendency to obtain more 
of an oval cross-section as opposed to perfectly circular. This however was an 
inconsequential result and did not affect device performance. Additionally, there was a 
small open core through the center of the rolled microchannels. This has been reported 
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previously and does not adversely affect regeneration through the microchannels 
themselves. [109] 
4.3.4 SMT Integration  
 Easily integrating micro-chips and other electronics is incredibly important to the 
overall utility of any flexible/elastomeric device, not just the GT-RE or a peripheral nerve 
interface. As mentioned previously it provides the opportunity to integrate components 
into the device, such as a high channel wireless data transmission chip, which may not 
exist yet. The vast majority of electronic components commercially available come in 
surface mount packaging necessitating surface mount integration techniques which have 
traditionally been challenging and complex.  
 The methodology reported here directly addresses this need, is incredibly simply 
to implement and is translatable to industry practices. As mentioned in the methods a 
spacer was used to set an 80 µm bond line between the surface mount bonding pads of 
the PCB and those of the GT-RE. This bond line is crucial and is what enables the surface 
mount approach to provide stable conductivity. Due to the incredibly small bonding pads 
and proximity between the pads of the GT-RE and those on commercial components 
available, an incredibly small volume of conductive epoxy is necessitated to avoid 
shorting neighboring bonding pads. Initial attempts to merely place a small volume of 
conductive epoxy between the sets of bonding pads without the spacer yielded an open 
circuit despite the presence of conductive epoxy. 
  The conductive epoxy is a two part solution consisting of an epoxy base and 
silver particles. It was observed that application of small volumes led to a reduced ratio of 
silver particles to epoxy. This was believed to be the inherent issue behind the poor 
conductivity. Furthermore, upon curing the epoxy shrinks and with the reduced number 
of silver particles this led to an open circuit. This was validated experimentally by 
drawing straight conductive epoxy traces of different thicknesses/widths on glass. As the 
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volume of the trace was reduced, conductivity from one end of the trace to the other also 
disappeared. Based on these observations, the devised solution became to ensure a larger 
presence of silver particles in the volume of applied conductive epoxy. As the conductive 
epoxy was supplied by the manufacturer at a standard ratio of silver particles to epoxy, 
reducing the epoxy content was not feasible. Furthermore, reducing the epoxy content 
would have increased the viscosity of the conductive epoxy making it extremely 
challenging to deliver small volumes on the order of a single nanoliter.  
 Instead a spacer was introduced between the sets of bonding pads to enable a 
larger volume of conductive epoxy (2 – 3 nanoliters) to be applied without concern of 
shorting neighboring bonding pads. This volume was calculated based on the size of the 
bonding pads and the thickness of the spacer. The spacer created an 80 µm bond line 
which provided a larger z-axis for the conductive epoxy to occupy. This can be observed 
in Figure 18A where a side view of the GT-RE bonding pads and PCB ponding pads is 
shown with a ‘column’ of conductive epoxy providing the electrical connection. In this 
image a 120 µm bond line was used to aid in visualization. A top down view is also 
shown where both sets of bonding pads can be seen along with conductive epoxy and 
another set of bonding pads lacking conductive epoxy. The slight increase in volume of 
conductive epoxy determined by the bond line ensured a higher silver particle to epoxy 
ratio which resulted in a closed circuit between the sets of bonding pads. Of note, the GT-
RE bonding pads were 190 µm x 105 µm which is comparable to the terminals of the 
smallest commercially available chip resistors (01005: 200 µm x 100 µm terminals) and 
components used in today’s electronics. The ‘column’ of conductive epoxy proved to be 
mechanically stable as failure due to the GT-RE – PCB junction was never observed 
during the fabrication process or after implantation. Attempts to physically remove the 
PCBs from the PDMS substrate resulted in failure and tearing of the PDMS substrate, not 
the PDMS-conductive epoxy interface indicating a high bond strength. Furthermore, the 












Side view Bottom view
2mm
Intan Tech. microchip
Surface mount PCB w/ 
off-chip components
 
Figure 18. Surface mount technology (SMT) integration. 
(A) Side view and bottom up view of a surface mount PCB attached using a column of 
conductive epoxy. The bondline resulting from the spacer (out of image) between the 
substrate MEA and PCB is identified in the side view. Two layers of conductive epoxy 
pertaining to two connected sets of bonding pads are shown in the bottom up view. (B) 
Integration of the Intan Technologies microchip and off-chip components with the GT-
RE. 
 
is unlikely to affect any application utilizing this approach. In fact, a bond line of 40 µm 
was validated for conductivity but was not utilized due to difficulties with hand 
application of such small conductive epoxy volumes. Industry grade dispensers would 
likely not have this issue. This approach is therefore widely applicable to the integration 
of the smallest surface mount devices commercially available with flexible and 
elastomeric substrates for a wide range of applications.  
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 The goal of developing this SMT integration approach was to allow the easy 
integration of both the Intan Technologies 32 channel multiplexer amplifier chip 
(including off-chip components) and a PCB hub with signal extraction wires. The Intan 
Technologies chip was integrated with the PDMS GT-RE (Figure 18B) and was utilized 
only in an in vitro setting for reasons detailed later. The PCB wire hub with signal 
extraction wires was integrated with the Parylene C GT-RE and was utilized in an in vivo 
setting.  
4.3.5 Hermetic Packaging 
 To enable operation of the PDMS GT-RE with the Intan Technologies chip and 
the Parylene C GT-RE with the PCB wire hub in aqueous based environments such as 
peripheral nerve interfacing, hermetic packaging techniques were developed. These 
techniques centered on the use of Parylene C for insulation and silicone adhesive for 
mechanical protection and insulation. While Parylene C was deposited using vapor 
deposition polymerization, the silicone adhesive was supplied as a viscous liquid 
requiring the development of molds for encapsulation and a release layer from the molds. 
The release layer utilized was a positive photoresist which was spray coated uniformly 
over the mold. This was a highly effective release layer allowing easy removal of the 
encapsulated parts. It is important that a positive photoresist was used because exposure 
to light allowed the photoresist to become soluble in developers. Negative photoresists on 
the other hand would have undergone crosslinking when exposed to light making them 
insoluble and necessitated that the mold be utilized in a dark room devoid of light to 
avoid crosslinking.  
 In addition to the insulation and encapsulation of the PCB hub with the Parylene 
C GT-RE’s, the signal extraction wires were divided up, braided and threaded through 
two silicone tubes for mechanical protection and further insulation. This can be seen in 










Figure 19. Hermetically encapsulated Parylene C GT-RE integrated with signal 
extraction wires for in vivo implantation. 
(A) Top down view showing the surface mount PCB with signal extraction wires. (B) 
Side view where the microchannel region is visible. 
 
the total footprint of the GT-RE was approximately 9 mm x 12 mm. The cable connecting 
the microchannel micro-electrodes to the bonding pads was kept at an angle during 
silicone adhesive encapsulation which forced it to cure in the angle observed. This 
allowed the microchannel region to be placed over the PCB and reduce the overall 
footprint of the GT-RE. A local ground wire can also be observed near the PCB region.  
In these images, the stainless steel wrap around the microchannels has been omitted to 
enable better visualization of the microchannel region and nerve cuff. The encapsulated 
PDMS GT-RE with the Intan Technologies chip can be observed in Figure 20. Here the 
microchannel region was left unrolled and lacked the SU-8 microchannel walls to 







Figure 20. Hermetically encapsulated PDMS GT-RE integrated with Intan 
Technologies microchip for multiplexing and amplification. 
(A) Examples of the PDMS GT-RE flexibility. (B) Example of PDMS GT-RE 
stretchability. Note that in these images the GT-RE lacked the SU-8 microchannel walls 
for demonstration purposes. 
 
 The hermetic packaging for the PCB region and headcap was the most 
challenging aspect of the entire fabrication process as the silicone adhesive steps were 
largely done by hand application or utilized molds for encapsulation. During the silicone 
adhesive encapsulation small air bubbles would occasionally remain within the silicone 
adhesive during the curing process. These were not a concern however as they were not 
in contact with the PCBs, signal extraction wires or any other electrical connection. So 
while silicone adhesive is an imperfect moisture barrier and moisture /water would 
eventually accumulate within the air bubbles, this would not adversely affect the function 
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of the GT-RE’s. Regarding the signal extraction wires, braiding and filling the silicone 
tubes with silicone adhesive proved to be a mechanically robust method of protecting 
them from mechanical forces during fabrication and implantation. Due to the braiding 
and presence of the silicone adhesive, any forces applied to a single wire would get 
distributed across the 16 other wires within the silicone tube. Breakage of wires was 
never observed.  
4.4 Conclusions 
 Taken together, the five processing solutions for photolithography on PDMS, 
SMT integration technique, and hermetic packaging approaches enabled the fabrication 
of flexible and elastomeric GT-RE’s with PDMS or Parylene C as the substrate material 
for use as an implantable peripheral nerve interface. Besides applicability to peripheral 
nerve interfacing, the five processing solutions developed enable the patterning of high-
density MEAs and interconnects using industry translatable processes for flexible and 
stretchable electronics. The novel stress relief features provide a new avenue of 
investigation for mask design criteria when patterning on materials with large thermal 
coefficients of expansion. Furthermore, the interplay between thick-film 
photolithography, oven curing processes, exposure time, feature size, and development 
vs. etching are all important considerations which need to be evaluated together. Any one 
of these alone is unlikely to enable mass development of PDMS based electronics. 
However together, they drastically increase the viable processing window one can utilize 
for fabrication. The SMT integration technique developed addresses the critical need for 
an easy, industry translatable technique for incorporating off the shelf commercial 
components necessary for advanced flexible/elastomeric electronics, including neural 
interfaces. The hermetic packaging approach utilized two established methods for 
insulating and encapsulating the GT-RE enabling evaluation in an aqueous environment, 
a fundamental criterion for awake and freely moving electrophysiology in animals.  
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CHAPTER 5   
 Evaluation of the Georgia Tech Regenerative Electrode (GT-RE) for 
Single Unit Action Potential Recordings 
5.1 Introduction 
 Today, neural prosthetics provide a small fraction of the functionality of the 
natural limb they are meant to replace. However, compelling evidence in the last decade 
has shown that amputees retain significant motor and sensory function in peripheral 
nerves post-amputation which has paved the way for bidirectional sensorimotor 
prosthetics. [1] A bidirectional sensorimotor prosthetic aims to record volitional motor 
commands from peripheral nerves to control a robotic limb, while sensors on the device 
produce direct stimulation of peripheral nerves to deliver sensory feedback. Advances in 
robotics have led to high dimensionality robotic limbs, but the peripheral nerve interface 
(PNI) remains the “weak-link” due to the lack of reliable, specific engagement of large 
numbers of independent electrodes with the peripheral nerve. It is imperative for a fully 
functional peripheral interface to communicate with the nerve in a highly specific and 
reliable manner so to deliver and receive discrete information relevant for natural 
sensation and movement. 
 Penetrating peripheral nerve interfaces, such as the Utah Slanted Electrode Array, 
must penetrate the nerve in order to place its electrode tips near axon profiles and provide 
the specificity needed. [39,41,120] Cuff electrodes have seen some clinical translation 
and mitigate this injury to the nerve, but do so at the expense of recording and stimulation 
specificity. [36–38] The cuff electrodes reside outside the nerves epineurium where the 
distance from axons is too great to record single unit action potentials. [6,39] 
Accordingly, while being helpful in a number of clinical applications, their overall utility 
is limited. Regenerative peripheral nerve interfaces, including the traditional Sieve 
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electrode, seek to provide a balance of specificity without nerve injury by allowing 
nerves and axons to regenerate close to integrated electrodes. [48,51,54,121,122] It is 
important to note that this in many ways necessitates a target clinical population of 
amputees or individuals with a nerve injury where the device can be implanted at the time 
of surgery. Unfortunately all of these hallmark peripheral nerve interfaces, while 
significant engineering accomplishments, fail to record large numbers of single unit 
action potentials from axons chronically and cannot enable the full functionality of a 
robotic limb. [4–6,39,40,53,54] 
 Microchannels are a relatively new approach to peripheral nerve interfacing and 
offer some unique and significant advantages over these previous approaches. One of the 
fundamental issues with peripheral nerve interfacing is the low impedance extracellular 
fluid surrounding axons. This low impedance fluid significantly reduces the extracellular 
amplitude of action potentials (APs) by effectively shunting them to ground and as a 
result reduces the viability of all previous PNI approaches. [6] Another important 
consideration is the node of Ranvier placement which occurs at least every 2 mm along 
the length of an axon. [7,55] Nodes of Ranvier are locations of an axon where the AP is 
largest in amplitude due to a gap in myelin insulation. This forces a spatial requirement 
on peripheral nerve interfacing where electrodes need to be as close to the nodes as 
possible. Previous peripheral nerve interfacing approaches are unable to take this spatial 
requirement into account, again reducing overall electrode viability. [6,39,46,53] In 
contrast, axons can be placed or forced to regenerate through small microchannels on the 
order 100 µm. Doing so effectively constrains the low impedance extracellular fluid 
thereby increasing the extracellular resistance and preventing the AP signal from 
dissipating as easily. As a result the extracellular amplitudes of the APs are significantly 
larger enabling higher signal to noise recordings. [6] Furthermore, making the 
microchannels longer than 2 mm effectively guarantees the presence of a node of Ranvier 
within the microchannel. This coupled with the increased extracellular resistance enables 
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node of Ranvier independent recordings because the amplitude of the AP signal is 
relatively constant throughout the microchannel. [6] This theory has been modeled and 
well validated in previous in vitro studies. [6,56] 
 Microchannel in vivo studies have focused on evaluating the efficacy of recording 
single unit action potentials using electrodes contained within the microchannels. These 
rodent studies have ranged from acute recordings where axons have been placed within 
microchannels to terminal recordings after chronic implantation where axons have 
regenerated through microchannels. [49,50,58,59,109] Significant work has also gone 
into validating the chronic stability of nerves and axons after they have regenerated into 
and through microchannels with an eye towards clinical translation to an amputee 
population. [109] However, none of these previous studies have evaluated a fully 
integrated microchannel interface with large numbers of microelectrodes and signal 
extraction capabilities enabling recordings in awake and freely moving rodents. This is a 
needed next step on the path towards clinical translation.  
 Here we have developed and evaluated a microchannel interface, the Georgia 
Tech – Regenerative Electrode (GT-RE), and its ability to be utilized for challenging 
single unit action potential recordings in awake and freely moving rodents. First, in vitro 
functionality of the GT-RE’s was explored using artificial neural signals. Secondly, in 
vitro dorsal root ganglia (DRG) studies were utilized to validate cytocompatibility after 
microfabrication of the GT-RE’s which involved a number of toxic solvents and 
processes. Finally, in vivo the large electrode count GT-RE’s were implanted in the rat 
sciatic nerve transection model. In vivo recordings were performed while the rats were 
awake and ambulating to evaluate the capability to record single unit action potentials 





5.2 Materials and Methods 
5.2.1 GT-RE Design 
 The basic concept of the GT-RE microchannel interface was shown previously in 
Figure 13. A micro-electrode array (MEA) was integrated into a flexible polymer layer, 
either PDMS or Parylene C. The electrodes were 80 µm x 40 µm and spaced once every 
third microchannel to allow for an equal distribution of electrodes throughout the cross-
section of the GT-RE post rolling. A common bipolar reference was placed near the 
bonding pads and a common pseudo-tripolar reference was designed with electrode sites 
at the entrance and exit of every microchannel containing an electrode. In some cases 
during in vivo testing a local low impedance wire was used as a bipolar reference instead. 
The referencing design along with the electrodes, traces, and bonding pads was shown 
previously in Figure 14. SU-8 microchannel walls were patterned on top of the flexible 
MEA and a capping PDMS layer was then adhered on top of the SU-8 microchannel 
walls. This formed a sheet of 97 microchannels with electrode sites housed in the base of 
the microchannels. This sheet was rolled perpendicularly to the direction of the 
microchannels forming a cylinder matching the shape and size of the rat sciatic nerve. 
The microchannels were 100 µm wide, 100 µm tall, and 3.5mm long with 20 µm wide 
microchannels walls. These dimensions were based on previous work that in part 
investigated microchannel sizes and the relationship to nerve regeneration in a clinically 
translatable amputee animal model. [109]  
 Metal traces connected to the micro-electrodes in the microchannels ended at a 
series of bonding pads intended for surface mount connection to a PCB. The PCB 
integrated with the PDMS GT-RE’s contained the Intan Technologies 32-channel 
amplifier multiplexer micro-chip (RHA2132) and associated components. The PDMS 
GT-RE’s were utilized in in vitro functional testing. The PCB integrated with the 
Parylene C GT-RE’s was used as a wire attachment hub and had 34 multi-stranded 
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stainless steel wires soldered accounting for the electrodes, references, and a local 
ground. These signal extraction wires were connected to an Omnetics 36 channel 
percutaneous connector which allowed eventual connection to a separate off-board 
amplifier for electrophysiology experimentation. The Parylene C GT-RE’s were used in 
both in-vitro and in vivo functional testing.  
5.2.2 In Vitro Functionality  
 Previously recorded neural signals were used as an artificial signal source to 
evaluate the GT-RE functionality. The GT-RE’s were placed with the 
electrode/microchannel region submerged in PBS. The previously recorded neural signals 
were output from a computer as an audio signal and, using a stripped audio cable 
submerged into the PBS, played into the PBS. It was attempted to then record the 
artificial neural signals through the PDMS GT-RE electrodes integrated with the Intan 
Technologies micro-chip or the Parylene C GT-RE electrodes integrated with the PCB 
hub for signal extraction wires. 
5.2.3 In Vitro Cytocompatibility 
 In vitro cultures of lumbar dorsal root ganglia (DRGs) were used to assess the 
cytocompatibility of the GT-RE’s post fabrication accounting for the fabrication process 
and various solvents used. Given the similarity between the fabrication process for the 
PDMS and Parylene C GT-RE’s and the fact that cytcompatibility was previously 
evaluated for PDMS/SU-8 microchannels [109], only Parylene C GT-RE’s were utilized 
in this experiment. The culture methodology has been previously reported [109]. Briefly, 
unrolled GT-RE’s lacking the PDMS cover layer were placed at the bottom of tissue 
culture wells. No protein coatings of any kind, such as laminin, were used to help with 
cell adhesion or overall cytocompatibility. DRG’s were explanted from P0 rat pups, the 
nerve roots were dissected away and the DRG’s were placed on the unrolled GT-RE’s at 
the entrance to the microchannels. During the first several hours of incubation a thin layer 
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of DMEM/F12 media with 10% fetal bovine serum and 50 ng/mL nerve growth factor 
(NGF) (Roche) was applied prevent the DRG’s from floating and allow adhesion to take 
place. Following this the culture wells were filled with the same media which was 
replaced every two days including the NGF.  
 The DRG cultures spanned a total of two weeks at which point they were fixed 
with 4% paraformaldehyde in PBS for 20 min and washed three times with 1X PBS. To 
allow visual assessment of neurite outgrowth, Schwann cell migration, and overall 
cytocompatibility, the cultures were reacted with antibodies to the 160 kDa neurofilament 
protein (1:500, mouse IgG1 NF160, Sigma) and S-100 (1:250, rabbit IgG S100, Dako) 
overnight at 4° C. This was followed by the secondary antibodies goat anti-mouse IgG1 
Alexa 594 (1:220, Invitrogen) and goat anti-rabbit IgG Alexa 488 (1:220, Invitrogen). 
Finally, cell nuclei were marked by incubating in DAPI diluted to a concentration of 10 
mM in PBS for 15 min at room temperature. The fluorescently labeled cells and nuclei 
were visualized using a Zeiss upright microscope and the images were captured with an 
Olympus digital camera. 
5.2.4 GT-RE Implantation, Electrophysiology and Signal Analysis  
 To prepare the GT-RE’s for implantation, a silicone tube was placed around the 
rolled microchannels acting as a nerve cuff for suturing. Stainless steel foil (Multipurpose 
304 Stainless Steel Foil .002" thick, McMaster-Carr) was then wrapped around the nerve 
cuff and connected to a ground wire acting as an implantable electrical shield for the GT-
RE. The stainless steel wrap served as a large ground and pseudo-faraday cage to help 
shunt EMG and other electrical artifact to ground. There was also another short 2 cm wire 
emanating from the headcap which was wrapped around a stainless steel screw using to 
secure the headcap to the skull. This served as another ground in the case of wire 
breakage. For sterilization purposes, the GT-RE’s were immersed in ethanol for 24 hours. 
A vacuum line was used to ensure ethanol was drawn into and through the microchannels 
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and to prevent bubbles from remaining. After 24 hours the GT-RE’s were transferred to 
sterile PBS and incubated for another 24 hours to remove all traces of ethanol prior to 
implantation. The transfer took place without breaking a liquid environment ensuring air 
was not introduced to the microchannels.  
 The GT-RE’s were implanted in the rat sciatic nerve transection animal model. In 
isoflurane anesthetized rats, the sciatic nerve was transected at the mid-thigh and the GT-
RE was sutured to the proximal and distal segments of the cut nerve. The musculature 
was then reapposed with the two silicone tubes containing the 34 signal extraction wires 
emerging from between the muscle flaps. The silicone tubes and attached headcap were 
burrowed subcutaneously to a midline incision at the top of the skull. Importantly, the 
silicone tubing was tethered using non-resorbable 5-0 sutures to the underlying 
musculature along its path to the skull in order to provide strain relief during normal rat 
movement. These tethering points occurred near the upper thigh and then again above the 
spinal cord by the pelvis creating a large S-shaped curve. At the midline incision, the 
periostium was retracted with a periostium scraper. 40% phosphoric etch gel (Henry 
Schein) was applied to clean the skull surface and six stainless steel screws were drilled 
into the skull. Screws were placed anterior to bregma, posterior to bregma and posterior 
to lambda, on both sides of the midline. Next, the burrowed head stage was situated onto 
the skull and affixed using UV curable dental cement (Henry Schein) which was applied 
to the screws and the head stage. The skin was then wound clipped around the head cap 
forming a percutaneous connector for the electrophysiology experiments. 
 Electrophysiology experiments were performed 3 weeks after the GT-RE 
implantation. Recordings using the GT-RE were taken while the implanted rats were 
ambulating on a treadmill in order to record ‘naturally occurring’ single unit action 
potentials. This is in contrast to electrically evoked multi-unit activity which requires 
stimulation of the nerve and is not nearly as challenging or translatable in terms of 
assessing neural interfacing capability. The general electrophysiology methodology has 
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been reported previously. [123,124] Briefly, the rats were placed on a level, single lane 
Plexiglas-enclosed treadmill (53 cm x 10 cm x 14 cm; Columbus Instruments, Columbus, 
OH, USA) set to a modest speed of 10 m/min. The implanted GT-REs were connected to 
an amplifier through the percutaneous headcap connector. 100 seconds of recordings 
were taken, amplified by 1000x using a bandpass of 300 – 3000 Hz and digitized for off-
line analysis. Additional filtering was performed in software from 400 Hz to 3200 Hz 
using a 4 pole Butterworth filter. All recorded signals were sampled at 10KHz. Single 
unit action potentials were identified and sorted using the publicly available semi-
automated spike sorting algorithm Wave_clus. [125]  
 The number of microelectrodes that recorded single unit action potentials was 
used to determine the overall electrode yield of the GT-RE. To ensure that the identified 
single unit action potentials were not double counted across two or more electrodes, a 
cross-talk screen was performed. One millisecond time windows centered on the 
timestamps of an AP recorded using a given electrode in a device were compared to the 
timestamps of all other APs identified across all other electrodes of the same device. If 
there was more than 50% overlap between the occurrence/timestamps of multiple APs, 
the waveforms were visually analyzed for similarity in shape, excluding differences in 
amplitude and numbers of occurrence. Similarity in amplitude was not used as 
determinant criteria of cross-talk due to the fact that if an action potential acquired from a 
given electrode also appeared on another through cross-talk, it would likely appear 
reduced. The number of occurrences of the single unit action potentials was also not used 
as a determinant criteria based on similar logic. The number of occurrences of an AP 
could at most be the same, if not likely fewer on the receptive electrode than the source 
electrode conducting the true signal. If it was determined that across two or more 
electrodes the waveform shapes were visually identical, the action potential was then 
assigned to the electrode which recorded the largest average amplitude and greatest 
number of occurrences of that waveform.  
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5.3 Results 
5.3.1 In vitro Functionality 
 The GT-RE’s microelectrodes were functionally tested in vitro for their ability to 
be used to appropriately detect neural signals. The microelectrodes had a mean 
impedance of 640 kΩ measured at 1 kHz. Evaluating the ability to record neural signals 
was accomplished by recording an audio neural signal played into PBS containing the 
GT-RE. A schematic of the setup is shown in Figure 21A. An example of the recorded 
audio neural signals, along with a magnified portion showing single unit action 
potentials, taken using the Parylene C GT-RE integrated with the PCB hub for signal 
extraction wires is shown in Figure 21B. This recording was obtained from a single 
microelectrode of the Parylene C GT-RE. Single unit APs as small as approximately 30 
µV in amplitude were successfully recorded. A similar recording taken using the PDMS 
GT-RE integrated with the Intan Technologies 32 channel multiplexer amplifier chip is 
shown in Figure 21C. Microelectrodes with traces that were physically cut on purpose in 
both the Parylene C and PDMS GT-RE’s did not result in successful recordings of the 
audio neural signals, as expected.  
5.3.2 In vitro Cytocompatibility 
 DRGs were cultured on unrolled GT-RE’s lacking the capping PDMS layer to 
assess overall cytocompatibility for a peripheral nerve interfacing application. In general 
the DRGs adhered well to the Parylene C where they were initially placed at the entrance 
to the SU-8 microchannels. A representative DRG culture stained for axons (red) and 
Schwann cells (green) is shown in Figure 22A. The electrodes and traces are the curved 
darker vertical lines and the SU-8 microchannel walls are the faintly fluorescent 
horizontal lines. The DRG is located on the left side of the microchannels. Portions of the 
image appear overexposed due to the high degree of cellular growth. Despite the intense 
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Figure 21. In vitro functional testing using artificial neural signals. 
(A) Schematic of in vitro setup where an audio cable was used to play artificial neural 
signals into PBS containing the GT-RE. (B) Example recording of the artificial neural 
signal taken using the Parylene C GT-RE integrated with a PCB hub for signal extraction 
wires validating functionality. (C) Example recording of the artificial neural signals taken 














Figure 22. In vitro cytocompatibility studies of the GT-RE. 
(A) DRG in vitro culture with axon processes and migrating Schwann cells on ‘open’ 100 
µm wide microchannels. Axons bundles and Schwann cells observed emanating from the 
DRG were aligned and oriented in the microchannels. The axons and Schwann cells 
grew/migrated out past the 3.5 mm long microchannels where the axons bundles appear 
to disperse. Axons (red); Schwann cells (green); DRG and regions of axon/Schwann cell 
co-localization appear orange; Microchannels are visible as dark horizontal regions 
separated by faintly auto-fluorescent SU-8 walls; Electrode traces are visible as vertically 
curving lines. (B) Bright field images of axons and Schwann cells at the electrode region 
of the microchannels and at the end of the microchannels.  A sheet of Schwann cells is 
present over the entire substrate making it difficult for individual cell identification. 
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supporting multi-cellular growth emanating from the DRGs. Both axons and Schwann 
cells grew and proliferated in a highly robust manner past the end of the microchannels in 
under 2 weeks. In general, axon extension and Schwann cell migration were aligned and 
oriented in the direction of the microchannels. Axon extension and Schwann cell 
migration from the explanted DRGs also appeared to be preferential towards the 
microchannels. The degree of extension and migration towards the microchannels was so 
extreme that the bulk mass of the DRGs actually moved onto the microchannels from 
their original location at the entrance of the microchannels.  
 Axons emanating from the DRG’s formed bundles of axons similar in nature to 
fascicles found in nerves in vivo. For the most part these bundles stayed within a single 
microchannel, but at times can be observed growing over the microchannel wall into a 
neighboring microchannel. However, the growth continued in a general unidirectional 
manner. Regardless of the microchannel, the axons, and Schwann cells, seemed equally 
likely to grow on the Parylene C substrate as the SU-8 microchannel walls. It was also 
observed that the axon bundles tended to disperse at the end of the microchannels (Figure 
22A). It was difficult to fluorescently image the Schwann cells due to the large degree of 
proliferation and resulting fluorescence intensity. The exposure time had to be 
significantly reduced as a result making the degree to which Schwann cells are present 
seem significantly less than in reality. Bright field images of the microchannel region and 
exit side of the microchannels have been included in Figure 22B to illustrate the striking 
degree of proliferation. A ‘sheet’ of Schwann cells was present on the surface of the GT-
RE.  
5.3.3 In vivo Electrophysiology 
 All 4 Parylene C GT-RE’s, with an average of 19 electrodes (63.33 %) ± 3.9 
standard deviation, successfully recorded a multitude of unique single unit action 
potentials 3 weeks after implantation in an awake and freely ambulating scenario. As 
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noted in the Methods, single unit APs were deemed unique based first on a comparison of 
the timestamps of the APs. If the occurrence of different APs overlapped more than 50% 
the waveforms were visually assessed for similarity in shape. If deemed similar, the AP 
was assigned to a single electrode to prevent double counting the AP across two or more 
microelectrodes. The average peak-to-peak amplitude of the APs was approximately 125 
µV with a 77 µV standard deviation. The average signal-to-noise ratio (SNR) was 
calculated by dividing the peak-to-peak amplitude of each AP by the peak-to-peak noise 
band (2 times the standard deviation) and averaging the resulting individual SNRs. This 
was found to be 2.98 with a 1.4 standard deviation. Note that the APs were not subtracted 
out or removed from the raw signal for noise band calculation. In some cases the 
presence of large artifacts during a given trial would affect the noise band calculation. 
These trials were not included in the analysis. Figure 23 depicts a stereotypical raw signal 
recorded using an electrode from a single GT-RE. Identified single unit APs from the raw 
signal along with the respective spike raster plots are shown as well. In many cases, 
multiple single unit APs could be identified in a recording from a single electrode. 
However, extensive spike sorting to identify all possible single unit APs recorded using 
every electrode was not performed due to the time intensive nature of the analysis. Figure 
24 depicts an example GT-RE and all the micro-electrodes integrated in the 
microchannels that were successfully used to record single unit APs. Examples of the 
APs from all of the micro-electrodes are shown alongside the MEA image.   
 An evaluation of the success of each microelectrode in recording an AP based on 
spatial location within the cross-section of the GT-RE was also performed. Each 
microelectrode position was taken, and out of the four GT-RE’s, evaluated for the % 
success in recording an AP. This is depicted as a color map in Figure 25A where solid 
green, light green, light red, and solid red indicate the given microelectrode recorded an 
AP in 100%, 75%, 50%, and 25% of the GT-RE’s, respectively. A statistical analysis was 
performed comparing the average percent success of recording an AP using the innermost  
 109 

















































0 10 20 30 40 50 60 70 80 90 100





Figure 23. GT-RE in vivo stereotypical recording in awake and ambulating rats. 
(A) Spike raster plots of two identified APs from the raw signal shown in (B). (B) Raw 
recording signal over 100 seconds. (C) Waveforms of two single unit action potentials 
identified in the raw signal. Dotted lines signify 1 standard deviation from the mean. 
Colors correspond to the raster plots in (A). 
 
15 microelectrodes vs. the outermost 15 microelectrodes. This is depicted in Figure 25B 
where the inner half of the microelectrodes in the GT-RE were on average 15% more 
successful at recording APs compared to the outer half of the microelectrodes. 
 While the Parylene C GT-RE’s were all successful in recording a multitude of 
single unit action potentials at week 3, by week 6 the Parylene C insulation exhibited 
signs of delamination from the Parylene C base layer in the cable region of the GT-RE. 
This is shown in Figure 26 where forceps have been inserted between two previously 
adhered Parylene C layers after they were physically separated. As such, recordings were 
not analyzed at the 6 week time point. However, it is important to note that while the 
Parylene C GT-RE’s were eventually non-viable and the Parylene C exhibited signs of 





Figure 24. Collage of AP waveforms from a GT-RE. 
Example waveforms recorded using a single GT-RE. Dotted lines signify 1 standard 
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Figure 25. Recording success of inner microelectrodes compared to outer 
microelectrodes across all GT-RE’s.  
(A) Color map of percent success of recording an AP for each microelectrode across all 
GT-RE’s. Solid green indicates the given microelectrode successfully recorded an AP in 
all GT-RE’s. Light green indicates the given microelectrode recorded an AP in 75% of 
the GT-RE’s. Following from this, light red indicates 50% of the GT-RE’s and solid red 
indicates 25% of the GT-RE’s. * indicates microelectrodes that were not connected 
during recordings and therefore not included in the analysis. (B) Quantitative analysis of 
the average percent success of recording an AP using the inner electrodes of the GT-RE 
compared to the outer electrodes of the GT-RE. On average, the inner half of the 
microelectrodes in the GT-RE were statistically more successful at recording an AP 














Figure 26. Parylene C GT-RE delamination. 
(A) Example of delamination in the Parylene C cable between the passivation and 
substrate layers after 6 weeks of implantation. The rolled microchannel region with the 
regenerated nerve is clearly visible. Gold traces in the Parylene C cable leading from the 
microchannel region to bonding pads (out of image) are also clearly visible. (B) Forceps 
have been inserted between the Parylene C passivation layer and Parylene C substrate 
layer to aid in identifying the region of delamination. 
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delamination from the Parylene C it was initially adhered to or itself. This is despite 
extensive physical attempts to cause visible delamination of the silicone adhesive. The 
PDMS GT-RE’s, utilizing the PCB wire hub, were also implanted and recordings 
attempted at the 3 week time point. However the recordings lacked identifiable 
waveforms and had a peak-to-peak noise band of approximately 4 µV indicative again of 
delamination and a short to ground. This was immediately validated upon explantation 
where the various PDMS layers had separated exposing the microelectrode traces and 
conductive epoxy junctions to the body.  
5.4 Discussion 
 The vast majority of commercially available advanced prosthetic limbs provide 
only a fraction of the functionality of the natural limb they are meant to replace. This 
short coming largely stems from an individual’s inability to ‘control’ the advance 
prosthetic.  As a result, there remains a great need to design technology that enables 
seamless integration between conscious thought and resulting prosthetic limb movement 
for amputees. Peripheral nerve interfacing has the potential to provide such integration by 
obtaining neural signals from an amputated nerve which are intended for muscle 
activation and natural limb movement. These biological signals can then be translated 
into digital input for robotic limb control. Furthermore, there is the opportunity to implant 
a peripheral nerve interface at the time of surgery in the cases of amputation or nerve 
repair.  
 In the last 5+ years, there have been significant advancements in establishing the 
groundwork for microchannels as a viable avenue to chronic peripheral nerve interfacing. 
Acute non-regenerative implementations of microchannels have been evaluated where 
dissected nerves strands were placed in microchannels and recordings performed. 
[50,58,59] These studies validated the potential for microchannels to be used in vivo for 
single unit AP recordings. Other studies implanted microchannel interfaces and 
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performed terminal evaluations post-regeneration of transected nerves through the 
microchannels. [49,109,126] These studies validated the potential for microchannels to 
be implemented chronically and the potential to record single unit action potentials after 
chronic implantation. To date however, fully integrated – large electrode count 
microchannel interfaces have not been implemented and evaluated in awake and freely 
moving rodents. While such an accomplishment is arguably the most challenging 
experimentation model for evaluating a peripheral nerve interface, it is a necessary step 
towards clinical translation.  
 Here we have developed and evaluated a high micro-electrode count peripheral 
nerve interface, the GT-RE, for the ability to record single unit action potentials in awake 
and ambulating rodents. First the functionality of the devices was validated in vitro 
through functional testing as well as DRG cytocompatibility studies. Finally the GT-RE 
was evaluated in vivo to assess the potential for chronic peripheral nerve interfacing in 
the rat sciatic nerve animal model. Two GT-RE’s were developed with different substrate 
materials, either PDMS or Parylene C. In general however, the GT-RE’s were designed 
as a sheet of 97 microchannels with gold microelectrodes integrated into the base of the 
microchannels. The microelectrodes were placed in the center of every third 
microchannel. The sheet of microchannels was rolled to form a spiral conduit that 
matched the shape and size of the rat sciatic nerve. This design allows standard 
microfabrication and lithography techniques to be used to fabricate the device which is 
eventually rolled into a 3-dimentional structure. The microelectrodes themselves were 
connected to bonding pads via small gold traces in a cable which was then connected to a 
surface mount PCB containing either the Intan Technologies 32 channel multiplexer 
amplifier microchip (RHA2132) or basic signal extraction wires. The goal of integrating 
the Intan Technologies microchip was to evaluate the ability to integrate commercial off 
the shelf components into the GT-RE as they become available. An example might be an 
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implantable large channel wireless chip. Examples of the GT-RE prior to implantation 
were previously shown in Figure 19. 
 In vitro functional testing was utilized to assess the capability of the GT-RE’s to 
record single unit action potentials similar in size and nature to what would be encounter 
in vivo. Both types of GT-RE’s were successful in this regard, recording artificial neural 
signals injected into PBS on the order of 30 µV. Recordings from the PDMS GT-RE with 
the integrated Intan Technologies chip can be seen in Figure 21C. In vitro functionality 
testing of the Parylene C GT-RE utilized the PCB hub for signal extraction wires. An 
example recording from a single electrode of the Parylene C GT-RE is shown in Figure 
21B. The ability to record the artificial neural signals through both the PDMS and 
Parylene C GT-RE’s validated that the microelectrodes integrated in the GT-RE’s were 
functional. Additionally, the GT-RE’s could be used for neural recordings of some of the 
smallest AP’s commonly observed in vivo. It is also significant that the artificial neural 
recordings were accomplished using the Intan Technologies chip and PCB hub integrated 
via the novel SMT integration technique discussed earlier. These results validated the 
SMT integration technique, the applicability of the technique to flexible and elastomeric 
substrates, and the ability to integrate various commercially available components into 
the GT-RE as needed.  
 Despite in vitro functional success with GT-RE’s utilizing the Intan Technologies 
microchip, the microchip itself was not continued forward in later experiments. This was 
in part because the microchip and accompanying data transmission cable were physically 
too large to implant as they were not designed for implantation. Furthermore, many 
difficulties were encountered when attempting to build a custom LabVIEW program to 
interrogate the chip and custom miniaturized PCB with off-chip components shown 
previously in Figure 18B. These attempts faced numerous physical limitations associated 
with the transmission of high speed digital signals over long distances. Due to these 
limitations, transmission of data could only be achieved over shorter distances (1-2 feet), 
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which was not sufficient for use in freely moving animals. The use of lower sampling 
frequencies and acquisition rates was also explored, however proved to be insufficient for 
the intended application. Since the Intan Technologies chip was not necessary to evaluate 
the GT-RE as a microchannel interface, the PCB acting as a hub for signal extraction 
wires was utilized in all later in vivo experiments. 
 Cytocompatibility studies revealed that the toxic fabrication processes used to 
produce the GT-RE’s are not retained with the devices and that the GT-RE’s are suitable 
for implantation. Results were obtained without any surface coatings or treatments of any 
kind including plasma treating to increase hydrophilicity or protein coating such as 
laminin to facilitate adhesion and cytocompatibility. In fact the axon growth and 
Schwann cell proliferation was so robust that imaging became extremely challenging due 
to the overall levels of fluorescence and resulting appearance of overexposure (Figure 
22A). The Schwann cells in particular proliferated to a degree that was largely 
unexpected as they formed a sheet of cells across the substrate (Figure 22B). The axons 
interestingly formed bundles similar to fascicles observed in vivo and reminiscent to 
those observed in a previous regeneration study where microchannel fascicles were 
described (Figure 22A). [109] These axon bundles grew out past the 3.5 mm long 
microchannels and likely would have continued if the microchannels were longer. This 
was previously observed in terms of axon length where growth occurred out to 4 mm in 
just seven days even though the axon bundles were not present. [109] It does appear 
though, that without the presence of the microchannel topography the axon bundles did 
not continue growing farther but instead disassembled and the axons congregated near the 
exit of the microchannels (Figure 22A). This suggests that the formation of the axon 
bundles is inherently tied to the presence of the microchannels. Furthermore, the 
formation of axon bundles in this study as compared to the lack thereof in the previous 
studies is attributed to the 100 µm wide microchannels used here as opposed to the 50 µm 
or 75 µm wide microchannels used previously. [71,109] The 100 µm wide microchannels 
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used here also matches those used in vivo in the previous study where uniform fascicular 
growth characterizing ‘microchannel fascicles’ was observed. [109] This further supports 
the hypothesis that in vitro axon bundle formation is a microchannel structure based 
phenomena. In contrast, axon bundle formation is unlikely to be a material based 
phenomenon of Parylene C vs. PDMS as both have been establish as cytocompatible in 
general and with DRGs in particular. Adhesion of DRGs and associated 
proliferating/migrating cells types was also observed on both substrates further indicating 
a lack of differences stemming from material selection.  
 It was also interesting to observe that the mass of the DRG’s cultured on the GT-
RE’s in all cases actually migrated from their original position closer to or even onto the 
microchannels. Specific attraction to the SU-8 microchannel walls does not appear to 
explain this however, as it was noted earlier that the axon bundles did not seem 
particularly inclined to grow there versus on the Parylene C. Despite the lack of material 
preference for growth or proliferation, the axons and Schwann cells were aligned and 
oriented to the direction of the microchannels, as expected. It is also worth noting any 
axon growth and Schwann cell proliferation on top of the microchannel walls is 
inconsequential to the in vivo application as there would be a capping PDMS layer 
forcing the axons and Schwann cells to remain within the microchannels.  
 The GT-RE implants were tolerated well by the rats with no additional discomfort 
other than that stemming from the initial surgery. The size of the GT-RE however did in 
many ways fill the cavity below the biceps femoris muscle and significant increases in 
PCB size would be difficult to accommodate, at least in a rat animal model. Placing the 
microchannels over the middle of the PCB was a significant advantage as it allowed the 
PCB to be placed deeper into the leg of the rat and is recommended for future 
experiments. Both the PDMS and Parylene C GT-RE’s were tested in vivo at a 3 week 
time point. This time point was chosen to allow enough time for axons from the proximal 
end to regenerate into and likely through the microchannels. Data from an unpublished 4 
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week study showed ample regeneration in similarly sized microchannels. Unfortunately, 
no useful data was recorded using the PDMS GT-RE at the 3 week time point. 
Recordings only showed incredibly low noise bands on the order of 4 µV indicating a 
short to ground and likely delamination. Upon explantation at the 3 week time point, this 
was confirmed visually with delamination of the PDMS passivation and PDMS substrate 
layers. It is unknown when during the 3 week implantation the delamination occurred.  
 Recordings using the Parylene C GT-RE’s however were quite successful at the 3 
week time point. An example of a raw signal from a stereotypical microelectrode within a 
microchannel is shown in Figure 23B. A multitude of single unit APs was identified 
within this and other raw signals across the many electrodes from the GT-RE’s. 
Examples are depicted in both Figure 23 and Figure 24. Overall 63% of the 
microelectrodes integrated into the microchannels of the GT-RE were successfully used 
to record single unit APs. This is a significant finding considering previously reported 
success rates with other microchannel interfaces and especially given that the GT-RE is a 
large electrode count microchannel interface with 30 integrated microelectrodes. 
[49,50,58,59,109] The single unit AP amplitudes and SNRs reported here also fell within 
ranges previously reported in studies using microchannels in acute scenarios or 
terminally after implantation. [49,50,58,59,109] Furthermore, the GT-RE enabled 
successful recordings in awake and ambulating animals building significantly on these 
previous acute and terminal experiments. The ability to record and identify single unit 
APs is the paramount criteria peripheral nerve interfaces are judged by when considering 
a host of clinical applications from bladder control to robotic limb control. Accordingly, 
the findings reported here give significant credence to further work developing these 
technologies which target eventual clinical application.  
 Interestingly, it was found that the inner microelectrodes of the GT-RE were on 
average more successful at recording single unit APs when compared to the outer 
microelectrodes as shown in Figure 25A and B. A previous study evaluating regeneration 
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of axons through microchannel scaffolds noted that microchannels lacking axon 
regeneration tended to reside near the periphery of the device. [109] Given the early 3 
week time point used in this study compared to the 8 week time point in the previous 
study, this effect could have been exacerbated here as regeneration would not yet have 
stabilized and could still be occurring in the outer microchannels. Myelination would also 
be ongoing and may be lagging in the outer microchannels. The net effect would be 
reduced AP recording success with the outer microelectrodes. That being noted, it is 
expected that the difference in AP recording success between the inner and outer 
microelectrodes would diminish over the following weeks and months as the regeneration 
stabilizes. These findings are also important from a design perspective as researchers 
performing microchannel interfacing at earlier time points such as 3 weeks should bias 
microelectrode placement towards the center of the device.  
 Given the 3 week time point used for these electrophysiology recordings and the 
fact that the axons had to traverse a 3.5 mm gap before reaching the distal segment, it is 
highly unlikely these axons reinnervated their distal targets. Therefore, this early 
recording time point is in some ways similar to a nerve amputee animal model where the 
amputated nerve permanently lacks it distal reinnervation targets. As such, the success of 
recording a multitude of single unit APs at this early time point can be used as an 
indicator that microchannel interfacing in an amputee scenario would also likely be 
successful. This is especially true given previous work which has investigated and shown 
the regenerative capacity and stability of amputated nerves once they have grown into 
and through microchannel devices. [109] It can also be surmised that a majority of the 
single unit APs recorded were likely motor units due to the fact that the input for most 
sensory units would be in the distal targets which had yet to be reinnervated. Therefore, 
the total number of APs recorded was likely significantly lower than what could be 
recorded at future time points once reinnervation occurs and sensory input generates 
additional APs. This may in part account for the electrodes which did not successfully 
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record single unit APs. Of course recording sensory APs is only relevant to scenarios 
where sensory input is of value. For advanced prosthetic control in particular, the number 
of reliably recordable motor APs is the first primary concern. However, recording 
sensory APs and utilizing conduction blocking techniques holds significant value for 
mitigating the chronic and often debilitating pain individuals experience post-amputation 
in addition to providing sensory feedback through prosthetics.  
 While there was significant success at the 3 week time point with Parylene C GT-
RE’s, delamination issues in the cable region were observed similar to that of the PDMS 
GT-RE’s at a 6 week time point. An example of the delamination in the cable region can 
be observed in Figure 26. The rolled microchannel region with the regenerated sciatic 
nerve and the microelectrode traces leading to the bonding pads (out of image area) can 
also be visualized in the figure. The fact that delamination occurred in the Parylene C 
GT-RE was unexpected given previous reports indicating the utility of Parylene C as a 
viable chronic substrate and insulator for in vivo applications with flexible cortical and 
retinal interfacing devices. [98,117,127–129] It has even been reported through multiple 
studies using accelerated failure testing that Parylene C should perform as a viable 
insulator on the order of years, out to more than 20 years, of implantation. [91–93,130] It 
seems evident that these accelerated failure tests must be viewed with significant 
precaution. One possible reason for the large discrepancy is the accelerated failure tests 
are most often performed in saline baths. This does not accurately represent the blood 
filled environment where numerous immune cells and components of the blood play 
active roles in attempting to degrade an implant. These processes are integral parts of 
device failure, in this case delamination. Another potential cause for the major 
discrepancy is the lack of mechanical or physical stress/movement during the accelerated 
failure tests. In these tests, the devices are stationary and not subject to motions typical of 
an in vivo environment, especially that of the limbs. This is also relatively true of cortical 
and retinal interfacing which occur in less movement prone regions and therefore subject 
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the devices to less physical or mechanical stress. In fact inspection of the Parylene C GT-
RE’s showed numerous areas of buckling and plastic deformation of the Parylene C in 
areas of high movement along with delamination occurring in those regions indicating 
physically/mechanically induced failure played a role in overall device failure.  
 While Parylene C – Parylene C delamination was observed at the 6 week time 
point, adhesion of the silicone adhesive used as an encapsulant to the GT-RE seemed 
incredibly robust. Attempts to physically remove the silicone adhesive were unsuccessful 
indicating strong bonding and resistance to delamination. It is recommended that future 
work investigate utilizing dilute forms of the silicone adhesive as a substrate for device 
fabrication in addition to being utilized for encapsulation purposes. The fabrication of 
such devices should not be significantly different from fabrication on PDMS as 
previously described and seem likely to solve the delamination issues encountered here.  
 In the end, the fact that both the PDMS and Parylene C GT-RE’s eventually 
suffered from delamination issues indicates a need for further materials development with 
regard to hostile in vivo environments. It is worth mentioning, that while the PDMS GT-
RE suffered from delamination well before the Parylene C GT-RE, the benefit of 
stretchability makes PDMS or silicone based devices far more attractive for future 
development. Parylene C is fundamentally only flexible as a 2-dimensional film. 
Application over a 3-dimentional object that can flex, for example a tube, causes 
buckling of the Parylene C at the region of bending and/or plastic deformation on the 
opposite side due to its inability to stretch. Both result in stress points within the Parylene 
C film and will eventually cause failure of the Parylene C after repeated motion. PDMS 
and silicone derivatives do not suffer from this disadvantage and therefore hold 
significantly more promise with devices that are subject to mechanical stress and/or 
trauma during their lifetime. Once these adhesion issues are mitigated in the in vivo 
environment, future work will need to investigate truly chronic AP recording capabilities 
using the GT-RE or other microchannel interfaces. While the 3-week time point shows 
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significant promise, additional failure mechanisms stemming from chronic implantation 
will need to be elucidated. These may be a combination of biotic and abiotic issues and 
solutions will need to be developed that directly target them. This however, does not take 
away from the significant promise shown by recording single unit APs from a large 
number of integrated microelectrodes at the 3-week time point. The capability of using a 
fully integrated microchannel interface, the GT-RE, for regenerative peripheral nerve 
interfacing in awake and ambulating rodents has been established. Future work will 
continue building upon these findings bringing microchannel interfacing closer to clinical 
translation. 
5.5 Conclusions 
 In this study a novel microchannel interface, the GT-RE, with large numbers of 
integrated microelectrodes was evaluated in a challenging, awake and freely moving rat 
animal model. Two different GT-REs were developed where one was composed of a 
PDMS substrate and the other of a Parylene C substrate. The GT-RE’s were integrated 
with either Intan Technologies 32 channel multiplexer amplifier chip or a PCB acting as a 
hub for signal extraction wires utilizing a novel surface mount technology (SMT) 
integration technique. In vitro functional testing validated the capability of both types of 
GT-RE’s to record single unit APs similar in size to those found in vivo as well as the 
SMT integration technique. DRG in vitro cultures revealed striking cytocompatibility of 
the GT-RE post-cleanroom processing with large degrees of axon growth and Schwann 
cell proliferation. Characteristics of the growth even resembled nerve fascicles normally 
found in vivo. Finally in vivo implantation of the GT-RE’s revealed the capability of 
microchannel interfacing to be utilized for high-throughput single unit AP recording in 
awake and ambulating rats. On average 63% of the 30 microelectrodes per device were 
successfully utilized towards this end as early as 3 weeks post-implantation marking a 
significant advancement in microchannel interfacing. At 6 weeks delamination of the 
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substrate materials for the GT-RE was observed indicating a need for future material 
development to enable chronic recordings. In vivo observations indicate silicone 
derivatives as a substrate material, in addition to an encapsulant, may be the path 
forward. In the end, the findings of this study help direct future technology development 
and enable truly chronic, pre-clinical testing of peripheral nerve interfacing using the 
relatively new microchannel approach.  
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CHAPTER 6  CONCLUSIONS AND FUTURE DIRECTIONS  
6.1 Conclusions 
 In the 2005, 1.6 million persons were living with a limb amputation (one in 190 
Americans) and it has been projected that by 2050 this number will more than double to 
3.6 million in the United States alone [8]. While these numbers do not compare to those 
of cancer or heart disease, they are still quite staggering when one considers the drastic 
loss in function and quality of life these individuals are forced to endure for their 
remaining years. Current day prosthetics do not adequately replace the function of the 
lost limb. While substantial progress during the last decade has occurred with regard to 
revolutionizing these prosthetics, most of it has focused on the robotics side. However, 
the ability to control and ‘feel’ through these advanced prosthetics lags behind. Inherently 
this stems from the lack of a seamless interface between the robotic limb and the 
individual. Amputees retain significant function in their nerves post-amputation, which 
offers a unique opportunity to establish this interface with the peripheral nerve. [1] 
 Traditional approaches to peripheral nerve interfacing have centered on 
penetrating the nerve with electrodes, wrapping electrodes around the outside of the 
nerve, or encouraging axons within the nerve to grow past electrodes in a regenerative 
model. While all of these approaches have shown the potential to record neural signals 
they fail to do so chronically or cannot record single unit APs and thereby fail to enable 
the full functionality of advanced prosthetics. These traditional approaches inflict nerve 
trauma and suffer from chronic scar formation, are not near axons to enable single unit 
AP recordings and/or fall victim to the incredibly small amplitudes of single unit APs 
which are largest only at the nodes of Ranvier. [4–6,36–41,53,54,120]  
 Here we evaluated a relatively new approach to peripheral nerve interfacing by 
using microchannel technology. It has been shown through modeling and in vitro studies 
that single unit APs from axons inside a microchannel are significantly larger in 
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amplitude and remain relatively constant throughout the length of the microchannel 
regardless of the node of Ranvier position. [6,56] These inherent characteristics of 
microchannels make them a promising approach to circumvent the challenges faced by 
previous approaches. Additional studies with microchannels have shown in vivo the 
capability of axons to regenerative through microchannels in a transection/non-amputee 
animal model. [57] Attempts to record from regenerated axons were also made using 
non-implanted electrodes inserted into the microchannels post-regeneration at the time of 
experimentation/recording. While only a handful of single unit APs were recorded, this 
suggests that these axons are in fact functional. [49] Other in vivo studies have 
investigated non-regenerative scenarios where nerves have been teased and rootlets 
placed within microchannels. Acute recordings have been performed in these scenarios 
further supporting the viability and potential for microchannel interfacing. [50,58,59] 
 This work builds upon these promising studies with the goal of bringing 
microchannel interfacing closer to clinical translation for amputees. The chronic 
integration of amputated nerves with microchannels and the ability to record APs after 
chronic implantation of microchannels permanently integrated with electrodes was first 
investigated. PDMS and SU-8 based microchannel scaffolds were developed towards this 
end and utilized permanent microwire electrodes for interfacing purposes. In vivo studies 
showed that at least at 8 weeks post amputation, 100 µm x 100 µm microchannels were 
able to sustain robust regeneration of axons in nearly 100% of the microchannels with 
space remaining within the microchannels for future tissue and axon maturation. Further 
analysis of the axons and nerve as it grew out the distal end of the microchannels showed 
a striking degree of spatially orchestrated regeneration matching the microchannel 
architecture forming ‘microchannel fascicles’ in the distal nerve stump. These 
microchannel fascicles were characterized by axon and Schwann cell groupings as well 
as the reformation of epineurial-like and perineurial-like sheaths of fibroblast 
arrangements all supported by a reorganized extracellular matrix. In general, the 
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microchannel architecture facilitated and encouraged parallel nerve fiber growth by 
directing axon regeneration through the microchannels and producing an organized 
microchannel fascicle morphology. Furthermore, the axons, Schwann cells, and 
endoneurial support structure immediately surrounding these cell types appeared to all be 
undergoing the normal regenerative process. Together these characteristics strongly 
suggest that microchannels are not only supportive of the proper initial microenvironment 
for regeneration but also for chronic stability of an amputated nerve. Additional evidence 
for this lies in the aforementioned display of characteristics being completely opposite to 
those commonly associated with neuropathic complications such as neuroma formation; 
one of the largest clinical concerns with implanting a device into an amputated nerve. 
These findings support the fundamental criteria of safety for a regenerative peripheral 
nerve interface targeted towards amputees. 
 In addition to the chronic stability of the amputated nerve with microchannel 
scaffolds, both spontaneous and sensory evoked single unit APs were successfully 
recorded in vivo. Additionally, multi-unit APs were recorded in response to electrical 
stimulation proximal to the microchannel implant. These recordings were accomplished 
using electrodes permanently integrated within the microchannels at a chronic time point 
a full five months after implantation. An assessment using the evoked multi-unit activity 
found overall device viability to be greater than 50% at this chronic time point. This 
calculation included all nonfunctional electrodes with broken leads. The stimulation ramp 
used during electrical stimulation also allowed the identification of multiple different 
axon populations within the various microchannels integrated with electrodes. 
Importantly, this could be used for mapping the distribution of different axon types 
within the microchannel interface to enable more selective and axon specific interfacing 
capabilities. This is discussed further in the following Future Directions section. Overall, 
the recordings of single and multi-unit action potentials were comparable if not better in 
some aspects to what has been previously reported with regard to numbers of functional 
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microchannel electrodes [13]. Notably, this was accomplished with a ‘simple’ device that 
lacked integrated MEAs and/or electrode passivation techniques. Instead simple off the 
shelf microwires were integrated and successfully used in a chronic setting. This is 
significant, because this microwire electrode based device could hold substantial utility 
for applications that do not require high-throughput peripheral nerve interfacing and large 
numbers of recorded APs. Finally, based on the electrophysiology data presented in Aim 
1, action potentials can be recorded from regenerated axons in microchannels with 
permanently integrated electrodes on a chronic timescale.  
 With this the stability and viability of regenerative microchannel interfacing was 
established, warranting the development of fully integrated microchannel interfacing 
technology to be utilized for awake and freely moving animal studies. Accordingly, this 
work focused next on developing these technologies which included A) integration of 
MEAs and interconnects into flexible and elastomeric substrates; B) integration of SMT 
onto flexible and elastomeric MEAs; and C) flexible and elastomeric polymer based 
hermetic insulation and encapsulation strategies enabling implantation. Integration of 
MEAs into elastomeric substrates such as PDMS has been a significant challenge that has 
prevented the wide spread use of PDMS as a substrate for high-density large count 
microelectrode arrays. Here we developed five processing solutions targeting the 
fundamental issues preventing successful patterning and photolithography on PDMS. 
These included 1) novel stress features, 2) thick film photolithography, 3) differential 
curing profiles in an oven, 4) large increases in exposure times to account for reduce 
photoresist crosslinking at the substrate interface, and 5) the addition of bulk etching as a 
method for photoresist removal in addition to standard development. Together these 5 
processing solutions drastically increase the processing window one has to design and 
fabricate high-density patterns on substrates with large coefficients of thermal expansion 
like PDMS. While in this work these five solutions have been used to develop flexible 
and stretchable MEAs, the number of applications for these solutions is extremely large.  
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One example of the utility for these solutions is the ability to effectively create a flexible 
and stretchable PCB. This could drastically change the form factor of today’s electronics 
from laptops to cell phones as they are all inherently tied to their mechanically rigid PCB 
or motherboard connecting the various electrical components. 
 Following the successful integration of MEAs into flexible and elastomeric 
substrates, an approach for SMT integration was developed to allow the easy addition of 
off the shelf electronics such as microchips and/or PCBs containing other components. 
This approach involved defining a minimum bondline to enable stable conductivity 
between sets of surface mount bonding pads. The bondline is necessary due to the 
nanoliter volumes of conductive epoxy needed to form an electrical junction with the 
incredibly small bonding pads of the smallest commercially available components used in 
today’s electronics. The resulting ‘column’ of conductive epoxy proved to not only 
provide stable conductivity but was mechanically robust through the entire fabrication 
process and following in vivo implantation/testing. Furthermore, this approach was 
successfully demonstrated in vitro and in vivo through the integration of two different 
surface mount PCBs containing either Intan Technologies microchip or signal extraction 
wires for AP recordings. In the end, this SMT integration technique is widely applicable 
to the incorporation of the smallest SMDs available with flexible and elastomeric 
substrates for a wide range of applications. Furthermore, it is incredibly simple to 
implement as all that is needed is a 40 µm spacer and is translatable to standard industry 
practices.  
 The third major area of technology development centered on polymeric based 
hermetic insulation and encapsulation approaches to enable implantation of the GT-RE’s. 
Two approaches were used in conjunction with Parylene C deposition for insulation and 
silicone adhesive encapsulation for mechanical protection as well as extra insulation. 
While the Parylene C failed due to delamination at the 6 week time point after in vivo 
implantation, the silicone adhesive displayed adhesion characteristics suggesting viability 
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for significantly longer periods of time. It is also important to note that the PDMS 
substrate and insulation layers of the PDMS GT-RE’s also suffered from delamination at 
an even earlier time point. This author feels it is due to the use of the sacrificial post 
technique for patterning the PDMS passivation layer. In this technique, the PDMS 
passivation layer is spun around sacrificial posts. This results in ripples within the PDMS 
film which was then allowed to rest for approximately 4 hours before curing giving time 
for these ripples to relax. During this time, it is believed the adhesion of the PDMS 
passivation layer to the PDMS substrate was lost. However, it is unknown whether 
avoiding the 4 hour rest period would solve this problem. The fact that the silicone 
adhesive did not have an adhesion failure in vivo and that the processing solutions for 
PDMS can likely be used with silicone adhesives suggests that future devices ought to 
explore silicone adhesives as a substrate material.  
 Overall the three major phases of technology development allowed the fabrication 
of advanced microchannel interfacing technology capable of being implanted and used 
for AP recording in the challenging awake and freely moving rodent animal model. 
Perhaps most importantly, these fabrication techniques are applicable to a broach range 
of next-generation devices spanning healthcare sensors, to diagnostics, to even consumer 
electronics.  
 Given that fully integrated microchannel technology was developed, the final 
aspect of this work focused on evaluating these devices for the ability to record single 
unit APs in awake and freely moving rodents as the next step towards clinical translation. 
As detailed previously, two types of GT-RE’s were developed where one type had a 
substrate materials of PDMS and the other type had Parylene C. Both types of GT-RE’s 
showed in vitro the capability to record artificial neural signals similar to the single unit 
APs that would be encountered in vivo. In vitro cytocompability studies showed the 
extensive cleanroom processing needed to fabricate the GT-RE’s did not result in toxic 
devices and did not induce cell death of the cell types prominent to a nerve.  
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 When both GT-RE’s were evaluated in vivo, the PDMS based GT-RE’s failed due 
to delamination before AP recordings could be performed at the 3 week time point. 
However, the Parylene C GT-RE’s were successfully utilized for recording a multitude of 
single unit APs across the 30 integrated microelectrodes. In fact 63% of the electrodes 
were successfully used towards this end, a significant milestone in microchannel 
interfacing. It was also found that the 15 innermost electrodes were more successful at 
recording single unit APs when compared to the 15 outermost microelectrodes. This 
difference, while significant, is likely to be temporary and may stem from the early time 
point used for recordings when regeneration is unlikely to be robust across the entire 
cross-section of the device. Instead at these early time points regeneration is typically 
most pronounced in the center agreeing with the findings of greater AP recording success 
with the innermost electrodes. This finding however, provides design criteria for 
researchers developing microchannel interfaces based on the timeline of their studies. If 
the study has a short timeline on the order of a few weeks, it would be prudent to bias the 
placement of electrodes towards the center of the device’s cross-section instead of having 
a uniform distribution.  
 While at 6 weeks delamination was again encountered with the Parylene C GT-
RE’s, once this issue is overcome these devices will likely be highly successful peripheral 
nerve interfaces. This is especially true given these results showing APs can be recorded 
from significantly large numbers of electrodes in the challenging awake and ambulating 
rat animal model. Finally, this is an important step towards clinical translation as the 
ability to record and identify single unit APs is the paramount criteria peripheral nerve 
interfaces are judged by when considering efficacy for robotic limb control. In the end, 
the findings of this work as a whole help direct and give significant credence to future 
technology development enabling eventual clinical application of microchannels for 
peripheral nerve interfacing.  
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6.2 Future Work 
 What follows is not only directions for specific future work regarding this thesis 
and microchannel technology, but also some thoughts regarding the field of peripheral 
nerve interfacing in general and future directions needed to enable translation of the 
many technologies being developed.  
6.2.1 Nerve – Microchannel Interface Chronic Stability 
 With an eye toward clinical translation, there remains significant work to be 
performed before microchannels can be used for peripheral nerve interfacing. First and 
foremost the regenerated nerve – interface stability needs to be further investigated. 
While the studies presented in this thesis suggest chronic stability of the amputated nerve, 
this needs to be validated at a significantly longer time point of at least 1 year. The major 
concern is that axon numbers would decrease during the many months following 
implantation. This being said, it is important to remember that the goal of a regenerative 
peripheral nerve interface is not to regenerate the nerve in its entirety. In contrast, it is to 
regenerate and maintain enough ‘normally’ functioning axons to enable peripheral nerve 
interfacing. Given the robust regeneration observed at 8 months it is unlikely to see a 
truly drastic reduction in axon numbers. Even if a 25% reduction in axon numbers were 
to be observed after 1 year of implantation, there would likely still remain enough axons 
to enable interfacing applications. It is also worth noting that quantification of axon 
numbers within microchannels needs to be normalized to the numbers of axons 
significantly proximal to the nerve. This will guard against skewing the data based on 
significant axon branching in the microchannels which is known to occur after 
regeneration.   
 If axon numbers do in fact decrease to significantly lower levels by 50% or more, 
there are some approaches which could be implemented to help mitigate this reduction. 
The study presented in Aim 1 of this thesis left the distal stump of the amputated nerve 
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free, as in un-sutured to any target. Clinically it is common to denervate an unused 
muscle at the end of an amputated limb and then suture an ‘important’ nerve into said 
muscle to help maintain chronic stability of the nerve. The same approach could be 
utilized here to help maintain the stability of the nerve after it has regenerated through the 
microchannels. Another approach could be to seed cells on the distal end of the 
microchannels to provide a target for reinnervation after regeneration. However this 
approach is not as clinically translatable as suturing the end of the microchannels into a 
denervated muscle. Another interesting approach could be to coapt the distal end of the 
microchannels with the distal nerve stump to the side of another uninjured nerve. A 
previous study showed connecting the distal portion of a transected nerve to an uninjured 
nerve helps sustain the distal nerve segment. [78] While this study looked at sustaining 
the distal nerve segment, it is likely that doing so with the end of the nerve regenerating 
through microchannels would also help sustain the nerve chronically.  
 Another important issue regarding nerve – interface stability is the stability of the 
action potentials being recorded through the microchannel interface. While action 
potentials were recorded using the GT-RE at the early time point of 3 weeks, the axons 
generating these APs are undoubtedly still undergoing the regenerative process. As weeks 
and months progress these axons will likely increase in diameter as well as have thicker 
myelin sheaths. These changes will lead to changes in AP waveform and perhaps even 
new APs will appear at later time points. Furthermore if axons are degenerating as is 
known to happen over the course of regeneration, APs which are recorded at early time 
points will disappear. This general instability in APs will make driving a prosthetic limb 
challenging due to changing control inputs. These changes need to be evaluated on a 
chronic timescale just as the nerve stability. Furthermore the effect of these changes 
regarding reliable control signals for advanced prosthetics needs to be determined and 
solutions generated if the effect is too detrimental.  
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6.2.2 Microchannel Interface Technology Development 
 While evaluating the stability of the nerve and APs is important, there also 
remains significant future work regarding technology development of the GT-RE, 
microchannel interfaces in general, and peripheral nerve interfacing at large. As noted, 
delamination was observed between the substrate and insulation layers of the GT-RE 
regardless of whether these materials were PDMS or Parylene C. This was largely 
unexpected given the literature supporting both of these materials and the relative lack of 
literature detailing the challenges of insulation and packaging. In general, significant 
attention is commonly placed on the design and fabrication of electrodes. In hindsight, 
this author feels insulation and packaging are actually far more challenging and get far 
less attention than they deserve. Insulation and packaging cannot be left to an 
afterthought of device fabrication and admittedly, this author was initially at fault for this. 
Initial material and substrate selection for electrode and device development must be 
made with an insulation and packaging solution in mind from the beginning. For instance 
utilizing a silicone adhesive or other silicone derivatives as a substrate material may be 
highly pragmatic based on the in vivo results of this thesis. It is the strong suggestion of 
this author to investigate device development using silicone adhesives as a substrate. Not 
only will this help with insulation and packaging challenges, but the fabrication 
techniques developed in Aim 2 can be directly applied. Another important note is that the 
importance of insulation and packaging must also be reflected in literature and cannot be 
left as a single line item as is commonly done where authors merely state ‘wires were 
encapsulated in silicone’. Cleaning and surface treatment procedures need to be 
elucidated and reviewers of manuscripts must demand this level of detail as it is already 
expected generally for electrode fabrication. 
 Regarding future work, it would also be worthwhile to investigate universally 
applicable packaging solutions. This is inherently extremely challenging as it requires the 
ability to circumvent material issues as well as application specific issues such as 
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mechanical stress in the case of peripheral nerve interfacing. Industry standard 
approaches are to utilize a metal enclosure for microchips and other non-lead 
components, which has been the case for decades. Polymers are potentially the way of the 
future. However, this remains to be fully investigated and validated. In many ways it is 
not just the polymer that matters but the approach used for packaging as well. Parylene C 
was initially thought to be a universally applicable material based on its room 
temperature deposition which was easily applied to many devices and applications. 
However its inability to stretch limits its capabilities drastically in mechanically or 
physically demanding environments. For this reason, this author feels that silicone 
derivatives hold much more promise. A final note on insulation and packaging is that 
much of the techniques used in this thesis were hand based. It would be advisable to 
develop more batch oriented techniques to increase efficiency and reduce inherent 
variability with hand fabrication.  
 In addition to future work investigating the challenging issues of insulation and 
packaging, the integration of on board microchips enabling multiplexing, amplification 
and wireless communication would be highly beneficial for a peripheral nerve interface. 
Work is currently being performed in the Ghovanloo lab at the Georgia Institute of 
Technology and undoubtedly elsewhere towards this end. Various electrophysiology 
companies such as Intan Technologies LLC, Plexon Inc., and Blackrock Microsystems 
also have commercially available headstages that enable multiplexing and amplification, 
but none of these are designed for implantation. A small footprint implantable microchip 
with multiplexing and amplification capabilities would reduce the number of wires and 
size of headcaps used during awake and freely moving electrophysiology. Furthermore, 
amplification of APs near the acquisition site could drastically help SNR. Finally, if these 
microchips were to integrate wireless communication it would completely eradicate the 
need for signal extraction wires and a headcap. This would in many ways simplify device 
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fabrication if the microchips were SMDs and the SMT integration technique from Aim 2 
was utilized. 
 Regarding SMT integration, it would be worthwhile to investigate methods of 
non-permanent integration. The technique developed in Aim 2, while widely applicable, 
is permanent in that any SMD device attached cannot be removed without destroying the 
substrate MEA. It would be highly advantageous if SMD components could be replaced 
with other SMDs as needed or as more advanced capabilities are invented. This would 
however necessitate abandoning conductive epoxy as the junction between the SMD and 
substrate MEA. Metals with low melting temperatures such as gallium based alloys could 
have some utility here if cavities connecting sets of bonding pads are filled with the 
liquid metal. To remove the electrical components the device could merely be heated to 
melt the gallium alloy junction enabling the component to be replaced. Upon cooling the 
gallium alloy would harden again.  
 Finally, new methods for developing microchannels with embedded electrodes 
could be developed. In this thesis a long sheet of microchannels with embedded 
electrodes was rolled to form a 3-D conduit matching the shape and size of a nerve. 
Another approach could be to lay sheets of microchannels with embedded electrodes on 
top of each other. The difficulty with this approach is how to navigated having metal 
traces for each layer of microchannels and embedded electrodes in different planes. One 
approach to navigate this issue could be to use a PCB with through-hole pins. The leads 
from the embedded electrodes could connect to ring-shaped bonding pads where the pins 
from the PCB could penetrate through the center. Conductive epoxy can be applied to 
this junction facilitating the electrical connection. As long as each layer of microchannels 
with embedded electrodes has leads of different lengths from the other layers there would 
be no overlap and each layer could be connected using the pin strategy. This approach 
has the advantage of circumventing the rolling and open core of the rolled microchannel 
scaffolds. It is envisioned that placing layers of microchannels on top of each other would 
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also be easier and less variable than hand rolling a sheet of microchannels. Another 
approach could be to utilize sheets of microchannels laid upon each other as just stated. 
However here, instead of integrated electrodes, needle like electrodes or the Transverse 
Intrafascicular Multichannel Electrode (TIME) could be inserted transversely through the 
microchannels. The footprint of these electrodes, if sufficiently small, would not hinder 
regeneration and could make the overall device fabrication drastically simpler.  
6.2.3 Motor and Sensory AP Signal Interpretation and Use 
 Once nerve – interface stability and technology development have been fully 
investigated, there lies the question of whether the AP signals recorded are enough to 
drive an advanced prosthetic. The key question is, how many action potential inputs are 
needed to replicate the motion of a limb using today’s prosthetics?  Following from this, 
the next question is how many electrodes are needed to reliably record those APs? 
DARPA’s relatively recent Broad Agency Announcement for Reliable Peripheral 
Interfaces (DARPA-BAA-11-08) mandated funded projects describe a credible trajectory 
to 22 independent output channels from a peripheral nerve interface. This suggests a 
minimum of 22 independent APs in order to derive the 22 output channels from a 
peripheral nerve interface, but this does not take into account recording APs which 
cannot be used as viable control signals, sensory APs for example. So the total number of 
recorded APs would need to be larger and this does not elucidate the number of 
electrodes needed to achieve this goal either. Furthermore, it is likely not possible to fully 
answer the questions of minimum APs and minimum electrodes yet as they are inherently 
dependent on each other. One cannot determine the minimum number of APs needed to 
control a prosthetic without first having enough electrodes in a peripheral nerve interface 
to do so. In order to determine how many electrodes are sufficient, one must know the 
minimum number of APs that need to be recorded. In the end researchers must first make 
larger count micro-electrodes, such as the 30 microelectrode GT-RE presented here, with 
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the hope that it has enough electrodes. AP recordings must then be performed to evaluate 
the number of usable APs that can be recorded and whether these are enough to drive 
prosthetic motion. If not, the peripheral nerve interface must have an even larger number 
of electrodes integrated and the cycle repeated.  
 To enable evaluation of the minimum number of APs needed, one can envision an 
interfacing experiment with the sciatic nerve where rats are ambulating during AP 
recordings, muscles electrodes record EMG activity from muscles of the leg, and motion 
tracking of the leg all occur at once. This experiment would allow correlation of recorded 
APs to muscle activation to leg movement and could help identify how many electrodes 
of those that record APs, are actually recording APs useful in determining leg movement. 
This could then be used to determine whether there are enough APs being recorded to 
replicate the full motion of the leg. This number of electrodes and APs is likely different 
from interface to interface and would need to be tested for each, regardless of whether it 
is a microchannel interface or a Utah Slanted Electrode Array.  
 An important consideration to the recording of APs for prosthetic control is 
whether single unit APs are even needed for prosthetic control. It could for instance be 
argued that multi-unit activity from multiple axons firing in synchrony corresponding to 
limb movement likely occurs in peripheral nerves. This is would be expected due to the 
redundancy in the peripheral nerve where multiple axons innervate the same muscle 
fibers and therefore would also carry the same signal and fire at the same interval. 
Furthermore, the inherent spatial organization of the nerve, while different on a micro-
scale from person to person, would likely place these axons next to each other making it 
easier to record a larger amplitude multi-unit AP. As such, recording these multi-unit APs 
could be used to drive prosthetic control. However, while this may be the case in an 
uninjured nerve, it is important to remember this may not be the case in a regenerated 
nerve and especially so with regenerative microchannel interfacing. Transected axons do 
not regenerate in straight lines and therefore do not hold the same spatial location as they 
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did prior to regeneration and would no longer lie next to each other. This may reduce or 
eliminate the multi-unit AP if the axons are too far apart from each other for an electrode 
to record from them at the same time. Furthermore, it is possible that these axons could 
regenerate into different microchannels thereby eliminating the multi-unit AP that 
previously existed and necessitating the recording of single unit APs. In the end it would 
need to be assessed whether enough of these multi-unit APs exist post regeneration to 
enable prosthetic control in the same way that the number of single unit APs needs to be 
assessed. 
 Another pertinent question is whether stimulation can be performed 
simultaneously during AP recording to enable sensory feedback for closed loop control of 
advanced prosthetics. Future studies should investigate whether sensory feedback for 
microchannel interfaces is only viable in ‘non-motor’ related microchannels. If so, it is 
necessary to determine whether a full spectrum of sensation is capable of being evoked. 
Experiments evaluating sensory feedback from peripheral nerve stimulation could utilize 
voltage sensitive dye and/or MRI techniques to image cortical activity in response to the 
peripheral stimulation. This also brings up the crucial issue of motor vs. sensory axon 
population distributions within and across microchannels. In an ideal scenario sensory 
axons would be contained to separate microchannels from those containing motor axons. 
This is highly unlikely to occur on its own, but techniques for mapping the axonal 
population of microchannels could elucidate the population differences between different 
microchannels. This could enable treating certain microchannels as predominantly motor 
or sensory to benefit of interfacing.  
 A clinically relevant technique that may lend itself to this identification challenge 
is microneurography and is similar to the stimulation ramp performed in Aim 1. The 
nerve after regenerating through the microchannels could be stimulated significantly 
proximal to the microchannel interface. This would allow APs of different conduction 
velocity to be separated over time and allow a mapping of the microchannel interface 
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based on time of AP occurrence. Conduction velocity is directly related to axon diameter 
which can be loosely correlated to predominantly motor or predominantly sensory 
populations. While this is not a perfect method to determine motor vs. sensory, it may be 
good enough given the large number of electrodes that can be integrated into a 
microchannel interface. Another potential method that is clinically relevant is to ask the 
patient or amputee to think about moving their limb and map the AP responses and do so 
for a variety of intended movements. Each microchannel could then be stimulated and 
sensation assessed to map the sensory component. A final method could be to use non-
invasive stimulation of the spinal cord to initiate a walking pattern while the body is 
raised. This would allow predominately motor activity, aside from proprioception, to be 
present in the peripheral nerve and may allow mapping of the microchannel interface.  
 Given the need to investigate motor vs sensory axon populations, it would be 
warranted to also investigate methods of inducing segregated motor and sensory 
regeneration. Developmental biology may have some interesting approaches given that 
axon pathfinding during development follows extremely specific trajectories for both 
motor and sensory axon types. However more biological studies may need to be 
performed to understand these pathfinding mechanisms before they can be implemented 
in nerve regeneration.  
6.2.4 Clinical Translation 
 While it is important to evaluate the next steps for microchannel interfacing in 
terms of technology development and the ability to interface with the nervous system, it 
is equally important to evaluate what is needed for clinical translation. Advanced 
prosthetics currently on the market largely have 8 EMG electrodes or fewer as control 
inputs. One might therefore assume than a peripheral nerve interface with greater than 8 
electrodes would be superior. While this is possible, it is important to note that the 8 
EMG electrodes are always motor control inputs whereas AP recordings from a 
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microchannel interface may or may not be motor related activity. For this reason the 
number of electrodes recording APs would need to be higher in the microchannel 
interface. However, if studies show that with ‘X’ number microchannel electrodes greater 
than 8 can be reliably used to record motor APs for prosthetic control then clinical 
translation ought to be considered. This is because, with regard to clinical translation, the 
goal should not be to develop a device that acquires all the motor signals from a nerve to 
enable the full functionality of an advanced prosthetic limb. Instead, the goal should be to 
develop technology that is better than what is currently available. Once that occurs it 
should be made available to amputees and patients so as to improve the standard of care 
and their quality of life as soon as possible. Attempting to build the perfect microchannel 
interface, or any peripheral nerve interface for that matter, which would enable perfect 
advance prosthetic function is likely a never ending goal. Clinical translation should not 
be tied to it.  
6.2.5 Failure Analyses and the Standardization of Neural Interfacing Research  
 The findings of this thesis show that microchannel can be used to record single 
unit APs from peripheral nerves. While it is unknown whether the APs recorded were 
motor or sensory units, the overarching question driving future microchannel technology 
development should no longer be ‘can microchannels be used for peripheral nerve 
interfacing’? Instead, with clinical translation in mind, the question to answer in the 
future is ‘what causes microchannel devices to fail during peripheral nerve interfacing’? 
In reality this is also what the entire field of peripheral nerve interfacing should be 
asking. By and large much of the work still being performed is focused on showing the 
possibilities for peripheral nerve interfacing; either the ability to record AP’s or stimulate 
and generate responses of some kind. This is not to say the work being done is not 
valuable, but merely that future work needs a slightly different trajectory. Issues of 
failure and/or replicability are the major upcoming hurdles for peripheral nerve 
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interfacing in general and for microchannel interfacing. Future work needs to incorporate, 
if not focus on, failure analyses. Mechanisms of failure are as important as success at this 
point because, in order to realize clinical translation, showing something is possible is not 
the same as showing something does not fail. Once these questions are asked researchers 
can target specific aspects of the failure and develop innovations that solve these issues.  
 This thesis is a perfect example of showing that microchannel interfacing is 
possible, however in the end failure was encountered due largely to issues with 
delamination. The delamination is an important finding as it directs future work. Silicone 
adhesives appear to be a path forward towards this end and could bring microchannel 
interfacing significantly closer to clinical translation. Additional, future chronic 
experiments with microchannel interfaces are also needed to elucidate failure 
mechanisms of the device, nerve or interaction between the two on a chronic timeframe. 
Along the same lines, experiments which do not evaluate failure mechanisms of devices 
are not as valuable at this stage of technology development. Examples include a number 
of acute studies where PDMS passivation was employed using the sacrificial post 
fabrication approach. As far as this author is aware, this is the first time a device using 
this approach has been implemented in vivo through implantation and failure was 
observed. This is likely because previous studies never evaluated these devices in a non-
acute scenario or evaluated potential failure mechanisms of the devices. 
 In some ways this seems to be a difference between science and engineering. The 
field of neural interfacing needs to progress to more of an engineering mindset where 
universally applied metrics and standards are used to evaluate research being conducted 
and results being published. An easy example is the vast number of papers using different 
equations to calculate SNR. Even worse are the numerous papers that don’t even report 
how they calculated SNR! In addition to a standardized method of reporting SNR, key 
characteristics of electrophysiology rigs should mandated by journals and reported to 
ensure researchers are using largely equivalent setups that would enable reproduction of 
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data as well as others to build off of published work. These characteristics should include 
baseline noise amplitude of the rig during recording sessions and a report of the 
frequency distribution of the noise. Furthermore, sampling, amplification, and filtering 
metrics should be standardized at least for all experiments recording single unit action 
potentials. It is well known that different filters will change the raw signal to different 
degrees making it difficult to easily compare results across experiments and researchers.  
 Standard design and implementation criteria for peripheral nerve interfaces should 
also be mandated and if not used or withheld, reasons should be enumerated. An example 
is the use of an implantable electrical shield as implemented with the Utah Slanted 
Electrode Array (USEA) [131] and also here through a stainless steel foil wrap. If the 
implantable electrical shield is not implemented there should be a good reason for not 
doing so which is published for others to view. Along these same lines outsourcing 
device fabrication and parts to industry should always be considered in the effort of 
standardization and reliability. This will help remove variability in handmade devices and 
aid in reproducibility across multiple research groups. An example is the outsourcing of 
the signal extraction wiring for the GT-RE to the Omnetics Connector Corp., which was 
enabled by the SMT integration technique developed in Aim 2. The electronics industry, 
and the Omnetics Connector Corp specifically, has spent years refining approaches for 
connecting and insulating small wires making them an ideal outsourcing option. 
Furthermore, industry has the metrics and standards previously mentioned already in 
place making their products reliable and more trustworthy.  
6.2.6 Strategy for Market Translation 
 Finally, it is worth mentioning that peripheral nerve interfacing as a solution to 
the loss of function with amputees and even clinical segments where nerve stimulation is 
an option, is likely not a viable business opportunity. Meaning, it is unlikely peripheral 
nerve interfacing will be profitable given the extreme costs associated with developing, 
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producing, and translating this technology and the incredibly small market size as 
enumerated in the Chapter 2. If peripheral nerve interfacing is to ever truly be market 
translatable, one would likely need to identify uses beyond recovery of function for 
disabled individuals.  
 In many ways the true greatness of a peripheral nerve interface, and neural 
interfacing in general, lies in the potential to interface with any electronic device. While 
helping amputees and disabled individuals is key, it will not make enough profit to 
sustain an industry sector. If however, the business goal is to enable interfacing with a 
host of electronics on the market today, the market segment for neural interfacing gets 
effectively multiplied by the number of new devices one could interface with. Any 
electronic consumer device that requires the input of a hand could be theoretically 
replaced with a peripheral nerve interface in the arm of an amputee or disabled 
individual. Instead of interfacing to a robotic arm and using a ‘mouse’ with a computer, 
the amputee could purchase an ‘app’ that enables them to bypass the robotic arm, and 
merely move the mouse by thinking. In fact this is done when training amputees to use 
advanced prosthetics today. However this could be a product that is sold. In the same way 
instead of a computer mouse, it could be a computer keyboard, a car, videogame 
controller or any number of other devices. In this way a business could potentially 
expand their effective market size, recoup the cost of the peripheral nerve interface and 
hopefully generate profit. This is of course making the optimistic assumption that the 
technology development of these ‘apps’ would not be a significant burden compared to 
the development of the neural interface itself.  
 In the end, a successful business strategy for neural interfacing would likely be far 
more intricate and may not even approach market translation with this same mindset. 
Nevertheless, this serves to initiate thoughts regarding market translation. While this 
aspect of technology development is not often focused on in an academic environment, it 
is a necessary component of making peripheral nerve interfacing a valuable technology to 
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mankind. Without it, the people originally intended to benefit from this technology will 









Figure A 1. Intan Technologies microchip PCB layout and components. 
(A) Custom PCB wiring layout with off-chip components detailed. (B) Custom PCB 
design where the top of the PCB is shown on the left and the bottom of the PCB is shown 
on the right. Actual images of the PCB are shown in the bottom row.  
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A.2. Supplemental Results  
 The following is additional work performed in Chapter 3 (Aim 1) specifically 
with regard to the study involving the regenerative microchannel interface that utilized 
permanently integrated microwire electrodes with the PDMS/SU-8 microchannel 
scaffolds.  
A.2.1. Nerve regeneration through the regenerative microchannel interfaces 
 Robust growth of axons and Schwann cells were observed through all 
microchannel interfaces after 5 months of implantation evidenced by 
immunohistochemical staining for NF160 and S100 markers, respectively (Figures A2(A) 
and (B)). Microwires running along the periphery of the microchannel scaffold can be 
seen in Figures A2(A) because the microwire insulation auto-fluoresces at the 594 nm 
wavelength used to visualize the axons. Within the microchannels, axons and Schwann 
cells were co-localized as expected and formed well consolidated mini-cords of 
regenerated tissue (microchannel fascicles). Additionally, these microchannel fascicles 
were surrounded by extracellular tissue similar to the fascicular organization of a normal 
nerve (Figures A2(C) and (D)). A number of channels could not be analyzed due to 
mechanical damage resulting in loss of microchannel integrity during the sectioning 
process. However, in all cases analyzed, microchannels containing electrodes also 
contained regenerated axons and Schwann cells. Furthermore, 88% of all microchannels 
in the device contained regenerated axons and Schwann cells. In general, the few 
microchannels that did not contain regenerated axons were positioned along the outer 
rings of the microchannel interface. 
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Figure A2. Regenerative Microchannel Interface Cross-Section. 
Stained for Axons (red) and Schwann Cells (green). (a) Axons; (b) Schwann cells; (c) 
Magnified overlay of axons and Schwann cells; (d) Further magnified overlay of axons 
and Schwann cells. 
 
A.2.2. SNR comparison between tripolar, bipolar and distant low impedance 
referencing paradigms 
A.2.2.1. Average SNR of single unit APs 
 A tripolar, bipolar, and distant low impedance reference were used in conjunction 
with spontaneous and sensory evoked single unit recordings taken using the regenerative 
microchannel interfaces. This allowed differences between the three referencing 
paradigms to be evaluated in an in-vivo setting using SNR as a measure of signal quality. 
Each SNR calculated for a unit represents a mean value of individual waveform 
amplitudes compared to the noise band taken during the recording time window. If one 
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referencing paradigm consistently yields higher SNRs than the other references, an 
average of the SNRs would also be higher. Accordingly, average SNRs obtained from 
selected units across tripolar, bipolar, and distant low impedance references were 
statistically compared. This is depicted graphically with standard error means in Figures 
A3. The tripolar, bipolar, and distant low impedance average SNRs were calculated to be 
1.56 ± 0.17, 1.55 ± 0.23, and 1.58 ± 0.19, respectively. There was no statistically 
significant difference between any of the three referencing paradigms using a Repeated 
Measures One-way ANOVA with the post hoc Tukey’s Multiple Comparison Test. 
 
Figure A3. Average SNR for tripolar, bipolar and distant low impedance 
referencing paradigms. 
Stained for Axons (red) and Schwann Cells (green). (a) Axons; (b) Schwann cells; (c) 
Magnified overlay of axons and Schwann cells; (d) Further magnified overlay of axons 
and Schwann cells. 
 
A.2.2.2. Average SNR variance of single unit APs 
 Another aspect of SNR that can be evaluated, in addition to the actual size, is the 
variability present within the SNR from each individual unit. This can have implications 
on spike sorting capabilities as greater variability means a less consistent action potential 
waveform. One way to evaluate this is to compare variances of the individual waveform 
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amplitudes used to calculate the SNRs across each referencing paradigm. If a specific 
reference is more reliable, the variance of individual waveform amplitudes within each 
unit will be smaller than that recorded using the other two references. This would also 
hold true for an average of waveform amplitude variances from all units within each 
referencing paradigm. Accordingly, average variances of waveform amplitudes from 
units recorded across the three referencing paradigms are depicted graphically in Figures 
A4. The tripolar, bipolar, and distant low impedance average waveform amplitude 
variances were 0.13, 0.18, and 0.32, respectively. There appears to be a trend where the 
average variance for the tripolar and bipolar reference are relatively similar, but lower 
than the distant low impedance variance. However, further statistics need to be performed 



























Figure A4. Average Variance of SNRs for tripolar, bipolar and distant low 
impedance referencing paradigms. 
Stained for Axons (red) and Schwann Cells (green). (a) Axons; (b) Schwann cells; (c) 
Magnified overlay of axons and Schwann cells; (d) Further magnified overlay of axons 
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